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SUMMARY 
 
The lateral spinal nucleus (LSN), located in the dorsolateral funiculus, is an area that has 
been poorly understood, but has been implicated in nociception.  To investigate the function 
of  this  nucleus,  three  broad  areas  were  investigated:  responses  to  nociceptive  stimuli, 
neurochemical relations to the NK-1 receptor, and projections from this nucleus to several 
brain centres, to try to gain a greater understanding of the functions of this nucleus.  The 
following conclusions can be drawn from the studies undertaken here: 
·  A series of double-labelling experiments for confocal microscopy were carried out in 
the rat (Sprague-Dawley) to investigate the LSN responses to a variety of peripheral 
cutaneous noxious stimuli.  It was found that the LSN responds to both thermal and 
chemical peripheral cutaneous noxious stimulation.  However, unlike as previously 
thought, only a small number of neurons in the LSN are activated by a peripheral 
noxious stimulus, with hot water (55°C applied to the hind-paw) activating the most, 
as revealed by Fos immunoreactivity.  Only 15% of LSN neurons showed response to 
this  peripheral  noxious  stimulus.    Interestingly,  unlike  the  superficial  dorsal  horn 
(SDH),  bilateral  activation  of  LSN  neurons  after  the  application  of  a  peripheral 
noxious stimulus was found in most of the experiments carried out. 
·  Triple and quadruple-labelling experiments for confocal microscopy were carried out 
in the rat to investigate neurochemical relations at this site. It was found that although 
the LSN is abundant in staining for substance P, the number of LSN neurons showing 
immunoreactivity for the target of substance P (the NK-1 receptor) represented only 
one-third of all neurons at this site.  However, substance P and nitric oxide synthase 
were associated with NK-1 neurons, and specifically nitric oxide synthase terminals 
were preferentially associated with NK-1 neuronal cell bodies.  However, unlike the  
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superficial  dorsal  horn,  nitric  oxide  synthase  terminals  were  not  associated  with 
inhibitory GABAergic neurons. 
·  Using  retrograde  injection  techniques  (in  the  rat)  combined  with  multiple 
immunolabelling for confocal microscopy, the LSN was shown to project to areas 
traditionally  associated  with  nociception  (caudal  ventrolateral  medulla  and 
mediodorsal thalamus) but also projected to the hypothalamus and also the lateral 
globus pallidus.  Indeed, the regions found to have the most projections from the LSN 
were  the  lateral  and  medial  hypothalamus,  with  most  of  those  neurons  (>80%) 
possessing  the  NK-1  receptor.    Interestingly,  although  numbers  of  retrogradely 
labelled  neurons  were  low,  they  represented  30%  of  all  labelled  neurons  that 
projected from the LSN to the lateral globus pallidus. 
In  conclusion,  the  extent  of  involvement  of  the  LSN  in  nociception  is  less  than 
previously thought, but with projections to the hypothalamus, it could be postulated that 
the LSN functions as an integrative nucleus for autonomic and homeostatic functions, 
and related motivational and affective responses to autonomic function. 
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LIST OF ABBREVIATIONS 
 
(Terms in italics are not defined in the text) 
 
 
AHA  Anterior hypothalamic area, anterior part 
AHC  Anterior hypothalamic area, central part 
AHP  Anterior hypothalamic area, posterior part 
AM  Anteromedial thalamic nucleus 
AMPA  alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AP  Anterior-posterior 
AVDM  Anteroventral thalamic nucleus, dorsomedial part 
AVVL  Anteroventral thalamic nucleus, ventrolateral part 
CaM  Calmodulin 
c-Fos  Cellular proto-oncogene from the immediate early gene transcription  
  factors 
cGMP  Cyclic guanosine monophosphate 
CGRP  Calcitonin gene related peptide 
ChAT  Choline acetyltransferase 
CM  Central medial thalamic nucleus 
CNS   Central nervous system 
Cpu  Caudate putamen (striatum) 
CTb  Cholera toxin B subunit 
Cu  Cuneate nucleus 
CVLM  Caudal ventrolateral medulla 
DAB  Diaminobenzidine 
DG  Dentate gyrus 
DMD  Dorsomedial hypothalamic nucleus, dorsal part 
DRt  Dorsal reticular nucleus 
DV  Dorsal-ventral 
ERK  Extracellular related kinase 
FG  Fluoro-Gold 
Fi  Flocculus 
FMRF  L-phenylalanyl-L-methionyl-L-arginyl-L-phenylalaninamide  
Fos  Nuclear phosphorylated protein 
GABA  Gamma-aminobutyric acid 
GAD  Glutamic acid decarboxylase 
Gly-T2  Glycine transporter 2 
GP  Globus pallidus 
Gr  Gracile nucleus 
Gr  Gracile fasciculus 
Hi  Hippocampus 
HRP  Horseradish peroxidase 
IAM  Interanteromedial thalamic nucleus 
ic  Internal capsule 
Ig  Immunoglobulin 
ip  Intraperitoneal 
LCN  Lateral cervical nucleus 
LGP  Lateral globus pallidus 
LH  Lateral hypothalamus  
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LHbL  Lateral habenular nucleus, lateral part 
LHbM  Lateral habenular nucleus, medial part 
L-NAME  N
ω-nitro-L-arginine methyl ester 
LPMR  Lateral posterior thalamic nucleus, mediorostral part 
LRt  Lateral reticular nucleus 
LSN  Lateral spinal nucleus 
LTP  Long term potentiation 
MD  Mediodorsal thalamic nucleus 
MDC  Mediodorsal thalamic nucleus, central part 
MdD  Medullary reticular nucleus, dorsal part 
MDL  Mediodorsal thalamic nucleus, lateral part 
MDM  Mediodorsal thalamic nucleus, medial part 
MDT  Mediodorsal thalamus 
MdV  Medullary reticular nucleus, ventral part 
Mfb  Medial forebrain bundle 
MH  Medial hypothalamus 
ml  Medial lemnisucs 
ML  Medial-lateral 
mlf  Medial longitudinal fasciculus 
MPC  Medial prefrontal cortex 
MRF  Medullary reticular formation 
NADPH-d  Nicotinamide adenine dinucleotide phosphate 
NeuN  Neuronal marker 
NK-1  Neurokinin-1 
NMDA  N-methyl-D-aspartic acid 
NO  Nitric oxide 
NOS  Nitric oxide synthase 
NPY  Neuropeptide Y 
NTS  Nucleus tractus solitarius 
Opt  Optic tract 
ox  Optic chiasm 
PAG  Periaqueductal grey 
PBS  Phosphate buffered saline 
PH  Posterior hypothalamic area 
PHA-L  Phaseolus vulgaris leucoagglutinin 
PKC-γ  Protein kinase C γ 
Po  Posterior thalamic nuclear group 
PRV  Pseudorabies virus 
PVP  Paraventricular thalamic nucleus, posterior part 
Py  Pyramidal tract 
Pyx  Pyramidal decussation 
RAmb  Retroambiguus nucleus 
RHO-D  Tetramethylrhodamine dextran 
Rt  Reticular thalamic nucleus 
RVM  Rostroventromedial thalamus 
SDH  Superficial dorsal horn 
SI  Substantia innominata 
SM  Nucleus of the stria medullaris 
Sm  Stria medullaris of the thalamus 
SP  Substance P  
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Sp5I  Spinal trigeminal nucleus, interpolar part 
SpV  Spinal trigeminal nucleus 
Sub  Submedius thalamic nucleus 
TC  Tuber cinereum area 
Th  Thalamus 
VA  Ventral anterior thalamic nucleus 
VDB  Nucleus of the vertical limb of the diagonal band 
VGLUT  Vesicular glutamate transporter 
VH  Ventral hypothalamus 
VIP  Vasoactive intestinal polypeptide 
VL  Ventrolateral thalamic nucleus 
VM  Ventromedial thalamic nucleus 
VMH  Ventromedial hypothalamic nucleus 
VMHA  Ventromedial hypothalamic nucleus, anterior part 
VMHC  Ventromedial hypothalamic nucleus, central part 
VMHVL  Ventromedial hypothalamic nucleus, ventrolateral part 
VP  Ventral pallidum 
VPL  Ventroposterolateral nucleus of the thalamus 
VPM  Ventral posteromedial thalamic nucleus 
VRt  Ventral reticular nucleus 
WGA  Wheat germ agglutinin 
XII  Hypoglossal nucleus 
ZI  Zona incerta 
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Pain is such a versatile sensation, and differs from other somatosensory modalities in 
that emotions such as fear, anxiety and feelings of unpleasantness are experienced along 
with it.  However, over the centuries, pain has not been as clearly defined as it is today.  
The Romans and the Greeks were the first to put forward an idea of sensation, with the 
thought that the brain and nervous system have a role in the perception of pain.  However, 
it  was  not  until  the  Middle  Ages  and  into  the  Rennaissance  (1400’s-1600’s)  that  the 
evidence  developed  to  support  these  earlier  theories.    Leonardo  Da  Vinci  and  his 
contemporaries came to believe that the brain was the central organ for sensation, with Da 
Vinci himself later developing the idea that the spinal cord was the route that sensations 
were transmitted to the brain. 
Into the 16
th and 17
th centuries, the study of the body and the senses continued to be a 
mystery and wonder for the world’s philosophers. Moving into the 19
th century, pain came 
to dwell under a new domain – science, with an increasing knowledge base.  Indeed today, 
pain research is an enormous, ever-growing field, with much interest in trying to unravel 
the complex neural circuitry of the brain and spinal cord.  With a greater understanding of 
these pathways, therapeutic options for acute and chronic pain conditions were developed, 
which is something that could only have been dreamt of several centuries ago.   
Nowadays, the spinal cord is established as essential for the transmission of sensory 
information  to  the  brain,  and  for  the  regulation  of  motor  and  autonomic  functions.    It 
receives sensory information from somatic and visceral receptors passing through dorsal 
roots,  transmitting  to  higher  regions  of  the  brain  through  ascending  tracts  and  sends 
information to somatic and visceral targets via the ventral roots. 
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1.  General layout of the spinal cord 
When the spinal cord is examined in transverse section, it is composed of a central grey 
matter  (butterfly-shaped)  comprising  cell  columns  oriented  along  the  rostro-caudal  axis 
(containing  neuronal  cell  bodies,  dendrites  and  axons  that  are  both  myelinated  and 
unmyelinated), surrounded by the white matter comprising the ascending and descending 
myelinated and unmyelinated fasciculi (tracts).  The general layout of the spinal cord is 
shown in Figure 1.1. 
In each half of the spinal cord there are three funiculi: the dorsal funiculus (between the 
dorsal horn and the dorsal median septum), the lateral funiculus (located where the dorsal 
roots enter and the ventral roots exit) and the ventral funiculus (found between the ventral 
median fissure and the exit point of the ventral roots). 
Based on detailed studies of neuronal soma size (revealed using the Nissl stain), Rexed 
(1952)  proposed  that  the  spinal  grey  matter  is  arranged  in  the  dorso-ventral  axis  into 
laminae and designated them into ten groupings of neurons identified as I – X. 
Lamina I contains the terminals of fine myelinated and unmyelinated dorsal root fibres 
that pass first through the zone of Lissauer (dorsolateral funiculus) and then enter lamina I 
mediating pain and temperature sensation (Christensen and Perl, 1970; Menétrey et al., 
1977; Craig and Kniffki, 1985; Bester et al., 2000).  The neurons here have been divided 
into  small  neurons  and  large  marginal  cells  characterised  by  wide-ranging  horizontal 
dendrites  (Willis  and  Coggeshall,  1991).  They  then  synapse  on  the  posteromarginal 
nucleus.  From here the axons of these cells pass to the opposite side and ascend as the 
lateral spinothalamic tract. 
Lamina  II  is  immediately  below  lamina  I,  referred  to  as  the  substantia  gelatinosa.  
Neurons here modulate the activity of pain and temperature afferent fibres, though intrinsic 
neurons here do not contain the target for substance P, the NK-1 receptor (Bleazard et al.,  
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1994), which is however found in lamina I, III and IV (Naim et al., 1997).  Lamina II has 
been sub-divided into an outer (dorsal) lamina II (IIO) and an inner (ventral) lamina II (IIi) 
based on the morphology of these layers with stalked cells found in larger numbers in 
lamina IIO but stalked and islet cells were found throughout lamina II (Todd and Lewis, 
1986).  Indeed, lamina IIi was also found to be different in its neurochemical profile with a 
greater  predominance  of  protein  kinase  C-γ  (PKC-γ),  an  important  enzyme  in  signal 
transduction, which will be discussed in greater detail in Chapter 4.  Lamina II is the region 
which  receives  an  extensive  unmyelinated  primary  afferent  input,  with  very  little  from 
large myelinated primary afferents (except for distal parts of hair follicle afferents in some 
animals; Willis and Coggeshall, 1991).  The axonal projections from here are wide and 
varied  with  some  neurons  projecting  from  the  spinal  cord  (projection  neurons),  some 
passing to different laminae and some with axons confined to a lamina in the region of the 
dendritic tree of that cell e.g. intralaminar interneurons, local interneurons and Golgi Type 
II cells (Todd, 1996). 
Lamina III is distinguished from lamina II in that it has slightly larger cells, but with a 
neuropil similar to that of lamina II.  The classical input to this lamina comes from hair 
follicles  and  other  types  of  coarse  primary  afferent  fibres  which  includes  Pacinian 
corpuscles and rapidly and slowly adapted fibres. 
Lamina IV is a relatively thick layer that extends across the dorsal horn.  Its medial 
border is the white matter of the dorsal column, and its lateral border is the ventral bend of 
laminae I – III.  The neurons in this layer are of various sizes ranging from small to large 
and the afferent input here is from collaterals and from large primary afferent fibres (Willis 
and Coggeshall, 1991).  Input also arises from the substantia gelatinosa (lamina II) and 
contributes to pain, temperature and crude touch via the spinothalamic tract (Siegel and 
Sapru, 2006).  
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Lamina V extends as a thick band across the narrowest part of the dorsal horn.  It 
occupies the zone often called the neck of the dorsal horn.  It has a well demarcated edge 
against the dorsal funiculus, but an indistinct lateral boundary against the white matter due 
to the many longitudinally oriented myelinated fibres coursing through this area.  The cell 
types are very homogeneous in this area, with some being slightly larger than in lamina IV 
(Willis and Coggeshall, 1991).  Again, like lamina  IV, primary afferent input into this 
region is from large primary afferent collaterals as well as receiving descending fibres from 
the corticospinal and rubrospinal tracts with axons also contributing to the spinothalamic 
tracts (Siegel and Sapru, 2006).  In addition, in the thoracolumbar segments (T1 – L2/3) the 
reticulated division of lamina V contains projections to sympathetic preganglionic neurons 
(Cabot et al., 1994). 
Lamina VI is present only in the cervical and lumbar segments.  Its medial segment 
receives  joint  and  muscle  spindle  afferents,  with  the  lateral  segment  receiving  the 
rubrospinal and corticospinal pathways.  The neurons here are involved in the integration 
of somatic motor processes. 
Lamina  VII  present  in  the  intermediate  region  of  the  spinal  grey  matter  contains 
Clarke’s  nucleus  extending  from  C8  –  L2.    This  nucleus  receives  tendon  and  muscle 
afferents  with  the  axons  of  Clarke’s  nucleus  forming  the  dorsal  spinocerebellar  tract 
relaying information to the ipsilateral cerebellum (Snyder et al., 1978).  Also within lamina 
VII  are  the  sympathetic  preganglionic  neurons  constituting  the  intermediolateral  cell 
column in the thoracolumbar (T1 – L2/3) and the parasympathetic neurons located in the 
lateral aspect of the sacral cord (S2 – 4).  In addition Renshaw cells are located in lamina 
VII and are inhibitory interneurons which synapse on the alpha motor neurons and receive 
excitatory collaterals from the same neurons (Renshaw, 1946; Siegel and Sapru, 2006).  
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Lamina VIII and IX are found in the ventral grey matter of the spinal cord.  Neurons 
here receive descending motor tracts from the cerebral cortex and the brainstem and has 
both alpha and gamma motor neurons here which innervate skeletal muscles (Afifi and 
Bergman, 2005).  Somatotopic organisation is present where those neurons innervating the 
extensor muscles are ventral to those innervating the flexors, and neurons innervating the 
axial musculature are medial to those innervating muscles in the distal extremities (Siegel 
and Sapru, 2006). 
Lamina X is the grey matter surrounding the central canal and represents an important 
region  for  the  convergence  of  somatic  and  visceral  primary  afferent  input  conveying 
nociceptive and mechanoreceptive information (Nahin et al., 1983; Honda, 1985; Honda 
and Lee, 1985; Honda and Perl, 1985).  In addition lamina X in the lumbar region also 
contains preganglionic autonomic neurons as well as an important spinothalamic pathway 
(Ju et al., 1987a,b; Nicholas et al., 1999). 
Extensive literature exists in this complex circuitry, with a great deal of research on the 
spinal cord focussing on the grey matter.  Although much progress in understanding has 
developed since Rexed’s (1952) first classification of the grey matter into laminae from his 
classical  works  using  the  cat,  an  area  that  has  received  little  attention,  and  is  poorly 
understood, is the lateral spinal nucleus (LSN) located in the dorsolateral funiculus. 
From this point on the aim of this introductory chapter is to review the limited literature 
available regarding the LSN.  The review has been subdivided into sections examining the 
existing evidence which ascribes potential roles to this unusual nucleus.  The framework is 
set out as follows: 
·  Definition of the LSN 
·  Morphology of cells in the LSN 
·  Neurochemical profile of the LSN   
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·  Mechanisms of activation, and projections of, the LSN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
21 
 
 
 
 
2.  The definition of the LSN 
In 1951, Rexed and Brodal described a separate nucleus forming a longitudinal cell 
column situated ventrolateral to the dorsal horn in the lateral funiculus of the first and 
second  cervical  segments  of  the  cat’s  spinal  cord.    It  was  believed  that  this  nucleus 
projected to the cerebellum and that it received afferent fibres ascending in the spinal cord.  
This  nucleus  was  referred  to  as  the  nucleus  cervicalis  lateralis,  or  the  lateral  cervical 
nucleus (LCN).  However, in 1951, Rexed also found that in the rat, guinea pig, mouse, 
rabbit and man, the lateral cervical nucleus was either non-existent, or existed in a form 
different from that described in the cat (though no details of these findings were presented).  
Lund  and  Webster  (1967),  however,  reported  the  presence  of  cells  in  the  dorsolateral 
funiculus  of  the  upper  two  cervical  segments  of  the  spinal  cord  of  the  rat  and  they 
considered this group of cells to represent the LCN as described in other species.  Their 
findings therefore contradicted those of Rexed (1951).   
However,  through  observing  the  distribution  of  acetylcholinesterase  activity  in  the 
spinal cord of the rat, Gwyn and Waldron (1968) demonstrated a group of cells present in 
the  dorsolateral  funiculus  extending  in  a  continuous  column  from  the  spinomedullary 
junction to sacral levels of the spinal cord.  They occupied a position ventral to the dorsal 
horn, similar to that described for the LCN in the cat by Rexed and Brodal (1951) and by 
Brodal and Rexed (1953), but, whereas in the cat, the nucleus is restricted to the upper two 
cervical segments of the spinal cord, in the rat, the column extends throughout the length of 
the spinal cord, defined then as the lateral spinal nucleus (LSN).  Figure 1.1 demonstrates 
the position of the LSN in the spinal cord.   Later evidence revealed however, that the 
enzyme acetylcholinesterase was not a specific marker for cholinergic cells (Albanese and 
Butcher,  1980;  Greenfield,  1991),  but  it  was  noted  that  the  LSN  differed  from  the 
superficial dorsal horn in the nature of the neuropil.  
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3.  The morphology of the LSN and its neurons 
The neurons in the LSN have been shown to have a multipolar appearance through 
Golgi studies (Réthelyi, 2003), which have confirmed earlier descriptions by Alvarez et al. 
(2000) who used metabotropic glutamate receptor immunostaining.  Jiang et al. (1999), 
through single cell staining following intracellular recordings, also demonstrated multipolar 
cells.  Fusiform cell bodies have been noted in the LSN (Giesler et al., 1979; Giesler and 
Elde, 1985).  Spindle-shaped cells have also been identified at all segmental levels (Gwyn 
and Waldron, 1968), though in Réthelyi’s (2003) Golgi study, they occurred only rarely. 
The cells in the LSN are small (compared with anterior horn cells), ranging from 8 to 
36 m by 4 to 12 m (Gwyn  and Waldron, 1968).  Réthelyi (2003) noted similar sized 
perikarya with his study showing cells in the range of 20 to 35 m.  This compares to the 
medium to large cells of the cat LCN, where they were shown to be 20 to 50 m. (Rexed, 
1951; Morin and Catalano, 1955). 
 The  LSN  neurons  form  a  continuous  column  underneath  the  pial  surface  of  the 
dorsolateral funiculus.  Some of the dendrites remain within the column of the perikarya, 
while others have been identified passing either laterally or medially (Réthelyi, 2003).  Of 
those medially oriented LSN neurons, Menétrey et al. (1982) demonstrated that they passed 
into lamina I, whereas Bresnahan et al. (1984) found occasional dendrites almost apposing 
the  pial  surface.    However,  Réthelyi’s  (2003)  electron  micrographs  revealed  that  the 
dendrites also pass to the pial surface.  This brings into question the possibility that the 
LSN  neurons  may  be  under  the  influence  of  components  of  the  cerebrospinal  fluid 
surrounding the spinal cord (Vigh et al., 2004). 
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4.  Neurochemical profile of the LSN and its involvement in nociception 
As previously mentioned, Gwyn and Waldron (1968, 1969) were the first to investigate 
the profile of the LSN using acetylcholinesterase, but this was subsequently shown not to 
be a specific marker for cholinergic cells (Albanese and Butcher, 1980; Greenfield, 1991).  
Leah and co-workers (1988) were the first group to investigate, in detail, the neurochemical 
profile  of  the  LSN  from  examining  ascending  tract  cells  in  the  rat  lumbosacral  region 
containing neuropeptides.  They revealed that 90% of peptidergic ascending tract cells were 
congregated in two distinct areas – the LSN and the region surrounding the central canal.  
The  LSN  had  the  highest  percentage  of  neuropeptides  containing  ascending  tract  cells 
which  included  vasoactive  intestinal  polypeptide  (VIP),  bombesin,  dynorphin  and 
substance  P  (SP),  with  their  axons  projecting  in  a  variety  of  tracts  including  the 
spinomesencephalic, spinoreticular and spinosolitary tracts.   
 
4.1  Excitatory Interneurons in the LSN 
4.1.1  Substance P in the LSN 
Ljungdahl et al. (1978) first reported that large numbers of fibres in the LSN were 
richly stained for SP with others confirming this (Gibson et al., 1981; Dalsgaard et al. 
1982; Senba, 1982).  However, in the first examination of the origins of SP containing 
fibres within the LSN, Barber et al. (1979) reported that transection of lumbar dorsal roots 
markedly reduced the number of labelled fibres in the nucleus ipsilaterally.  They also 
noted that, since combined hemisection of the cord and dorsal rhizotomy failed to eliminate 
SP labelling in the LSN, it was likely that some of the labelled fibres within the LSN 
originated segmentally.  In further studies, however, the possibility of an input from SP 
containing dorsal root fibres to the LSN has been questioned.  Larabi et al. (1983) re-
examined the effects of dorsal rhizotomy on fibres in the LSN and concluded that, although  
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such operations markedly reduced the number of labelled fibres in the adjacent dorsal horn, 
little if any reduction was produced in the LSN unless the radicular arteries were obstructed 
or cut during rhizotomies.  Bresnahan et al. (1984) and Cliffer et al. (1988) also showed 
that rhizotomies have little, if any, effect on SP immunostained fibres in the LSN.   In 
addition, Bresnahan et al. (1984) found that application of horseradish peroxidase (HRP) to 
the proximal stumps of cut dorsal roots labelled very few primary afferent terminals in the 
LSN (the adjacent dorsal horn contained a large number of labelled fibres).  The failure to 
label more than a  few  fibres in the  LSN  following application of HRP to dorsal roots 
strongly suggests that the majority of SP stained fibres within the LSN are not central 
processes of primary afferent fibres.  This finding also indicated that very few of the fibres 
within the LSN (whether they contain a peptide or not) originate in dorsal root ganglia.  
Bresnahan et al. (1984) did find HRP labelling of terminals in the LSN when HRP was 
injected into the dorsal horn, a finding that suggests the existence of a projection from 
neurons in the adjacent dorsal horn to the LSN.  In other studies where colchicine was 
injected intrathecally to increase the peptidergic labelling of cell bodies (Seybold and Elde, 
1980; Sasek et al., 1984), many dorsal horn neurons (Ljungdahl et al., 1978; Barber et al., 
1979;  Bresnahan  et  al.,  1984)  and  the  majority  of  LSN  cell  bodies  were  found  to  be 
immunoreactive  for  SP.    In  addition,  unlike  the  superficial  dorsal  horn  where  all  SP 
containing primary afferents are thought to contain calcitonin gene-related peptide (CGRP), 
the marker associated with large myelinated primary afferents (Chung et al., 1988; Naim et 
al., 1997; Todd et al., 2003), the LSN does not contain any CGRP (Olave and Maxwell, 
2004).  It therefore appears that the primary sources of SP stained fibres in the LSN is the 
adjacent dorsal horn, and perhaps, the LSN itself.   
As  SP  exerts  its  biological  actions  by  a  high  affinity  interaction  with  the  SP,  or 
neurokinin–1 (NK-1) receptor, it could be postulated that the LSN may be involved in  
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nociception, as the majority of lamina I neurons with the NK-1 receptor are thought to be 
activated by nociceptors, as most show internalisation of the receptor (Mantyh et al., 1995) 
or express c-Fos (Doyle and Hunt, 1999; Todd et al., 2005). 
 
4.1.2  Glutamate in the LSN 
Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) 
with synaptic terminals of spinal sensory afferents strongly immunoreactive for glutamate, 
indicating a glutamatergic function (De Biasi and Rustioni, 1988, 1990; Broman et al., 
1993; Valtschanoff et al., 1994).  This conclusion is confirmed by extensive physiological 
evidence of AMPA- and NMDA- mediated synaptic responses in spinal neurons evoked by 
dorsal root afferent stimulation (Salt and Hill, 1983; Jessel et al., 1986; Schneider and Perl, 
1994;  Li  et  al.,  1998)  and  the  presence  of  AMPA  and  NMDA  receptor  subunits 
postsynaptic  to  spinal  sensory  synapses  (Alvarez  et  al.,  1994;  Popratiloff  et  al.,  1996, 
1998a,b). 
Recently,  three  glutamate  vesicular  transporters  (VGLUTs)  have  been  characterised 
(reviewed by Fremeau et al., 2004) and have been shown to be present in axons belonging 
to largely non-overlapping populations of glutamatergic neurons throughout the CNS (Ni et 
al., 1995; Bellocchio et al., 1998, 2000; Aihara et al., 2000; Takamori et al., 2000; Fremeau 
et al., 2001; Sakata-Haga et al., 2001; Kaneko et al., 2002).  Varoqui et al. (2002) reported 
initially  that  VGLUT1  and  VGLUT2  were  present  in  the  spinal  cord,  but  in  differing 
locations: VGLUT2 throughout the grey matter, with VGLUT1 found in laminae III – VI, 
the intermediate grey matter and the ventral horn.  In addition, Todd et al. (2003) showed 
that myelinated primary afferents in lamina I were VGLTU2 immunoreactive whereas all 
those in deeper lamina were VGLTU1 immunoreactive, with some in laminae III – VI 
appearing to contain both transporters.  VGLUT3 on the other hand has been demonstrated  
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in the cortex and hippocampus (reviewed by Fremeau et al., 2004) where scattered cells 
showed VGLUT3 mRNA and protein were identified (Schafer et al., 2002; Fremeau et al., 
2002),  however  these  also  co-localised  with  glutamic  acid  decarboxylase  (GAD),  the 
enzyme  responsible  for  synthesising  GABA  (Fremeau  et  al.,  2002)  where  symmetric 
synapses  onto  the  cell  bodies  and  proximal  dendritic  shafts  of  pyramidal  cells  by 
immunoelectron microscopy, raised the possibility of glutamate co-release with GABA at 
inhibitory synapses. In addition, Gras et al. (2002) also demonstrated that the VGLUT3 
was also found in all cholinergic interneurons of the striatum, as well as in serotoninergic 
neurons from the raphe magnus. 
Alvarez et al. (2004) demonstrated only minimal labeling of VGLUT1 within the LSN, 
with others unable to detect VGLUT1 at all (Li et al., 2003; Todd et al., 2003; Olave and 
Maxwell,  2004).    However,  VGLUT2  has  been  shown  in  abundance  in  the  LSN  as 
demonstrated by Li et al., 2003; Todd et al., 2003 and Alvarez et al., 2004.  In addition, 
Olave and Maxwell (2004) also found VGLUT2 labeling to be abundant and co-localised 
with the adrenergic receptor α2c.  As VGLUT2 has been found in the superficial dorsal 
horn, especially within lamina I (an area established in its role in nociception), is found in 
peptidergic  axons  likely  to  be  derived  from  intrinsic  neurons  containing  neurotensin, 
enkephalin, somatostatin and SP (suggesting that these are also glutamatergic (Todd et al., 
2003))  and  has  been  established  in  its  role  in  nociception  (Moechars  et  al.,  2006),  the 
VGLUT2 within the LSN may serve a role in nociceptive processing.  However, unlike the 
superficial dorsal horn which receives direct primary afferent input, the LSN does not, and 
it may be that the VGLUT2 serves a very different role in nociception at this site. 
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4.2  Inhibitory interneurons in the LSN 
4.2.1  GABA and glycine in the LSN 
GABA is the major inhibitory neurotransmitter in the dorsal horn of the spinal cord and 
also plays a role in the ventral horn (Todd and Maxwell, 2000).  GABA is synthesised by 
glutamic acid decarboxylase (GAD) which exists in two isoforms with slightly different 
molecular weights referred to as GAD65 and GAD67 (Martin and Tobin, 2000), coded by 
different genes (Erlander and Tobin, 1991). 
GABA  can  produce  presynaptic  inhibition  of  primary  afferents  through  axoaxonic 
synapses, and inhibition postsynaptically of spinal neurons, mediated through axosomatic 
and axodendritic synapses.  Indeed, the inhibitory role of GABA can be seen when the 
GABAA receptor antagonist bicuculline (or the glycine receptor antagonist strychnine) is 
locally applied to the spinal cord in the rat where it produces behavioural signs of tactile 
allodynia (Yaksh, 1989), and can cause low threshold mechanical stimuli to produce a 
flexion withdrawal reflex (Sivilotti and Woolf, 1994). 
Specifically, in the superficial dorsal horn (SDH), where nociceptive information is first 
processed, approximately 30% of neurons in lamina I and II, and 45% of lamina III neurons 
are GABA immunoreactive (Todd and Sullivan, 1990), and these cells are assumed to be 
GABAergic inhibitory neurons.  Glycine like immunoreactivity is also present in neuronal 
cell bodies in these laminae, but is limited to those that are GABA immunoreactive.  Of 
those neurons in laminae I and II, 33% and 43% respectively contain GABA and glycine.  
However, as much as 64% of neurons contain both GABA and glycine in lamina III (Todd 
and Sullivan, 1990). 
GABA is produced through decarboxylation of L-glutamate by the enzyme GAD.  Two 
isoforms of this GAD exist, coded by different genes (Erlander and Tobin, 1991) and have 
been classified as GAD65 and GAD67 based on their molecular weights.  Within the LSN,  
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although not formally discussed, it can be seen from the photomicrographs, that the LSN 
shows mild to moderate staining with GAD (McLaughlin et al., 1975).  In addition, Mackie 
et  al.  (2003)  also  have  shown  both  GAD65  and  GAD67  exists  within  the  LSN,  with 
moderate staining.  Olave and Maxwell (2004), through studies with the α2c adrenergic 
receptor,  also  demonstrated  moderate  to  abundant  GAD  staining,  and  of  those 
approximately  10%  co-localised  with  the  α2c  adrenergic  receptor,  however  most  of  the 
adrenergic receptors co-localised with VGLUT2.  
Within the SDH, GABA immunoreactive  axon terminals and cell bodies frequently 
contain relatively high levels of glycine (Todd and Sullivan, 1990; Todd et al., 1996), and 
there is evidence that GABA and glycine can act as co-transmitters at synapses in the spinal 
cord (Jonas et al., 1998; Keller et al., 2001).  However, in the LSN there is only minimal 
staining with Gly-T2 (Olave and Maxwell, 2004), a marker for glycine (Zafra et al., 1995), 
and it may be that with such low levels, the GABA in the LSN may not be related to 
glycine at all, unlike the situation in the SDH.  
 
4.2.2  GABA and NOS in the LSN 
Previously it had been reported that neuronal nitric oxide synthase (nNOS) and the 
enzyme  responsible  for  its  synthesis  –  nicotinamide  adenine  dinucleotide  phosphate 
(NADPH-d) – are located in the superficial dorsal horn, the area around the central canal 
(Dun et al., 1992; Valtschanoff et al., 1992a), the intermediolateral nucleus and the LSN 
(Valtschanoff  et  al.,  1992a;  Nazli  and  Morris,  2000).    Nadelhaft  and  Booth  (1984) 
demonstrated that most nNOS immunoreactive fibres terminating in the dorsal horn arose 
from dorsal  root  ganglion (DRG) neurons.   Later, Aimi et al.  (1991)  revealed that the 
number of NOS positive immunoreactive DRG cells over all spinal segments may not be as 
large as first anticipated, suggesting an intrinsic origin of the NOS would be more likely.   
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Laing  et  al.  (1994)  completed  an  extensive  investigation  characterising  the  NOS 
immunoreactive  neurons  showing  them  to  be  most  numerous  in  lamina  II  –  III.  
Valtschanoff  et  al.  (1992b)  demonstrated  that  of  those  NOS  immunoreactive  axonal 
boutons in lamina II, many possessed GABA immunoreactivity, suggesting an inhibitory 
role.  This was confirmed by Laing et al. (1994) who showed glycinergic immunoreactivity 
in NOS neurons in lamina I – II.  However, NOS immunoreactive neurons in lamina III 
were not found to co-localise with glycine.  In addition, Spike et al. (1993) revealed that 
choline acetyltransferase (ChAT) immunoreactive neurons in lamina III were found to be 
NADPH-d positive, suggesting that those neurons in this lamina which contain GABA and 
acetylcholine, are also capable of synthesising NO.  Blottner and Baumgarten (1992) also 
revealed that of all NOS immunostained neurons in the intermediolateral column, nearly 
half co-localised with ChAT.  However, unlike the large NO interneurons of the monkey 
cerebral cortex that express neuropeptide Y (NPY) immunoreactivity, none of the lamina I 
– III NOS immunoreactive neurons expressed NPY. 
The exact function of NOS is still under great debate.  Behavioural (Malmberg and 
Yaksh, 1993) and pharmacological studies (Kawabata et al., 1994; Semos and Headley, 
1994; Lin et al., 1999) have indicated that NO is a modulator of nociceptive processes, but 
there is no agreement on its precise role and it may have both hyperalgesic and analgesic 
effects (Hoheisel et al., 2005).  As NOS is found in the LSN (Valtschanoff et al., 1992a; 
Nazli and Morris, 2000), it may well be associated with GABA as it is in the SDH, but may 
not be related to glycine, due to the low levels of Gly-T2 (Olave and Maxwell, 2004).  In 
addition,  NOS  in  the  LSN  has  also  been  found  to  co-localise  with  interferon-γ  and 
synaptophysin  (Vikman  et  al.,  1998)  and  using  Nitro-L-arginine-ester  (L-NAME),  a 
blocker of NOS, can at least partially inhibit the nociceptive response to interferon-γ in rats  
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(Xu et al., 1994).  Therefore, the role of NOS in the LSN may serve a role in nociception, 
although may be very different to what is understood regarding the SDH. 
 
5.  Mechanisms of activation, and projections of, the lateral spinal nucleus 
Ling  et  al.  (2003)  suggested  that  the  LSN  could  be  directly  innervated  by  primary 
afferents.  Using electrophysiological techniques, they identified the C afferent fibres from 
the  gastrocnemius  muscle  and  performed  iontophoretic  injections  of  Phaseolus  vulgaris 
leucoagglutinin (PHA-L).  This showed that the unmyelinated muscle primary afferents 
projected rostrocaudally in the dorsolateral funiculus with projections both in a medial and 
lateral direction (from observation of their diagrammatic representations) and also passed 
into lamina I and II, with smaller numbers projecting to lamina III.  However, most of the 
research into the activation of the LSN suggests that in fact it is not directly influenced by 
cutaneous stimulation, but actually from collateral activation. 
Through electrophysiological studies, Grudt and Perl (2002) demonstrated that some 
lamina  I  neurons  were  relatively  large  with  extensive  dendritic  arborisation  in  the 
horizontal dimension and possessed a prominent thick axon.  These axons were noted to 
pass ventrally and course to the contralateral side to project in the ventral lateral funiculus.  
This raises the distinct possibility that this type of lamina I neuron is activated directly by a 
primary afferent responding to peripheral noxious stimulation, and, from there, activates 
the LSN neuron through an axon collateral (Han et al., 1998; Craig et al., 2001; Grudt and 
Perl,  2002;  Todd  et  al.,  2002;  Olave  and  Maxwell,  2004).    This  strengthens  previous 
electrophysiological  studies  demonstrating  collateral  activation  of  the  LSN,  rather  than 
direct  primary  afferent  input  (Giesler  et  al.,  1979;  Menétrey  et  al.,  1980).    Indeed,  as 
previously mentioned, the source of SP in the LSN is thought to be either from the adjacent 
SDH, or the LSN itself (Barber et al., 1979; Larabi et al., 1983; Bresnahan et al., 1984;  
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Cliffer et al., 1988).  As the LSN is stimulated by spinal interneurons with a rich content of 
SP,  VGLUT2,  enkephalin,  dynorphin,  somatostatin,  vasoactive  intestinal  polypeptide, 
bombesin and FMRF (Jessel et al., 1978; Seybold and Elde, 1980; Giesler and Elde, 1985; 
Cliffer et al., 1988; Olave and Maxwell, 2004), this adds further weight to the suggestion 
that the LSN is not directly activated by primary afferent fibres. 
However, Neuhuber (1982) and Neuhuber et al. (1986) demonstrated that some afferent 
fibres from the greater splanchnic nerve, the inferior mesenteric plexus, and the hypogastric 
nerve also terminate in the LSN.  This would suggest that the LSN could receive a visceral 
input,  which  will  be  discussed  later.  Therefore,  there  may  be  more  primary  afferents 
terminating  in  the  white  matter  either  directly,  or  close  to,  the  LSN  than  was  first 
appreciated. 
Additionally, neurons in the LSN are not directly activated by cutaneous stimulation, 
have no spontaneous activity and possess axons with slow conduction velocities (i.e. the 
unmyelinated  range)  and  can  project  contralaterally  (46%),  and  bilaterally  (40%) 
(Menétrey and Besson, 1981).   
Petkó  and  Antal  (2000)  used  anterograde  and  retrograde  labelling  techniques  and 
showed that neurons in the lateral part of one superficial dorsal horn could project to the 
contralateral superficial part of the dorsal horn, with the possibility of involvement of the 
LSN.  This could suggest that one LSN, could be activated by both the ipsilateral and 
contralateral lateral dorsal horn (with commissural fibres going between one LSN and the 
opposite).    Also,  from  their  diagrams,  the  LSN  neurons  themselves  may  project 
contralaterally and could be activated reciprocally.  This could also explain the work by 
Olave and Maxwell (2004) that showed bilateral activation of c-Fos in the  LSN.  The 
knowledge  at  the  moment  of  the  mechanisms  underlying  bilateral  activation  of  LSN 
neurons is limited.  
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LSN  neurons  may  also  be  activated  by  descending  fibres  that  originate  from 
supraspinal nuclei, which in turn are activated  by  ascending  fibres of  spinal projection 
neurons located in the superficial dorsal horn.  Suzuki et al. (2002) showed that superficial 
dorsal horn neurons which express the NK-1 receptor activate descending pathways which 
control spinal excitability.  This could also explain the c-Fos activation bilaterally in Olave 
and Maxwell’s study (2004) as there could be ascending activation of descending systems 
which project bilaterally to the LSN. 
Pechura  and  Liu  (1986)  used  retrograde  fluorescent  double  labelling  of  the 
periaqueductal grey (PAG) and the medullary reticular formation (MRF) which showed 
that double labelled neurons in the LSN were present.  As the PAG and the MRF are 
strongly implicated in descending modulation of spinal neuronal activity, especially that 
resulting from noxious stimulation (Basbaum and Fields, 1984), this could imply that the 
LSN has a role in nociceptive pathways. 
Initially, retrograde labelling studies showed that LSN neurons do not project to the 
thalamus (Giesler et al., 1979; Kevetter and Willis, 1982).  However, Gauriau and Bernard 
(2004) used anterograde labelling (in the rat) with the sensitive markers PHA-L and/or 
tetramethylrhodamine-dextran (RHO-D) injected microiontophoretically.  They found that 
when the LSN was labelled, it was very specific in its bilateral projection to the lateral and 
medial portions of the caudal region of the mediodorsal thalamic nuclei, as well as to the 
posterior thalamic group (triangular part).  There was some spread into the most lateral 
portion  of  the  laminae  I-III  but  retrograde  studies  that  have  been  performed  prior  to 
Gauriau and Bernard (2004) indicate that, in the cervical enlargement of the rat, the lateral 
portion of laminae I-III projects scarcely, or not at all to the thalamus, whereas numerous 
LSN neurons project to the thalamus (Granum, 1986; Burstein et al., 1990b).  This pathway 
from  the  LSN,  to  the  thalamus,  and  from  there  to  the  forebrain,  forms  part  of  the  
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somatosensory relays.  This could form a direct and specific role in the emotional affective 
component of pain (Gauriau and Bernard, 2004).  This is significant in that the mediodorsal 
thalamic nuclei project to the medial and orbital regions of the prefrontal cortex and the 
LSN-mediodorsal pathway could be implicated in the emotional and cognitive aspects of 
pain (Gauriau and Bernard, 2004). 
Using  the  retrograde  tracer  Fluoro-Gold  (FG),  Burstein  et  al.  (1990a)  demonstrated 
extensive projections of the LSN to the hypothalamus.  It was shown that up to 25% of the 
input to the hypothalamus came from the LSN, throughout the full length of the rat spinal 
cord.  Work by Li et al. (1997) also confirmed projections of the LSN to the hypothalamus. 
Retrograde labelling studies and SP immunoreactivity also showed that the LSN has 
extensive projections to the hypothalamus, as well as to the septal region (Li et al., 1997).  
The hypothalamic projection sites included, not only the lateral hypothalamus but also to 
the  paraventricular  hypothalamic  nucleus  and  the  posterior  hypothalamic  area.    The 
paraventricular nucleus is composed of magnocellular neurosecretory neurons constituting 
the paraventriculohypothalamic system and non-endocrine neurons, some of which send 
projection fibres to the pain-related brainstem structures including the PAG, raphe nuclei, 
and  parabrachial  nuclei,  with  the  posterior  hypothalamic  area  being  involved  in  the 
generation of emotional stress and the regulation of body temperature (Armstrong, 1995; 
Saper, 1995).  In addition two neuroendocrine systems are activated in the animal when 
coping  with  stressors:  the  hypothalamopituitary-adrenocortical  system,  in  which  the 
paraventricular  hypothalamic  nucleus  is  involved,  and  the  hypothalamosympathico-
adrenomedullary system in which the posterior hypothalamic area seems to be involved. 
(Agnati  et  al.,  1991;  Armstrong,  1995)    Thus,  from  the  study  by  Li  et  al.  (1997),  the 
projection fibres from the spinal cord that have SP immunoreactivity that project to the 
paraventricular  hypothalamic  nucleus  and/or  the  hypothalamic  area  are  likely  to  be  
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implicated in the elicitation of stress response.  In particular, projection fibres from the 
LSN of the lower lumbar and sacral cord segments may mediate nociceptive information of 
visceral origin to the paraventricular hypothalamic nucleus and exert regulatory influences 
on the endocrine and autonomic systems through the paraventriculohypophyseal system.  
However affective motivational responses to peripheral stimulation is served by the septal 
area.  The limbic system including the septal region is necessarily involved in nociception 
because  it  is  strongly  coupled  with  emotional  and  affective  states.    Thus  the  direct 
projections  from  the  LSN,  and  deep  part  of  the  dorsal  horn  to  the  septal  region,  are 
presumed to be involved in motivational-affective aspects of nociception (Li et al., 1997). 
Also, transneuronal studies have been done using pseudorabies virus (PRV) injected 
into the kidney (Schramm et al., 1993) and stellate ganglion (Jansen et al., 1995) have 
shown  that  the  LSN  innervates  different  types  of  sympathetic  preganglionic  neurons.  
Jansen  and  Loewy  (1997)  have  also  shown  that  neurons  in  the  LSN  become 
transneuronally labelled after PRV injections into the superior cervical ganglion, stellate 
ganglion, celiac ganglion or adrenal gland.  Also, they showed direct projection of the LSN 
to sympathetic preganglionic neurons using PHA-L.  These results suggest that the LSN 
has a descending sympathetic projection system, and may trigger a sympathetic response 
(eg. increase in blood pressure, release of catecholamines) during intense, acute visceral 
pain.  So, as well as being influenced by visceral nociceptive information, the LSN may 
have a feedback to the sympathetic system in response to this. 
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Figure 1.1.  Position of the LSN in the spinal cord.  A single transverse section of L5 with 
immunofluorescence for the neuronal marker NeuN (red) to highlight the neuronal population 
predominantly in the grey matter on the left hand side of this Figure, with a diagrammatic 
representation of. Rexed’s laminae (1952) being highlighted to the right hand side (as indicated 
by Roman numerals for each of the laminae).  The position of the LSN can be seen in the 
dorsolateral funiculus, close to the superficial dorsal horn.  Scale bar = 500 m. 
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Chapter 2 
 
 
Aims and General Experimental Procedures 
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1.  Aims 
The purpose of this first section is to  give a  general account of the principal aims 
pursued,  hypotheses  to  be  tested  and  for  each  of  the  investigations,  an  outline  of  the 
experimental approaches.  The specific details of each of these procedures will be detailed, 
as appropriate, in the experimental sub-division in each chapter. 
There are three main areas of focus of this study that will give a greater understanding 
of the nucleus of the dorsolateral funiculus, the LSN: 
· Nociception and the LSN 
· NK-1 and excitatory and inhibitory terminals in the LSN 
· NK-1 projection targets of LSN neurons to brain centres, including the brainstem 
 
Investigation 1 
Hypotheses:   
a)  LSN neurons receive cutaneous information 
b)  LSN neurons are activated by noxious cutaneous stimulation  
c)  There is a variable degree of expression of Fos depending on the stimulus, as in the 
superficial dorsal horn (SDH) 
Aims: 
a)  Identify if LSN neurons receive information from the skin 
b)  Identify the types of stimuli that activate LSN neurons 
c)  Quantify  the  extent  of  LSN  neurons  that  respond  to  different  types  of  peripheral 
noxious stimuli 
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Expression of the immediate early  gene  c-Fos  was induced by the application of a 
noxious  thermal  or  chemical  stimulus  to  the  left  hind-paw.    This  method  was  used  to 
identify LSN neurons that could be activated by different types of nociceptive stimuli, and 
allowed direct comparison with the SDH. Combining this approach with double labelling 
immunocytochemistry  (with  the  neuronal  marker  NeuN)  allowed  quantification  of  the 
neuronal populations in the LSN, both ipsilateral and contralateral to the stimulus.  It also 
allowed direct comparison between different stimuli that may have influenced the LSN, 
and proportionally how many neurons were activated by different stimuli. 
 
Investigation 2 
Hypothesis 1: 
a)  As SP is present in abundance in the LSN, the majority of LSN neurons are NK-1 
immunoreactive 
b)  If  a  majority  of  LSN  neurons  are  immunoreactive  for  the  NK-1  receptor,  only  a 
minority  be  immunoreactive  for  protein  kinase  C-γ  (PKC-γ),  which  like  the  NK-1 
receptor, has also been associated with nociceptive processing (Malmberg et al., 1997)  
Aims: 
a)  To identify the relationship between SP and the NK-1 receptor in the LSN, and quantify 
the total neuronal population that is immunoreactive for the NK-1 receptor 
b)  To quantify the total neuronal population in the LSN that are immunoreactive for PKC-
γ 
c)  To identify if any relationship exists between NK-1 and PKC-γ in the LSN 
 
The NK-1 receptor, the target of SP, is found within the LSN and the role of NK-1 is 
well established as playing a role in nociception (especially within the SDH).  As the LSN  
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has  been  implicated  in  nociception  (as  previously  discussed),  triple  labelling 
immunocytochemistry  (for  examination  with  the  confocal  microscope)  was  used  to 
quantify  the  total  neuronal  population  in  the  LSN  (using  NeuN)  that  possessed  this 
receptor, and that of protein kinase C- γ (PKC-γ) which also serves a role in nociceptive 
processing (Malmberg et al., 1997)). 
 
Hypothesis 2:   
a)  As nitric oxide synthase (NOS; the enzyme responsible for synthesising nitric oxide 
(NO)), has been found to enhance the release of SP in the SDH (Garry et al., 1994; 
Aimar et al., 1998; Kamasaki et al., 1995), SP and NOS will be intimately related 
immunocytochemically in the LSN 
b)  If a close relationship exists between SP and NOS, as in the SDH, then the same will 
hold for the relationship of NOS and the target of SP, the NK-1 receptor in the LSN  
c)  As  in  the  SDH,  the  NOS  terminals  in  the  LSN  will  be  associated  with  inhibitory 
GABAergic neurons  
Aims: 
a)  To identify the relationship that exists between SP and NOS in the LSN 
b)  To identify the contact nature of NOS terminals to NK-1 neurons, and then quantify 
this relationship  
c)  To identify, and then quantify, the relationship and proportion of NOS terminals to 
excitatory (glutamatergic) and inhibitory (GABAergic) terminals in the LSN 
 
With both NOS and the NK-1 receptor involved in nociception in differing ways as 
previously  discussed,  triple  labelling  immunocytochemistry  (for  examination  with  the 
confocal microscope) was used to identify if a relationship between SP, NK-1 and NOS in  
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the  LSN  existed.    In  addition,  quadruple  labelling  immunocytochemistry  was  used  to 
identify NK-1 neurons  and NOS terminals in the  LSN, and identify the co-localisation 
patterns of NOS terminals and their contact relationship with NK-1 neurons. 
  Within  the  SDH,  many  NOS  containing  neurons  are  associated  with  inhibitory 
GABAergic neurons, as well as glycinergic and cholinergic neurons (Valtschanof et al., 
1992b; Laing et al., 1994).  However, within the LSN there are few cholinergic terminals 
(Olave  and  Maxwell,  2004)  and  no  GlyT-2  –  a  marker  associated  with  glycinergic 
terminals (Zafra et al., 1995).  Therefore, within the LSN they may be associated with only 
GABAergic (glutamic acid decarboxylase (GAD) expressing neurons).  To ensure they do 
not  arise  from  excitatory  terminals,  immunocytochemistry  was  also  combined  with 
VGLUT2, known to exist in glutamatergic neurons throughout the CNS, as discussed in 
Chapter 1, page 8. 
 
Investigation 3 
Hypothesis: 
a)  If NK-1 neurons are abundant in the LSN, then many will be projection neurons and  
      target brain areas known to be involved in nociception 
Aim:  
a)  to quantify the proportion of NK-1 projection neurons that project to several brain and 
brainstem  regions  from  the  LSN  known  to  be  involved  in  nociception,  and  related 
aspects of pain 
 
Retrograde labelling of projection neurons was combined with either triple or quadruple 
labelling  immunocytochemistry  (for  examination  with  the  confocal  microscope).    The 
retrograde tracer cholera toxin B subunit (CTb) was combined with NeuN and NK-1 to  
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quantify LSN neurons that contained each of these markers that projected to several brain 
regions that have been implicated in nociception.  For the quadruple labelling experiments, 
two brain regions were injected – one with CTb and one with Fluoro-Gold (FG), and this 
was combined with NeuN and the NK-1 receptor, again to quantify the LSN projections 
possessing these markers. 
 
2.  General Experimental Procedures 
The purpose of this section is to give a broader understanding of some of the techniques 
that have been used throughout this study, and to provide a basis for the more specific 
detailed experimental sub-division that will be detailed later in chapters 3, 4 and 5. 
 
2.1  Multiple immunolabelling for confocal microscopy 
This  is  a  technique  which  allows  the  identification  of  several  antigens  in  the  same 
section, say for example (as in this work) the spinal cord.  The antigens can be peptides, 
neurotransmitters,  enzymes  or  receptors.    The  basis  of  immunolabelling  for  confocal 
microscopy is generally two-fold: 
· Incubation of sections of the spinal cord with a cocktail of primary antibodies (up to  
  four), which have been raised in different species.  This technique allows the   
  combination of  various different antigens to be detected in a single section. 
· Incubation of the sections with a cocktail of species-specific secondary antibodies,  
  each one of which is coupled to a different fluorophore.  The secondary antibody is an  
  immunoglobulin (Ig) raised in donkey, which is directed against a specific species  
  e.g. rabbit, rat, goat etc.  The resulting secondary antibody will bind to any antigen of  
  the species, and therefore readily identified by the fluorophore which it is also  
  attached to it.  
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After the appropriate incubations and rinses, the sections are mounted and subsequently 
ready  to  be  scanned  (or  stored  in  a  freezer  at  -20ºC  until  ready  to  be  examined).  
Immunoreactivity  for  each  of  these  antigens  can  be  visualised  separately  by  the 
corresponding  fluorophore  coupled  secondary  antibody.    Images  from  the  same  optical 
section can also be merged to allow the relative spatial distribution of the antigens to be 
studied. 
Exceptionally two primary antibodies from the same species can be used provided that 
the antigens identify different cellular compartments.  For instance, the NK-1 receptor is 
localised to the cell membrane and VGLUT2 is localised to terminals.  For this reason both 
antigens  can  be  labelled  with  a  primary  antibody  of  the  same  species  and  the  same 
secondary  antibody  and  it  is  still  possible  to  differentiate  the  two  types  of 
immunoreactivity.  Figures 4.4 and 4.5 illustrate immunoreactivity for the NK-1 receptor 
and VGLUT2 that has been obtained using primary antibodies raised in the same species 
(i.e. guinea-pig anti-NK-1 and guinea-pig anti-VGLUT2), which were revealed with the 
same  secondary  antibody  (i.e.  donkey  anti-guinea-pig  IgG  coupled  to  the  fluorophore 
rhodamine-red). 
 
2.2  Confocal microscopy 
The Radiance 2100 (Hemel-Hempstead, UK) confocal laser scanning microscope was 
used in all investigations.  It is equipped with four lasers: argon, green helium neon, red 
diode and blue diode which allowed the scanning of sections that had been labelled with 
four secondary antibodies, each one being coupled to a different fluorophores (Table 2.1). 
This  method  allowed  the  same  region  of  the  cell  to  be  identified  with  different 
fluorophores.    With  the  Radiance  2100  microscope,  scanning  can  be  performed 
simultaneously.    
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2.3  Control experiments used in immunocytochemical methods 
Positive and negative controls 
Although  immunocytochemistry  is  a  powerful  investigative  tool,  it  depends  on  the 
specificity of the antibody binding e.g. to the epitope of the protein used as an immunogen, 
and could be affected by fixation or detergents (Josephsen et al., 1999).  The antibody 
specificity  requires  that  the  antibody  binds  only  to  the  protein  that  contained  the 
immunogen peptide.  Today, many antibodies are generated to synthetic peptides and are 
purified with the immunising peptide based on affinity thus resulting in a reduction in 
possibility that the antibody binds to epitopes not found on the original peptide (Burry, 
2000). 
Therefore, controls are crucial in ensuring that the detection of the appropriate antigen 
is what results in the labelling seen using immunocytochemistry.  Initially, to demonstrate 
that the labelling found is due to the primary antibody specifically, the primary antibody 
can  be  either  omitted  (Schuster  and  Powers,  2005)  or  replaced  with  similarly  diluted 
normal serum from the same species, keeping all other experimental procedures the same 
i.e. a negative  control (Petrusz et al., 1976).   In addition to negative  controls, positive 
controls can be done using tissue selected to contain (or not contain) the protein to confirm 
the specificity of the antibody. This should demonstrate immunoreactivity for this protein 
at the appropriate sites, but a lack of immunoreactivity in those components that are known 
not to contain that protein.  Josephsen et al. (1999) also showed that sections could be used 
with several different antibodies that are directed against the same structure for labelling. 
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Absorption controls 
The specificity of an antibody as demonstrated by appropriate controls is crucial in 
understanding the localisation of compounds in cells/tissues.  One valuable control in the 
detection of a specific molecule is the absorption or pre-absorption technique where the 
antigen  being  examined  needs  to  be  present  in  its  pure  states  in  great  amounts.    The 
primary antibody is incubated with the pure, exogenous antigen, and then applied to the 
tissue being investigated.  If the antibody is specific for the exogenous antigen, the “pre-
absorption” should prevent the antibody from recognising the tissue antigen (Hockfield et 
al., 1993).  However, this technique demonstrates only the specificity of the antibody for 
the incubating peptide/protein but does not prove the specificity of the antibody for the 
protein in whatever tissue is being examined (Swaab et al., 1977; Willingham, 1999). 
 
Controls for double labelling immunocytochemistry 
Double (multiple) labelling in immunocytochemistry allows two (or greater) different 
antigens to be examined in a single preparation (Wessendorf and Elde, 1985).  Therefore it 
allows the determination of whether or not two different cell types can express unique 
antigens. 
Two types of double labelling can be undertaken – direct and indirect.  Direct double 
labelling uses two primary antibodies, where at least one is conjugated directly to a marker, 
and can be from the same species or of the same isotype (Hockfield et al., 1993).  However, 
performing indirect double labelling can be undertaken with unlabelled primary antibodies 
from  different  species  or  unlabelled  primary  antibodies  from  the  same  species  but  a 
different immunoglobulin (isotype).  Then, isotype- or species - specific labelled secondary 
antibodies  can  then  be  utilised  in  identifying  the  antigens  recognised  by  the  primary 
antibodies.  However, when the antibodies are from identical species or isotype, indirect  
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double labelling can also be undertaken by the addition of blocking steps and sequential 
incubations  with  a  primary  antibody,  the  relevant  secondary  antibody,  an  alternative 
primary  antibody,  and  the  next  relevant  secondary  antibody.    However,  as  well  as  the 
control experiments which have to be undertaken for verification of the specificity of the 
antibodies used, additional controls have to be used. 
If double labelling experiments are undertaken using primary antibodies from differing 
isotypes or species, the final concentration of each antibody should be identical to that 
established  for  single  labelling.    Mixtures  of  two  primary  antibodies,  if  produced  in 
different  species,  or  if  they  have  unique  isotypes,  can  be  used  if  say,  for  example, 
fluorescent secondary antibodies are available for detection of these primary antibodies.  
However, an essential negative control in indirect double labelling is to make sure that each 
individual secondary antibody is specific for the appropriate primary antibody.  This is 
identified by incubation of a separate tissue sample with each primary antibody and then 
with an inappropriate secondary antibody (Hockfield et al., 1993).  No labelling should be 
found in this case i.e. no cross-reactivity should be present within the tissue examined. 
If, on the other hand, double label immunofluorescence is performed using primary 
antibodies from the same isotype or species, control experiments have to be undertaken in 
addition to the ones detailed above.  As a positive control, the order should be reversed in 
primary  antibody  incubation  and  the  labelling  should  be  identical  to  that  undertaken 
initially.   For a negative control, the tissue should be incubated only  with the primary 
antibody, but no secondary antibody conjugated to a fluorochrome.  This is then followed 
by  incubation  with  the  first  primary  antibody,  with  incubation  in  an  excess  unlabelled 
secondary antibody solution, and then with an incubation in which the secondary antibody 
is conjugated to the secondary fluorochrome (Hockfield et al., 1993).    If primary antibody 
sites are saturated, this should result in tissue that is unlabelled.  However, if labelling is  
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present,  the  experiments  are  repeated  using  a  greater  concentration  of  the  unlabelled 
secondary antibody, or a reduced secondary antibody concentration conjugated with the 
secondary fluorochrome.  If, after this, cross-reactivity is still found, the antibodies are not 
used for double labelling experiments. 
 
Antibodies used within the subsequent studies  
The studies undertaken in subsequent chapters involve a total of ten different primary 
antibodies and three fluorescent secondary antibodies, all of which have been extensively 
documented  in  the  literature,  and  gave  staining  patterns  consistent  with  those  seen 
previously. 
The mouse monoclonal antibody used was generated against cell nuclei extracted from 
mouse brain and was found to react with the protein specific to neurons (Mullen et al., 
1992).  This antibody labels all neurons (and no glial cells) within the rat spinal cord (Todd 
et al., 1998).  The rabbit c-Fos antiserum was raised against a synthetic peptide sequence 
common  to  all  c-Fos  proteins  (Hunt  et  al.,  1987)  and  has  been  used  in  many 
immunocytochemical studies of the spinal cord (Hunt et al., 1987; Williams et al., 1989, 
1990a,b; Olave and Maxwell, 2004; Todd et al., 1994, 2005).   
The sheep antiserum against neuronal nitric oxide synthase used later (nNOS), or the 
K205, has been assessed using Western blotting (Herbison et al., 1996).  They showed that 
the antibody recognised one main protein with a molecular mass of 155Kd in lanes with the 
recombinant nNOS and rat hypothalamus.  Other smaller protein bands were present in 
both lanes and were assumed to be fragments of the nNOS.  Herbison et al. (1996) also 
performed liquid phase absorption experiments and demonstrated that all immunoreactivity 
was abolished by absorption of the K205 antiserum with the recombinant nNOS protein.  
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The guinea pig antiserum against the vesicular glutamate transporter 2 (VGLUT2) has 
been  examined  by  Mathur  and  Deutch  (2008).  They  examined  the  specificity  of  the 
VGLUT2 antibody, and also the vesicular glutamate transporter 3 (VGLUT3) antibody by 
performing controls eliminating the primary antibodies and found no staining.  In addition, 
they also incubated sections in a solution containing the VGLUT3 primary antibody, but 
not the VGLUT2 antibody, having both secondary antibodies present.  From that, they 
demonstrated  only  VGLUT3,  and  no  VGLUT2  immunoreactivity  and  no  non-specific 
immunofluorescence with either the VGLUT2 or VGLUT3 primary antibodies.  As well as 
that study, numerous other authors have shown the terminal staining that is found using this 
antibody, as discussed in detail in chapter 4. 
The guinea-pig antiserum against the NK-1 receptor used in subsequent studies showed 
staining identical to that from the well characterised rabbit anti-NK1 receptor antibody 
(Vigna et al., 1994; Polgár et al., 1999) and the rat NK-1 receptor (Spike et al., 2003). 
The substance P monoclonal antibody  recognises the C-terminal of the peptide and 
therefore does not distinguish between substance P and the related tachykinins neurokinin 
A and B (Cuello et al., 1979).  Substance P and neurokinin A originate from the same gene 
(preprotachykinin  I),  but  neurokinin  B  arises  from  preprotachykinin  II.    Although 
neurokinin B is present in the dorsal horn, it is not detectable in primary afferents and is 
thought to originate from neurons within the spinal cord (Ogawa et al., 1985; Warden and 
Young, 1988; Too and Maggio, 1991).  The rat substance P has been well characterised 
previously by Naim et al. (1997) and Todd et al. (2000). 
The protein kinase C-γ (PKC-γ; C-19) used in chapter 4, investigation 2 is an affinity 
purified rabbit polyclonal antibody raised against a peptide mapping at the C-terminus of 
PKC- γ of mouse origin and has been shown to be highly specific by numerous authors 
(Takai et al., 1979; Nishizuka, 1984a; Osada et al., 1992; Polgár et al., 1999).  
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The goat polyclonal antibody was raised against CTb, and rabbit was raised against 
Fluorogold.  Specificity of each of these tracer antibodies was demonstrated by a lack of 
staining in areas of the central nervous system that did not contain neurons that had taken 
up and transported the tracer and by immunostaining found in populations of neurons that 
are known to project to the injection sites, as discussed in detail min chapter 5.  In addition, 
the  specificity  of  the  Fluorogold  antibody  was  directly  confirmed  by  comparing  the 
fluorescence (seen through a UV filter set) with that for the anti-Fluorogold in individual 
neurons.    All  experiments  examined  had  a  perfect  match  between  the  two  types  of 
fluorescence. 
Therefore,  to  minimise  suffering  to  animals,  as  requested  under  the  UK  Animals 
(Scientific  Procedures)  Act  1986,  and  the  fact  that  both  the  primary  and  secondary 
antibodies have been extensively characterised in the literature as quoted throughout the 
work presented, control experiments were not deemed appropriate. 
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Fluorophore  Excitation λ  Emission λ 
Alexa 488  494  518 
Rhodamine-Red  570  590 
Cyanine 5.18  650  670 
 
Table 2.1 Excitation-emission wavelengths corresponding to the fluorophores used. 
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Chapter 3 
 
Investigation 1: 
 
Nociceptive stimuli that activate LSN neurons 
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1.  Introduction 
c-Fos is an immediate early gene which is rapidly and transiently expressed in neurons 
in response to stimulation (Harris, 1998).  Transcriptional activation of the gene occurs 
within  minutes  of  stimulation,  with  the  accumulation  of  mRNA  reaching  its  peak 
approximately 30 to 40 minutes later.  The gene encodes for the nuclear protein Fos, and 
levels peak about two hours after induction of gene transcription.  Many stimuli have been 
found to activate neurons in the superficial laminae including noxious mechanical stimuli 
and heat and cold stimuli (Price et al., 1978; Ferrington et al., 1987; Han et al., 1998; Craig 
et al., 2001). 
After  noxious  peripheral  stimulation,  Fos  immunoreactive  neurons  are  found 
throughout the spinal grey matter, but there is general agreement that they are concentrated 
in the superficial dorsal horn (laminae I and II) and in a band across the deep part of the 
dorsal horn and intermediate grey matter, extending from the lateral reticulated part of 
lamina V, towards the area around the central canal (lamina X).  There are differences in 
the distribution in Fos immunoreactive neurons within the superficial dorsal horn following 
different types of acute noxious stimulus: cutaneous and subcutaneous stimulation giving 
rise  to  immunoreactive  neurons  throughout  lamina  I  and  II,  whereas  after  noxious 
stimulation of muscles, joints or viscera, immunoreactive neurons are common in lamina I, 
but rare in lamina II (Hunt et al., 1987; Menétrey et al., 1989).  There are also reports that 
repeated innocuous mechanical stimulation results in Fos immunoreactivity in neurons in 
laminae III and IV (Hunt et al, 1987; Jasmin et al., 1994; Menétrey et al., 1989). 
Some cells which develop Fos immunoreactivity after noxious stimulation are known to 
be projection neurons, with axons that terminate in the brainstem or thalamus (Menétrey et 
al., 1989; Tavares et al., 1993), however it is likely from the very high density of Fos 
immunoreactive cells that most are interneurons.  Neurons in laminae I to III of the dorsal  
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horn are highly diverse in terms of their neurochemical profiles (Willis and Coggeshall, 
1991; Todd and Spike, 1993).  Many of these neurons are not inhibitory, but it has been 
shown that approximately one-third are GABAergic in laminae I – III, and also use glycine 
or acetylcholine as a transmitter, (Todd and Sullivan, 1990; Todd, 1991).  Interestingly, 
Todd et al. (1994) showed that approximately one-fifth of c-Fos immunoreactive neurons 
in the SDH (laminae I – II) showed GABAergic immunoreactivity. 
More  recently,  Olave  and  Maxwell  (2004)  retrogradely  labelled  LSN  neurons  that 
projected to an area established in nociceptive processing, the caudal ventrolateral medulla 
(CVLM; Morton et al., 1983; Janss and Gebhart, 1988; Liu and Zhao, 1992) and combined 
this  with  the  induction  of  c-Fos  with  peripheral  noxious  stimuli  and  NK-1  receptor 
immunoreactivity.  They observed that a proportion of LSN neurons had been activated 
bilaterally  by  noxious  stimulation,  though  NK-1  projection  neurons  that  expressed  Fos 
were not very numerous.  As the SDH expresses Fos only unilateral to the side of noxious 
peripheral  stimulation  (Hunt  et  al.,  1987;  Harris,  1998;  Todd  et  al.,  1994,  2002),  this 
suggests  that  the  LSN  receives  nociceptive  information  in  a  very  different  way  to  the 
adjacent SDH. 
In the past Fos has been useful in demonstrating noxious mechanical, hot and cold 
stimuli activating neurons in the SDH (Hunt et al., 1987; Ferrington et al., 1987; Han et al., 
1998; Craig et al., 2001).  Therefore, the purpose of this study was to a) identify if LSN 
neurons received cutaneous information, b) to determine if the LSN neurons responded 
specifically to noxious cutaneous stimulation and finally, c) to use four different noxious 
peripheral stimuli to identify if there was a variable degree of expression of Fos dependent 
on the stimulus used. 
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2.  Experimental Procedures 
Induction of c-Fos  
Twelve adult male Sprague Dawley rats (Harlan, Loughborough, UK; 190-250g) were 
used in this study where they were housed under conditions of a 12 hour light-dark cycle 
with food and water provided ad libitum.  All experiments were performed in accordance 
with the UK Animals (Scientific Procedures) Act 1986 and the European Communities 
Council Directive (86/609/EEC).  They were anaesthetised initially with halothane in an 
enclosed  chamber  followed  by  injecting  a  ketamine  and  xylazine  mixture  (7.33  and 
0.73mg/100g i.p., respectively).  They were divided into four groups receiving one of the 
following noxious stimuli to the left hind-paw: 1) immersion of the hind-paw in hot water 
at 55ºC for 20 seconds (n = 3); 2) immersion of the hind-paw in cold water maintained at 
4ºC for 30 seconds every 2 minutes over a 2 hour period (n = 3); 3) topical application of 
100% mustard oil to the hind-paw (n = 3); 4) a subcutaneous injection of 50ml of 2% 
formaldehyde to the hind-paw (n = 3). The application of a peripheral noxious stimulus to 
one  limb  has  been  shown  to  induce  the  expression  of  Fos  mainly  in  neurons  in  the 
ipsilateral SDH, especially in the medial portion (Hunt et al., 1987; Todd et al., 1994, 
2002).  The animals were maintained under anaesthetic for 2 hours after the application of 
the  noxious  stimulus,  and  then  perfused  through  the  left  ventricle  with  4%  freshly 
depolymerised formaldehyde.  All efforts were made to minimise the numbers of animals 
used and any unnecessary discomfort. 
 
Immunocytochemical labelling for confocal microscopy 
Mid-lumbar spinal cord segments (L3 – 5) were removed and post-fixed overnight.  
Transverse 50 m sections were cut with a Vibratome, and alternate sections selected with 
10  collected  from  each  of  the  spinal  segments  (resulting  in  a  total  of  30  per  animal).   
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Sections  were  then  immersed  in  50%  ethanol  for  30  minutes  to  enhance  antibody 
penetration (Llewellyn-Smith and Minson, 1992).  For each of the above categories of Fos 
induced animals, immunocytochemical labelling was undertaken with mouse anti-NeuN 
antiserum  (diluted  1:1000;  Millipore,  Watford,  UK)  and  rabbit  anti-c-Fos  antiserum 
(diluted 1:2500, Santa Cruz, USA).  After a 48 hour incubation period, sections were rinsed 
in  phosphate  buffered  saline  (PBS)  and  incubated  for  3  hours  in  solutions  containing 
species-specific secondary antibodies raised in donkey, conjugated to rhodamine-red-anti-
mouse immunoglobulin (IgG; diluted 1:500, Jackson Immunoresearch) to detect NeuN, and 
Alexa-488-anti-rabbit  IgG  (diluted  1:100,  Molecular  Probes)  to  detect  Fos.    Following 
rinses  in  PBS,  sections  were  mounted  in  anti-fade  medium  (Vectashield;  Vector 
Laboratories, Peterborough, UK) and stored until required for analysis in a freezer at -20ºC. 
 
Quantitative analysis 
In all experiments, the left and right LSNs were scanned systematically by using a 
Radiance 2100 confocal laser microscope (Hemel-Hempstead, UK).  Tissue was scanned 
with a 40X and 60X oil-immersion lens and each image was captured at 1 m intervals in 
the z-axis with a zoom factor of 1.  In each animal, ten alternate sections were used for 
analysis from spinal segments L3 – 5 (i.e. a total of 30 per animal) and 2 fields were taken 
from each section (one from the left LSN and one from the right LSN).  Therefore, for each 
animal, a total of 60 fields were taken covering all spinal segments. Image analysis was 
undertaken for all experiments by using Neurolucida for Confocal (MicroBrightField, Inc., 
Colchester,  VT).    The  total  number  of  neurons  in  the  LSN  was  recorded  (from  NeuN 
staining) and then the green frequency was used to identify Fos immunoreactive neurons in 
each of the four categories of stimuli used. 
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3.  Results 
Fos immunoreactive neurons in the LSN after the application of a noxious stimulus 
The average number of sampled neurons over each spinal segment (including ± SD), as 
detected by the neuronal marker NeuN, was very consistent between experiments and also 
between the left (ipsilateral to stimulation) and right (contralateral to stimulation) sides of 
the spinal cord (left LSN, average ± S.D. = 78 ± 4.65; right LSN, 82 ± 6.21).  Following 
counting for each of the defined categories with one of four stimuli (hot water at 55˚C, cold 
water at 4˚C, 100% mustard oil or 50ml of 2% formaldehyde; n = 3 in each category), 
average percentages (±  S.D.) of the  LSN neuronal population identified through NeuN 
were calculated. 
There was a mean number of Fos immunoreactive neurons for each of the categories as 
follows: hot water at 55˚C, 8.58 ± 2.97% ipsilateral and 6.94 ± 2.06% contralateral to the 
side of stimulus (typical examples shown in Figs 3.1 and 3.2); cold water at 4˚C, 4.86 ± 
1.77%  ipsilateral  and  3.98  ±  1.80%  contralateral  to  the  side  of  stimulus;  mustard  oil 
(100%), 3.47 ± 1.46% ipsilateral and 2.45 ± 0.56% contralateral to the side of the stimulus; 
formaldehyde (2%, 50ml), 1.37 ± 1.06% ipsilateral and 0% contralateral to the side of the 
stimulus. These results are summarised in the histogram in Figure 3.3  
The average percentage of Fos positive neuronal cells (as identified by NeuN) in the 
left LSN (ipsilateral to the stimulus applied) and the right (contralateral to the stimulus 
applied) was very similar in each of the categories of stimulus applied.  In addition, using a 
one-way ANOVA, none of the differences between the left and right LSNs for each of the 
experimental  categories  were  found  to  be  significant  statistically.    However,  what  is 
notable in this study is the bilateral activation of the LSN neurons with a peripheral noxious 
stimulus  (apart  from  the  use  of  formaldehyde,  but  here  overall  number  of  c-Fos 
immunoreactive neurons in the ipsilateral LSN was very low).  This is in contrast to the  
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SDH where it is known that a peripheral noxious stimulus applied to the right hind limb 
induces the expression of Fos mainly in neurons in the ipsilateral dorsal horn, i.e. right, 
especially in the medial part of the SDH (Hunt et al., 1997; Todd et al., 1994; Doyle and 
Hunt, 1999; Todd et al., 2002).  The relations of Fos immunoreactivity between the LSN 
and  the  SDH  ipsilateral  and  contralateral  to  the  sides  of  stimulus  are  demonstrated  in 
Figure 3.1. 
However,  there  was  a  notable  difference  in  the  numbers  of  Fos  immunoreactive 
neurons between the different categories of stimulus applied, with the hot water at 55˚C 
showing  the  greatest  numbers  of  neurons  activated,  with  the  formaldehyde  stimulus 
demonstrating only very small numbers of Fos immunoreactivity suggesting that the LSN 
neurons are activated to a greater degree with a hot water stimulus compared to the other 
stimuli applied.    
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Figure 3.1.  Fos labelling in the SDH and the LSN.  A shows Fos labelling in the ipsilateral dorsal horn (as indicated by the 
arrows) as well as the LSN (as indicated by the *), whereas B shows Fos labelling in the contralateral LSN (as indicated by the *) 
but no labelling in the contralateral dorsal horn following application of the peripheral noxious stimulus (hot water at 55°C).  
Scale bar = 100 m, valid for both images. 
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Figure 3.2.  Fos neuron in the LSN.  Image of a transverse section of the LSN, superficial dorsal horn (SDH) and lateral 
funiculus shown in A – C (red, NeuN; green, Fos).  In A – C, 1 indicates a NeuN (red) labelled neuron in the LSN which shows 
Fos  (green)  immunoreactivity  contralateral  to  the  side  of  stimulation.    2  indicates  a  neuron  in  the  lateral  funiculus  also 
immunoreactive for Fos.  Numerous neurons are present in the LSN that do not demonstrate Fos immunoreactivity after hot water 
stimulation (55ºC).  Scale bar = 20 m. 
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Figure  3.3.    Histogram  summarising  the  percentage  of  NeuN  cells  in  the  LSN  that 
showed Fos immunoreactivity for each of the four stimuli used.  Three animals were used 
in each of the four categories.  Ipsilateral is the side of the stimulus i.e. left side, error bars = 
± S.D. 
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4. Discussion 
    Technical considerations 
The  mouse  monoclonal  antibody  used  in  this  study  (and  subsequent  studies  in  the 
following chapters) was generated against cell nuclei extracted from mouse brain and was 
found to react with the protein specific to neurons (Mullen et al., 1992).  This antibody 
labels all neurons (and no glial cells) within the rat spinal cord (Todd et al., 1998).  The c-
Fos  antiserum  was  raised  against  a  synthetic  peptide  sequence  common  to  all  c-Fos 
proteins (Hunt et al., 1987) and has been used in many immunocytochemical studies of the 
spinal cord (Hunt et al., 1987; Williams et al., 1989, 1990a,b; Olave and Maxwell, 2004; 
Todd et al., 1994, 2005).   
The distribution of c-Fos immunoreactivity after noxious peripheral stimulation was 
found throughout the spinal grey matter on the side ipsilateral to the stimulus applied (only 
very  sparse  contralateral  labelling)  but,  in  agreement  with  others,  was  concentrated  in 
laminae I and II (especially the outer (dorsal) part of lamina II) and in a band across the 
deep  part  of  the  dorsal  horn  and  intermediate  grey  matter,  extending  from  the  lateral 
reticulated area of lamina V, towards the area around the central canal (Lantéri-Minet et al., 
1993; Menétrey et al., 1989; Lima at al., 1993; Tavares et al., 1993; Todd et al., 1994, 
2005).  These areas are known to correspond to the terminal fields of primary nociceptive 
afferent  fibres  and  to  the  distribution  of  nociresponsive  neurons  identified  by 
electrophysiological recordings (Bullitt, 1991; Hunt at al., 1987; Presley et al., 1990).  In 
addition  to this, there  was  greater  c-Fos  immunoreactivity  in  the  more  medial  parts  of 
laminae I and II, but a less tightly organised arrangement of immunoreactivity in lamina V, 
in agreement with Bullitt (1991).   
Previous investigators (using the cat) have shown that there is indeed a somatotopic 
arrangement of the dorsal horn arranged mediodorsally, with the foot and toes represented  
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in the medial two thirds of the dorsal horn, and with the proximal leg and hip represented 
more laterally (Wall, 1953; Brown and Fuchs, 1975; Pubols and Golberger, 1980; Brown 
and Culberson, 1981; Light and Durkovic, 1984).  The rat also has a similar pattern of 
primary afferent termination (Ygge and Grant, 1983; Swett and Woolf, 1985; Molander 
and Grant, 1985, 1986).  As the stimulus was applied to the hindpaw, this would explain 
the arrangement of the Fos immunoreactivity in laminae I and II (greater proportion of Fos 
immunoreactivity in the medial portion of these laminae) and  also acts as a “positive” 
control for the LSN results which will be dealt with later.  In addition, the experiments 
undertaken within this study also show “positive” control staining for Fos in the lateral 
aspect of laminae I and II (Figures 3.1).  However, where a stimulus to induce Fos was not 
applied, there was little or no immunolabelling for Fos in the spinal cord, as shown by 
Olave and Maxwell (2004). 
Other types of stimulation have been shown to cause Fos immunoreactivity within the 
spinal cord; however there is a different distribution in response to noxious stimulation and 
non-noxious  (tactile)  stimulation.    For  example,  in  contrast  to  the  Fos  expression  in 
response to chemical and thermal stimulation, non-noxious stimulation (brushing of hairs, 
gentle manipulation of joints and walking) induces Fos immunoreactivity in the deeper 
laminae, namely III – VI (Hunt et al., 1987; Jasmin et al., 1994).  However, in numerous 
control studies where no stimulus was applied, only very sparse Fos immunoreactivity was 
identified in deeper laminae, including laminae III and IV (Menétrey et al., 1989; Presley et 
al., 1990; Jasmin et al., 1994; Hagihari et al., 1997).  Therefore, as it has been proven that 
only very little Fos immunoreactivity is present in “negative” controls, further sacrifice of 
animals was not undertaken in this present study to minimise further pain and unnecessary 
suffering under the UK Animals (Scientific Procedures) Act 1986.  
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Two anaesthetic combinations were used in this study – inhalational halothane and a 
mixture of ketamine and xylazine.  It has been shown that halothane as an inhalational 
anaesthetic can result in the suppression of Fos immunoreactivity, however only in the 
deeper layers of the grey matter (laminae III and IV) and not within neuronal populations in 
laminae I and II; suppression is minor compared to inhalational nitrous oxide, which was 
avoided in this, and subsequent studies (Hagihara et al., 1997).  As there was abundant Fos 
staining with the four stimuli used in laminae I and II, especially in the medial aspect (but 
also some staining found in the lateral aspect – see Figure 3.1) and the lateral reticulated 
area of lamina V, extending to the area around the central  canal, the influence of this 
anaesthetic could be assumed as minimal on Fos expression to the stimuli used. 
Ketamine (a non-competitive NMDA receptor antagonist acting at an allosteric site, 
Harrison  and  Simmonds,  (1985))  and  xylazine  (an  α2  adrenergic  receptor  agonist 
(McCurnin and Bassert (2002)) have not been shown to influence Fos expression upon 
noxious stimulation, and it has been suggested that these act supraspinally rather than at the 
dorsal  horn  level  (Yi  and  Barr,  1996).    Again,  the  effects  of  this  combination  on  Fos 
expression throughout the spinal cord (including the LSN) can be seen as minimal and will 
not significantly alter Fos expression with the stimuli used here. 
 
Fos immunoreactivity in the LSN 
The main finding of this study is that although Fos immunoreactivity has been detected 
in the LSN, particularly in response to hot water, overall Fos immunoreactivity is actually 
lower than what was anticipated. 
Olave and Maxwell (2004) quantified the number of LSN neurons projecting to the 
caudal ventrolateral medulla (CVLM; an area established in nociceptive processing) that 
also possessed the NK-1 receptor.  They had shown that more than one-fifth of all neurons  
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examined (including those projecting to the CVLM and/or containing the NK-1 receptor) 
showed  Fos  immunoreactivity  upon  using  a  thermal  noxious stimulus  peripherally  (hot 
water).  Compared to the Olave and Maxwell (2004) study, this work shows a smaller 
number of LSN neurons that demonstrate Fos immunoreactivity, even when using the same 
noxious stimulus peripherally.  
Unlike the SDH, where the highest concentration of Fos immunoreactive neurons are 
located ipsilateral to the peripheral stimulus (Hunt et al., 1987; Todd et al., 1994, 2002), as 
well as immunoreactivity found in the lateral reticulated area of lamina V, VII, VIII and X 
(Menétrey  et  al.,  1989),  LSN  neurons  showing  Fos  immunoreactivity  were  found 
bilaterally, and of approximately equal proportions. 
LSN  neurons  not  only  project  to  numerous  supraspinal  sites,  but  also  receive 
descending projection fibres from supraspinal nuclei including the raphe nuclei, brainstem 
reticular  formation  nuclei,  dorsal  column  nuclei  and  the  periaqueductal  grey  (PAG) 
(Carlton et al., 1985; Masson et al., 1991).  These in turn could be activated by ascending 
fibres of spinal projection neurons located in the SDH.  Suzuki et al. (2002) showed that 
SDH  neurons  possessing  NK-1  immunoreactivity  activated  descending  pathways  that 
influenced spinal excitability.  Therefore, the bilateral expression of Fos in the LSNs could 
be the result of ascending activation of descending systems projecting bilaterally to this 
nucleus.  In addition to this, Grudt and Perl (2002) demonstrated that some axon collaterals 
from lamina I neurons entered the area of the LSN, and also had their axons which passed 
ventrally, then contralaterally to project in the ventral white funiculus. From this, these 
neurons in lamina  I could be activated by primary afferent input to the SDH and then 
activate LSN neurons through collaterals.  Also, Petkó and Antal (2000) demonstrated that 
neurons in the lateral area of the SDH had commissural axons passing to the SDH on the 
contralateral side.  They also showed that labelling occurred in the LSNs after lateral dorsal  
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horn  injections.    Taken  together,  this  evidence  could  account  for  the  bilateral  Fos 
expression in the LSN after the application of noxious stimuli. 
The  other  significant  finding  of  this  study  also  demonstrates  is  that,  although  the 
immediate early gene c-Fos is rapidly and transiently expressed in neurons in response to 
stimuli (Morgan and Curran, 1989, 1991), there has been a notable difference dependent on 
the stimulus involved in the LSN, though not in the superficial dorsal horn.  Many types of 
stimuli have been documented to produce c-Fos expression and it has been assumed that 
neuronal activity in relation to nociception and the presence of Fos is related (Morgan et 
al., 1987; Hunt et al., 1987; Sagar et al., 1988).   
In addition, stimulation has to be strong and prolonged before quantifiable levels of Fos 
expression are achieved (Bullitt et al., 1992; Lima and Avelino, 1994) and not all neurons 
express  the  gene  when  activated  (Dragunow  and  Faull,  1989).  Even  the  ventral 
posterolateral  nucleus  of  the  thalamus  (VPL),  an  area  having  an  established  role  in 
nociception, did not result in Fos expression after noxious stimulation (Willis, 1985, 1989; 
Bullit, 1990). 
However,  what  the  present  study  does  add  is  that  although  the  LSN  appears  to  be 
activated  bilaterally  by  cutaneous  stimulation  (specifically  noxious  stimuli)  to  varying 
degrees depending on the stimulus used, and confirms and extends other studies that have 
implicated the LSN in nociception (Harmann et al., 1988; Battaglia and Rustioni, 1992; 
Schafer et al., 1994; Feil and Herbert, 1995; Jiang et al., 1999; Olave and Maxwell, 2004), 
the proportion of LSN neurons responding to a peripheral noxious stimulus is much lower 
than  may  have  been  expected.    Indeed,  with  the  stimulus  showing  the  greatest  Fos 
immunoreactivity, it only revealed a maximum of approximately 15% of all NeuN labelled 
neurons in the LSNs.  
70 
 
 
 
 
In summary, all stimuli that were used in the experiments detailed previously have 
shown high levels of Fos immunoreactivity in the superficial dorsal horn (especially the 
medial parts of laminae I and II).   However, even with the stimulus that demonstrated 
greatest Fos immunoreactivity in the LSN (hot water at 55°C), the overall numbers were 
low, representing at most 15% of all neurons.  It could be postulated that as there was a 
notable difference between the LSN and the superficial dorsal horn, it may well be that this 
nucleus  could  receive  nociceptive  input  from  areas  other  than  that  stimulated  in  these 
experiments i.e. nociceptive information from sites other than the hind-paw and may have a 
very different somatotopic organisation to the superficial dorsal horn. 
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Chapter 4 
 
Investigation 2: 
 
Relationship of axon terminals possessing NOS with NK-1 
neurons in the LSN 
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1.  Introduction 
 
Nitric  oxide  synthase  (NOS),  a  nicotinamide  adenine  dinucleotide  phosphate 
diaphorase (NADPH-d; Garthwaite, 1991), is the enzyme responsible for producing nitric 
oxide (NO) and its neuronal form (nNOS) is found in a variety of CNS neurons (Schmidt et 
al., 1991; Ruscheweyh et al., 2006).  NO is an unconventional diffusible intercellular factor 
(Garthwaite and Boulton, 1995) and its principal target is soluble guanylyl cyclase which 
induces  cyclic  3’,5’-guanosine  monophosphate  (cGMP).    In  the  spinal  cord,  many  cell 
bodies  containing  NOS  and  NADPH-d  are  located  in  the  SDH  (Dun  et  al.,  1992; 
Valtschanoff et al., 1992a) and a dense plexus of NOS-immunoreactive axon terminals is 
present in laminae I – III (Valtschanoff et al., 1992b; Laing et al., 1994; Bernardi et al., 
1995) which also contain co-localised GABA.  
Behavioural (Malmberg and Yaksh, 1993) and pharmacological studies (Kawabata et 
al.,  1994;  Semos  and  Headley,  1994;  Lin  et  al.,  1999)  have  indicated  that  NO  is  a 
modulator of nociceptive processes but there is no agreement on its precise role and it may 
have hyperalgesic and analgesic effects (Hoheisel et al., 2005). NO expression in the SDH 
is known to increase following peripheral application of noxious stimuli (Soyguder et al., 
1994;  Lam  et  al.,  1996).    This  is  often  accompanied  by  induction  of  c-Fos  which  is 
abolished following administration of the NOS inhibitor, N
ω -nitro-L-arginine methyl ester 
(L-NAME; Lee et al., 1992; Roche et al. 1996; Wu et al., 2000). Laminae I and IIo of the 
SDH  are  the  principal  termination  sites  of  SP  and  glutamate-containing  unmyelinated 
nociceptive  cutaneous  primary  afferent  fibres.    It  has  been  suggested  that  NO  has  an 
important  role  in  the  development  of  hyperalgesia  (Meller  and  Gebhart,  1993).  This 
involves activation of N-methyl D-aspartate (NMDA) receptors which in turn activate NOS 
to produce a NO/cGMP cascade which enhances the release of CGRP and SP from primary 
afferents fibres (Garry et al., 1994; Kamasaki et al., 1995; Aimar et al., 1998). Enhanced  
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release of glutamate and substance P is associated with central sensitisation (Wu et al., 
2000) which may be an underlying mechanism of hyperalgesia.      
Protein kinase C  (PKC) on the other hand, is an enzyme that is important as a common 
mechanism for signal transduction of various extra-cellular signals into the cell to control 
many physiologic processes (Nishizuka, 1984a,b, 1986).  In addition, it is believed to be 
involved in the process of sensitisation of dorsal horn neurons (Coderre, 1992; Mao et al., 
1992; Palečk et al., 1994). PKC is activated by a rise in intracellular Ca
2+ (for example 
through NMDA receptors) and through phospholipase C, which stimulates the formation of 
inositol  triphosphate  (IP3)  and  diacylglycerol  which  is  mediated  by  certain  G-protein 
coupled receptors (Nishizuka, 1984a; Berridge and  Irvine, 1989;  Bockaert et  al., 1993; 
Schoepp  and  Conn,  1993).    Candidate  receptors  in  the  dorsal  horn  include  type  I 
metabotropic  glutamate receptors (mGluR1 and 5) and NK-1 receptors (Coderre, 1992; 
Palečk  et  al.,  1994;  Schoepp  and  Conn,  1993;  Sluka  and  Willis,  1995).    Interestingly, 
Polgár et al. (1999a) have shown that some neurons with protein kinase C-γ (PKC-γ) in 
lamina I and in lamina III also possessed the NK-1 receptor.  It may well be postulated that 
substance P (which targets the NK-1 receptor) may also activate PKC-γ in those cells.  
Also, the involvement of excitatory amino acids and NK-1 receptors in both injury induced 
neuronal plasticity and in the stimulation of intracellular cascades leads to the translocation 
and  activation  of  PKC,  suggesting  that  PKC  may  be  involved  in  neuronal  changes 
produced by peripheral tissue injury that contribute to persistent nociception (Yashpal et 
al., 1995).  Malmberg et al. (1997) also showed, using knock-out PKC-γ mice, that PKC-γ 
is linked to the development of neuropathic pain as mice that lacked PKC-γ displayed 
normal  responses  to  acute  pain,  but  they  almost  completely  failed  to  develop  the 
neuropathic pain syndrome after partial sciatic nerve sectioning.  
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With  the  relations  of  PKC-γ  to  the  NK-1  receptor  as  previously  discussed  in  the 
superficial  dorsal  horn  (Polgár  et  al.,  199),  and  the  fact  that  it  requires  an  increase  in 
intracellular Ca
2+ like NOS (via calmodulin (Bredt and Snyder, 1990)), there may well be a 
close  interactive  relation  between  PKC-γ  and  the  NK-1  receptor  in  the  LSN,  like  the 
superficial dorsal horn. 
Therefore, the purpose of this study was to: a) identify the relationship between SP and 
the NK-1 receptor (as SP is abundant (Chapter 1, Pages 6 – 8)) in the LSN b) to quantify 
the proportion of neurons containing NK-1 in the LSN (and also protein kinase C- γ (PKC-
γ) which, like the NK-1 receptor, is also associated with nociceptive processing (Malmberg 
et al., 1997)) c) identify if a close relationship (as present in the SDH) exists between the 
abundant SP staining (Chapter 1, Pages 6 – 8) and abundant NOS staining (Valtschanoff et 
al., 1992a; Nazli and Morris, 2000) in the LSN d) identify and quantify the relationship 
between NOS and the NK-1 receptor and PKC-γ e) identify the co-localisation pattern of 
NOS terminals in the LSN, i.e. are they associated with GABAergic terminals, as in the 
SDH 
 
2.   Experimental Procedures 
Immunocytochemical labelling for confocal microscopy 
A total of ten male Sprague-Dawley rats (150-250g) were used in this study where they 
were housed under conditions of a 12 hour light-dark cycle with food and water provided 
ad  libitum.    All  experiments  were  performed  in  accordance  with  the  UK  Animals 
(Scientific  Procedures)  Act  1986  and  the  European  Communities  Council  Directive 
(86/609/EEC).  Each animal was anaesthetised with halothane in an anaesthetic chamber 
followed by i.p. administration of sodium pentobarbitone (1ml; 200mg/ml).  They were  
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perfused through the left ventricle initially with saline followed by a fixative containing 4% 
freshly depolymerised formaldehyde in phosphate buffer pH 7.6. 
The L3 – 5 lumbar segments were removed and post-fixed in the same solution for 
eight hours.  Transverse sections (50 m) were cut by using a Vibratome and placed in 50% 
ethanol  for  30  minutes  to  enhance  antibody  penetration  (Llewellyn-Smith  and  Minson, 
1992) and washed in phosphate buffer.  Sections from the 10 animals were then placed into 
one of four groups for immunocytochemical reactions.    Sections from the first group were 
processed for triple labelling immunofluorescence with the following primary antibodies: 
rabbit  anti-PKC-γ  (1:1000;  Santa  Cruz  Biotechnology),  guinea  pig  anti-NK-1  (1:1000; 
Sigma) and mouse anti-NeuN antiserum (1:1000; Millipore, Watford, UK) (n = 3).  The 
second  group  was  processed  for  triple  immunofluorescence  with  rabbit  anti-PKC-γ 
(1:1000; Santa Cruz Biotechnology), guinea-pig anti-NK-1 (1:1000; Sigma) and sheep anti-
NOS antiserum (1:2000; gifted by Dr P. Emson, Cambridge) (n = 3).  The third group was 
processed for quadruple labelling with rabbit anti-GAD (1:1000; Sigma), guinea-pig anti-
VGLUT2 (1:5000; Chemicon), guinea pig anti-NK-1 (1:1000; Sigma) and sheep anti-NOS 
antiserum (1:2000; gifted by Dr P. Emson, Cambridge) (n = 3).  Sections from the fourth 
group were processed for SP (1:100; Oxford Biotechnology), sheep anti-NOS antiserum 
(1:2000; gifted by Dr P. Emson, Cambridge) and guinea pig anti-NK-1 (1:1000; Sigma) (n 
= 3). After a 48 hour incubation period at 4°C, sections were rinsed in PBS and incubated 
for  2  hours  in  solutions  containing  species-specific  secondary  antibodies  (all  raised  in 
donkey) coupled to fluorophores:  Alexa 488 immunoglobulin (diluted 1:500; Molecular 
Probes)  to  identify  either  PKC-γ  (experiments  1  and  2),  GAD  (experiment  3)  or  SP 
(experiment  4),  rhodamine-red  immunoglobulin  (1:100;  Jackson  Immunoresearch)  to 
identify  NK-1  (all  experiments)  and  VGLUT2  (experiment  3)  and  cyanine  5.18 
immunoglobulin (1:100; Jackson Immunoresearch) raised against the corresponding animal  
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in the primary antibody to identify either NeuN (experiment 1) or NOS (experiments 2 and 
4).  Note that in the third group of experiments, both VGLUT2 and the NK-1 receptor were 
labelled with the same secondary antibody. This was possible because the NK-1 receptor is 
located  principally  on  cell  membranes  whereas  the  VGLUT2  is  found  within  axonal 
boutons.  For this reason both antigens can be labelled with a primary antibody of the same 
species (in this case guinea pig) coupled with the same secondary antibody thus allowing 
differentiation between the two types of immunoreactivity.  All antibodies were diluted in 
PBS with 0.3% Triton X-100.  Following the incubations in secondary antibodies, sections 
were  rinsed  thoroughly  in  PBS,  mounted  in  anti-fade  medium  (Vectashield;  Vector 
Laboratories, Peterborough, UK) and stored until required for analysis in a freezer at -20ºC. 
 
Quantitative analysis 
In all experiments, the left and right  LSNs were scanned systematically by using a 
Radiance 2100 confocal laser microscope (Hemel-Hempstead, UK).  Tissue was scanned 
with a 40X oil-immersion lens for experiments 1 (PKC-γ, the NK-1 receptor and NeuN) 
and  4  (SP,  NOS  and  the  NK-1  receptor).    The  60X  oil-immersion  lens  was  used  for 
experiments 2 (PKC-γ, NOS and the NK-1 receptor) and 3(GAD, VGLUT2, the NK-1 
receptor and NOS).  Each image was captured at 1 m intervals (all 4 experiments) in the z-
axis with a zoom factor between 1 and 5.  In each animal, ten alternate sections were used 
for analysis from segments L3 – 5 (i.e. a total of 30 per animal) and two fields were taken 
from each section (one from the left LSN and one from the right LSN).  For each animal 
therefore, a total of 60 fields were taken covering all spinal segments. Image analysis was 
undertaken for all experiments by using Neurolucida for Confocal (MicroBrightField, Inc., 
Colchester, VT).  
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Quantitative analysis involved the following steps: 
Experiment 1: PKC-γ, NK-1 and NeuN (n=3): 1) LSN neurons were identified (by NeuN) 
and counted after image capture. This enabled an estimation of the mean number of cells 
for segments L3 – 5. 2). The neurons were then placed into one of three categories: (A) 
those immunoreactive for NK-1; B) those immunoreactive for PKC-γ; (C) those double 
labelled for both NK-1 and PKC-γ. 
Experiment 2: PKC-γ, NOS and NK-1 (n=3): 30 immunoreactive NK-1, PKC-γ and NK-1/ 
PKC-γ  double-labelled  neurons  were  selected  in  total.    Ten  NK-1,  ten  PKC-γ  and  ten 
double-labelled neurons were selected from each animal (3 from L3, 3 from L4 and 4 from 
L5 in  each animal). The mean total contact of NOS terminals per 100 m
2 on labelled 
neuron  was  determined  by  using  Neurolucida  Explorer  on  cells  digitised  with  the 
Neurolucida programme. 
Experiment 3: GAD, VGLUT2, NK-1 and NOS (n=3); The LSN was identified, and using 
the blue channel (for NOS terminals), five NOS terminals were selected at random from a 
single optical section from the left and right hand side of each 50 m section (i.e. 10 NOS 
terminals per 50 m section) and 10 sections were examined for segments L3 – 5 i.e. 100 
terminals per segment. As three segments were analysed for each of the three animals, this 
resulted in 300 terminals per animal i.e. 900 terminals analysed in total. Initially, NOS 
terminals were visualised in the blue channel alone and marked.    The other channels were 
selected in turn (i.e. red, VGLUT2 and NK-1; green, GAD) and co-localisation with either 
VGLUT2 and/or GAD was recorded for each of the NOS terminals selected. 
Experiment  4:  SP,  NOS  and  NK-1  (n=3):  This  category  was  used  to  determine  the 
relationship of SP terminals and NK-1 immunoreactive neurons in the LSN. 10 sections for 
each spinal segment were examined (i.e. 90 in total).  
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3.  Results 
SP, NK-1 receptor and PKC-γ neurons within the LSN  
It was found that SP was abundant within the LSN, and found surrounding the neuronal 
cell body and dendritic tree of NK-1 neurons (Figure 4.1). In addition, NOS was found 
surrounding primarily the NK-1 cell body, and closely related to the SP staining around the 
NK-1 labelled neuron in the LSN. 
The average number of sampled neurons (including ± S.D.) determined by the neuronal 
marker NeuN for the L3 – 5 segments combined in the three animals was 196 ± 47.6.  Of 
those LSN neurons, 30.99±5.2% were immunoreactive for the NK-1 receptor, 9.02±1.2% 
were immunoreactive for PKC- γ and 2.78±0.76% were immunoreactive for both markers 
(Figure 4.2). Therefore  the majority (57.2 ± 6.8%) of  LSN neurons   (shown by NeuN 
labelling) were not immunoreactive for either NK-1 or PKC- γ (Figure 4.3)  
 
Relationship of NOS terminals to NK-1 and PKC-γ neuronal cell bodies and dendrites 
Three patterns of distribution of NOS terminals in the LSN were identified: 1) those 
scattered throughout the LSN (Figures 4.4 – 4.5), 2) those clustered around NK-1 labelled 
neurons  (Figure  4.4),  or  3)  clustering  of  NOS  terminals  around  unidentified  neurons 
(Figure 4.5).  Of those NK-1 immunoreactive neurons in the LSN, 72.4% had clusters of 
NOS terminals around the cell body and dendritic tree.  However, only 6.4% of non-NK-1 
immunoreactive  neurons  (i.e.  labelled  only  with  NeuN)  had  clusters  of  NOS  terminals 
surrounding the cell.   
Figure 4.6 shows the frequency of NOS terminal contacts on NK-1, PKC-γ and NK-1/ 
PKC-γ cells.  From these data it can be seen that the greatest density of NOS terminal 
contacts is associated with cell bodies of NK-1 immunoreactive neurons in the LSN (mean 
total contact / 100 m
2 ± S.D. of 6.68 ± 4.29).  This compares with 1.24 ± 0.73 for PKC-γ  
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immunoreactive neurons and 1.28 ± 0.39 mean total contacts / 100 m
2 of NOS terminals 
on double-labelled NK-1 and PKC-γ cells.  Very small number of NOS terminals contacted 
proximal dendrites of NK-1 and dual labelled neurons (0.4 ± 0.32, 0 and 0.59 ± 0.36 mean 
total  contacts  /  100 m
2  of  NOS  terminals  respectively).      Dendritic  trees  of  PKC-γ 
immunoreactive  neurons  were  insufficiently  labelled  to  permit  this  type  of  analysis. 
Contact densities of NOS terminals on the cell bodies of NK-1 immunoreactive neurons 
were significantly different from those associated with NK-1 dendrites, PKC- γ cell bodies 
and  double-labelled  cells  (one-way  ANOVA  p<0.0005).  This  suggests  that  NOS 
immunoreactive terminals preferentially target the cell bodies of  NK-1 immunoreactive 
neurons. 
 
Distribution of NOS-immunoreactive fibres within the LSN and patterns of co-localisation 
with GAD and VGLUT2 
Subsequently,  random  NOS  terminals  were  analysed  to  determine  their  relationship 
with  the  markers  VGLUT2  and  GAD  (markers  for  excitatory  or  inhibitory  amino  acid 
transmitters respectively).  It has been shown previously that GABA is co-localised within 
most  NOS  immunoreactive  boutons  in  inner  lamina  II  (Valtschanoff  et  al.,  1992b).  
However, in the LSN, only 22.1% of NOS terminals contained co-localised GAD and no 
co-localisation was found between NOS and VGLUT2 (Figure 4.7).   
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Figure 4.1.  The relationship of SP to the NK-1 receptor in the LSN.  A – C represent a 
confocal image built from 9 projected images.  A represents NK-1 in red, B represents SP in 
green, C represents NOS and D is the merged image of A – C.  Note that * represents NK-1 
neurons in the LSN.  SDH = superficial dorsal horn.  Scale bar = 20 m. 
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Figure 4.2. Neurochemical properties of LSN cells.  A - C, represents a series of confocal 
images of a transverse section of the LSN built from ten projected images (A, NeuN; B, 
PKC-γ; C, NK-1; D = merged image of A, B & C).  A PKC-γ immunoreactive cell (1) is 
adjacent  to  an  NK-1  labelled  neuron  (2)  and  NeuN  cells  that  are  not  labelled  for  either 
marker (3).  The superficial dorsal horn is present at the top left of each image (SDH).  Scale 
bar = 50 m.    
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Figure 4.3.  Histogram summarising the frequency of NK-1, PKC-γ and double-labelled NK-
1 and PKC-γ cells as a proportion of the total numbers of neurons in the LSN, identified with 
the neuronal marker NeuN. The majority (57.2%) of neurons in the LSN are not labelled for 
either NK-1 and/or PKC-γ; n=3; error bars =  ± S.D. 
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Figure 4.4.  Clustering of NOS terminals around an NK-1 cell in the LSN.  A - C, Single 
optical section in the transverse plane (A, NK1 and VGLUT2; B, GAD; C, NOS; D, merged 
image of A, B & C).  An NK-1 immunoreactive neuron (*) is associated with a dense plexus 
of NOS terminals which surround its cell body and also partly extend to its dendritic tree.  
Some GAD and VGLUT2 terminals are also associated with the NK-1 labelled cell.  The 
superficial dorsal horn (SDH) can be seen immediately to the left of the NK-1 neuron.  Scale 
bar = 20 m.  
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Figure 4.5.  Clustering of NOS, GAD and VGLUT2 around an NK-1 negative cell.  A – 
C represents 9 confocal images projected showing NK1 and VGLUT2 (A), GAD (B) and 
NOS (C).  A merged image of A, B & C is shown in D.  An NK-1 immunoreactive neuron 
can be seen to the left  of this image (*) which is not associated with  a cluster of NOS 
terminals. An unlabelled neuron is present at the right of the field (1) which is surrounded by 
NOS and VGLUT2 terminals with some GAD. Note the lack of clustering of VGLUT2, NOS 
and GAD around an NK-1 cell.  Scale bar = 20 m.  
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Figure 4.6.  A histogram showing the packing density of NOS terminal contacts on neuronal 
cell bodies (cb) and dendrites (d) of NK-1, PKC-γ and double-labelled cells in the LSN.   n = 
3; error bars = ± S.D. 
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Figure 4.7.  Co-localisation of GAD in some NOS terminals. A - C represents a single 
optical section (X60 oil immersion lens, zoom factor of 5) showing immunoreactivity for 
VGLUT2 (A), GAD (B) and NOS (C). D is a merged image of A, B & C.  NOS terminals 
that  co-localised  with  GAD  are  indicated  by  the  arrows.  Note  that  VGLUT2 
immunoreactivity is not co-localised within any of the NOS terminals and that the majority 
of NOS terminals do not show immunoreactivity for GAD.  Scale bar = 50 m. 
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4.  Discussion 
The main findings of this study are threefold: firstly, although the LSN displays strong 
immunoreactivity for SP, and is related to NK-1 neurons (e.g. see Barber et al., 1979 and 
Figure  4.1),  the  proportion  of  LSN  neurons  labelled  with  the  NK-1  receptor  is  only 
approximately one-third of the total neuronal population.  Secondly, a sub-population of 
NK-1 immunoreactive cell bodies (almost three-quarters of NK-1 neurons in the LSN) are 
densely innervated by NOS terminals (as well as SP), but this arrangement was not found 
for  cells  that  possess  immunoreactivity  for  PKC-γ  or  those  possessing  both  types  of 
immunoreactivity.    Thirdly,  while  NOS-immunoreactive  terminals  are  abundant  in  the 
LSN, less than a quarter of them contain GAD. Therefore, unlike the SDH, NOS terminals 
in the LSN are not derived principally from GABAergic inhibitory neurons.   
 
Origins of Substance P in the Lateral Spinal Nucleus  
Leah  and  co-workers  (1988)  performed  a  detailed  investigation  of  neuropeptide-
containing ascending tract cells in the rat lumbosacral spinal cord.  They found that 90% of 
peptidergic ascending tract cells were congregated into two distinct areas; the LSN and the 
region surrounding the central canal.  The neuropeptide-containing tract cells in the LSN 
were found principally to contain SP, VIP, bombesin and dynorphin (Barber et al., 1979; 
Bresnahan et al., 1984; Cliffer et al., 1988). In addition, axon terminals containing CGRP 
are not present within the LSN (Olave and Maxwell, 2004). As SP is co-localised with 
CGRP in peptidergic primary afferents, this is further evidence against a primary afferent 
source of SP axons in the LSN.   It also seems unlikely that the SP axons in the LSN 
originate  from  a  descending  source  as  Cliffer  et  al.  (1988)  have  shown  that  spinal 
transections do not reduce the numbers of SP-immunoreactive fibres.   It therefore appears  
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that the source of SP fibres in the LSN is principally segmental and it is likely that they 
originate from the adjacent dorsal horn, and perhaps also within the LSN itself.  
 
The NK-1 receptor and the LSN 
This study has shown that one-third of all neurons in the LSN possess the target of SP, 
the NK-1 receptor, which is well established as serving a role in nociceptive transmission 
in the superficial dorsal horn (Kuraishi et al., 1985; McCarson and Goldstein, 1991).  This 
in itself highlights an additional contrast to the SDH.  Indeed, although more than three-
quarters of spinothalamic tract neurons in lamina I possess the NK-1 receptor (Marshall et 
al.,  1996),  NK-1  neurons  constitute  only  10%  of  the  total  at  this  site  that  project  to 
established  areas  for  nociceptive  information  processing  e.g.  the  thalamus  and  the 
parabrachial nucleus (Ding et al., 1995; Marshall et al., 1996).  Therefore, it may well be 
that the LSN serves a role in nociception. Olave and Maxwell (2004) further developed the 
idea that the LSN may be involved in nociceptive processing when they demonstrated that 
a small proportion (approximately 10%) of these NK-1 neurons also expressed the nuclear 
protein Fos, in response to noxious thermal stimulation (see also Chapter 3).  Most of the 
NK-1 projection neurons that responded to noxious stimulation projected to the caudal 
ventrolateral  medulla  (CVLM),  an  area  of  the  brainstem  that  may  have  a  role  as  an 
inhibitory modulator of nociceptive transmission (Tavares and Lima, 2002).   
 
The Lateral Spinal Nucleus and NOS 
In the SDH, NOS arises principally from GABAergic and glycinergic neurons and is 
also found in a sub-population of cholinergic neurons (Valtschanof et al., 1992b; Laing et 
al., 1994) but the pattern of co-localisation in the LSN appears to be different as GAD is 
found within only a minority of NOS terminals in the LSN.  
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  However,  in  common  with  the  SDH,  NOS  terminals  in  the  LSN  do  not  contain 
VGLUT2. As VGLUT1 terminals are not present in the LSN (Olave and Maxwell, 2004) it 
is  probable  that  the  majority  of  NOS  terminals  in  the  LSN  do  not  contain  classical 
excitatory or inhibitory neurotransmitters. This raises important questions about the origin 
of the NOS terminals in the LSN.  No NOS containing neuronal cell bodies were identified 
in the LSN from the sections examined in this study suggesting that an intrinsic origin is 
unlikely.  In addition, it seems unlikely that many of them arise from the SDH, but one 
possibility is that they originate from the population of NOS cells found adjacent to the 
central canal which do not contain GABA or glycine (Laing et al., 1994).  Nevertheless the 
precise origin of NOS fibres in the LSN remains to be determined.  
 
NOS and cells possessing the NK-1 receptor  
In the present study, a close relationship between NOS terminals in the LSN and the 
majority  of  NK-1  receptor-expressing  neuronal  cell  bodies  has  been  shown.  This 
relationship was not observed for PKC-γ-containing neurons (which have an established 
role in nociceptive processing in the SDH (Malmberg et al., 1997)) or cells possessing 
immunoreactivity for both NK-1 and PKC-γ. Therefore, despite the close relationship that 
exists between the NK-1 receptor and PKC-γ in laminae I and II of the superficial dorsal 
horn (Polgár et al., 1999), the same does not hold true within the LSN.  Also, with so few 
neurons  possessing  PKC-γ  immunoreactivity  (and  dual  NK-1  and  PKC-γ 
immunoreactivity), the LSN may not be involved in processing neuropathic pain, as occurs 
in the dorsal horn (Malmberg et al., 1997) via PKC-γ dependant means. 
This study has not shown that the relationship between NOS axons and NK-1 cells is 
synaptic, but as NO is a diffusible neuromodulator, and given the intense concentration of 
NOS axons around these cells (mainly their cell bodies) it is reasonable to suggest that  
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when NOS axons are active, the levels of NO around these cells will be high.  However, 
not  all  NK-1  cells  were  associated  with  NOS  clusters  (approximately  one-quarter)  and 
some  cells  which  did  not  possess  NK-1  immunoreactivity  were  associated  with  these 
clusters, although their numbers were low, accounting for only 6% of the total neuronal 
population  (Figure  4.5).    Therefore  the  original  hypothesis  that  NO  is  preferentially 
associated with (and may even influence the activity of) NK-1 cells in the LSN selectively 
may only be partially correct and some other property of these cells may be the key factor 
which  governs  NOS  clustering.  Axons  of  LSN  cells  form  components  of  a  number  of 
ascending tracts, including the spinomesencephalic (Menétrey et al., 1982), spinosolitary 
(Pechura and Liu, 1986), spinothalamic (Granum, 1986; Burstein et al., 1990a; Gauriau and 
Bernard, 2004) and spinohypothalamic tracts (Burstein et al., 1990b; Li et al., 1997) and it 
may be that the combination of projection target and neurochemical signature is the key 
determinant. 
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Chapter 5 
 
Investigation 3: 
 
Brain projections of LSN neurons with NK-1 
immunoreactivity  
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a)  Spinohypothalamic projections from the LSN 
1.  Introduction 
It is widely believed different regions of the hypothalamus play differing roles in a 
variety of autonomic and neuroendocrine functions (reviewed by Siegel and Sapru, 2006).  
Stimulation of the lateral hypothalamus causes the parasympathetic outflow to predominate 
(Milam et al., 1980; Yoshimatsu et al., 1984), and as it has one of the largest descending 
inputs to the periaqueductal grey (PAG) of the rat, is implicated in descending modulation 
of spinal neuronal activity, especially that resulting from noxious stimulation, and without 
affecting reactions to other stimuli  (Beitz, 1982; Basbaum and Fields, 1984; Jensen and 
Yaksh,  1984;  Aimone  and  Gebhart,  1987;  Tasker  et  al.,  1987;  Aimone  et  al.,  1988).  
Stimulation of the medial hypothalamus and specifically the ventromedial hypothalamic 
nucleus, results in domination of the sympathetic outflow (Inoue et al., 1977; Niijima et al., 
1984; Yoshimatsu et al., 1984; Saito et al., 1989; Uyama et al., 2004).  In addition, the 
medial hypothalamus (especially the ventromedial area) has been suggested to have an 
additional role in the motivational reaction to a noxious stimulus (Bester et al., 1995; Braz 
et  al.,  2005).    Specifically,  it  has  been  suggested  that  it  is  involved  in  processing 
information that may threaten the animal, and organises the execution of innate defensive 
behaviours  (Siegel,  2005;  Borszcz,  2006).    The  paraventricular  area  on  the  other  hand 
consists of several nuclei and controls the autonomic nervous system, regulation of visceral 
organs  (Kannan  et  al.,  1987;  Uyama  et  al.,  2004)  and  coordinates  neurosecretions 
influencing the pituitary gland (Freund-Mercier et al., 1981). 
Previously, a direct spinohypothalamic pathway  was not identified (Bowsher, 1957; 
Mehler et al., 1960; Boivie, 1979; Craig and Burton, 1985) and it was believed that the 
afferent  pathway  for  somatosensory  information  to  the  hypothalamus  was  transmitted 
exclusively  via  indirect,  multi-synaptic  projections.    The  earliest  suggestion  of  a  direct  
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projection from the spinal cord to the hypothalamus was based on anatomical studies in the 
monkey.  Chang and Ruch (1949) demonstrated that sectioning the monkey spinal cord 
resulted in degeneration at the supraoptic decussation at several levels of the hypothalamus 
bilaterally.  Since then numerous anatomical and electrophysiological studies have revealed 
that  somatosensory  and  visceral  information  can  reach  the  hypothalamus  through 
monosynaptic pathways that originate in medullary dorsal horn neurons and from all levels 
of the spinal cord (Burstein et al., 1987; Katter et al., 1996a,b; Kostarczyk et al., 1997; 
Zhang et al., 1999; Malick et al., 2000).  The physiological studies in the cervical (Dado et 
al., 1994a), thoracic (Zhang et al., 2002) and lumbosacral segments (Burstein et al., 1987, 
1991) have shown that the majority of spinal cord neurons projecting to the hypothalamus 
are strongly  activated by  noxious thermal and mechanical stimuli with sacral segments 
activated by noxious stimulation of both visceral and cutaneous structures (Katter et al., 
1996a,b). 
In  addition  to  physiological  studies,  Burstein  et  al.  (1987)  performed  several 
retrograde tracing techniques by injecting Fluoro-Gold (FG) into the hypothalamus and 
demonstrated a large number of labelled neurons bilaterally throughout the length of the 
spinal  cord,  with  approximately  half  located  in  the  lateral  reticulated  area  and  a  lesser 
proportion  around  the  central  canal  and  marginal  zone.    From  their  retrograde  tracing 
studies, they also showed a relatively large number of cells in the contralateral superficial 
dorsal horn, though mainly in the lower cervical cord of the rat.  Kayalioglu et al. (1999) 
injected FG into the rat hypothalamus and from careful observations of their diagrams, 
demonstrated  not  only  labelled  neurons  in  the  deeper  laminae  and  the  area  around  the 
central canal, but also in lamina I.  However, the numbers in lamina I were considerably 
less than in the area around the central canal.  This contrasts with anterograde studies done 
by Gauriau  and  Bernard (2004), who found that most of the projecting neurons to the  
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hypothalamus were located in the deeper laminae, with most of these being in the lateral 
reticulated area of lamina V.  However, their study was limited to the cervical segments of 
the rat.   
One feature common to these studies is the bilateral projections to the hypothalamus 
from the LSN.  This nucleus has been shown to project through a variety of tracts including 
the  spinohypothalamic  (Burstein  et  al.,  1996),  spinomesencephalic  (Pechura  and  Liu, 
1986), spinosolitary (Leah et al., 1988) and spinothalamic tracts (Gauriau and Bernard, 
2004)  but  there  is  still  uncertainty  regarding  the  function  of  this  nucleus.    Olave  and 
Maxwell  (2004)  suggested  a  nociceptive  function  of  this  nucleus  and  this  has  been 
supported to a degree in chapters 3 and 4. 
A possible role in visceroception and visceronociception could be postulated as a role 
for the LSN as Neuhuber (1982) and Neuhuber et al. (1986) have shown that afferents from 
the  greater  splanchnic  nerve,  the  inferior  mesenteric  plexus,  and  the  hypogastric  nerve 
terminate in the LSN.  In addition, transneuronal studies using pseudorabies virus (PRV) 
injected into the kidney (Schramm et al., 1993) and stellate ganglion (Jansen et al., 1995) 
have shown that the LSN innervates different types of sympathetic pre-ganglionic neurons.  
Jansen  and  Loewy  (1997)  have  also  shown  that  neurons  in  the  LSN  become 
transneuronally labelled after PRV injections into the superior cervical ganglion, stellate 
ganglion, celiac ganglion or adrenal gland.  It may well be that, along with lamina I cells 
(which are also activated by acute visceral information, like LSN cells (Menétrey and de 
Pommery, 1991), the  LSN may trigger sympathetic responses during intense and acute 
visceral  pain  (Jansen  and  Loewy,  1997).    So,  as  well  as  being  influenced  by  visceral 
nociceptive information, a loop system may exist between the LSN, the aforementioned 
ganglia and the hypothalamus.  
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The aim of the present investigation was to quantify the laminar distribution (including 
the LSN) of NK-1 projection neurons to both the lateral and medial hypothalamus.  In the 
first instance, retrograde labelling of spinohypothalamic projection neurons with CTb was 
combined  with  triple-immunofluorescence  to  examine  the  relationship  of  projection 
neurons that possess the NK-1 receptor, and for accurate quantification of the LSN neurons 
projecting to either the lateral or medial hypothalamus, the neuronal marker NeuN was also 
used.  Neurons of this type are likely to be involved in the transmission of nociceptive 
information (Naim et al., 1997; Todd et al., 2002). 
 
2.  Experimental Procedures 
Confocal microscopy and quantitative analysis 
Eight adult male Sprague-Dawley rats (150-250 g; Harlan, UK) were used in this study.  
They were housed under conditions of a 12 hour light-dark cycle with food and water 
provided ad libitum.  All experiments were performed in accordance with the UK Animals 
(Scientific  Procedures)  Act  1986.    Each  animal  was  deeply  anaesthetised 
(ketamine/xylazine mixture, 7.33 and 0.73mg/100 g i.p.), placed in a stereotaxic frame and 
a craniotomy performed.  An aqueous solution of CTb (200nl of 1% CTb; Sigma, Poole, 
Dorset, UK) was injected into either the left lateral hypothalamus (co-ordinates anterior-
posterior  [AP]  +  7.2;  dorsal-ventral  [DV]  +1.6;  medial-lateral  [ML]  +1.8;  Paxinos  and 
Watson,  1997;  n=4)  or  the  left  medial  hypothalamus  (AP  +  7.2;  DV  +1.5;  ML  +0.8; 
Paxinos and Watson, 1997; n=4) through a glass micropipette which was connected to an 
air-pressure microinjection system with injections which were performed vertically into the 
appropriate site.  After  injection of the CTb, the pipette was left in-situ for 5 minutes 
backtracking of the tracer.  The wound was sutured after the procedure and the rats were 
allowed to recover.  Following 3 days survival, the animals were placed in a chamber  
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containing  halothane  and  once  anaesthetised,  received  a  lethal  dose  of  sodium 
pentobarbitone  (1  ml  i.p;  200mg/ml)  and  then  perfused  through  the  left  ventricle  with 
saline  followed  by  a  fixative  containing  4%  freshly  depolymerised  formaldehyde  in 
phosphate buffer pH 7.6.  The spinal segments C1 – 2, C5 and L3 – 5 were removed from 
each animal, notched on the left side to indicate the ipsilateral side to the injection, and 
post-fixed for 8 hours in the same solution.  Following fixation, transverse spinal cord 
sections  (50 m  thick)  were  cut  using  a  Vibratome  and  alternate  sections  retrieved  for 
examination from each spinal segment. 
Initially,  sections  were  treated  with  50%  ethanol  to  enhance  antibody  penetration 
(Llewellyn-Smith  and  Minson,  1992)  before  undergoing  triple-labelling 
immunofluorescence  with  a  goat  anti-CTb  antiserum  (diluted  1:5000;  Sigma,  Poole), 
mouse anti-NeuN antiserum (diluted 1:1000; Millipore, Watford, UK) and guinea pig anti-
NK-1 antiserum (diluted 1:1000; Sigma).  After 48 hrs incubation, sections were rinsed and 
incubated  overnight  in  solutions  containing  three  different  species-specific  secondary 
antibodies that were raised in donkey and coupled to fluorophores: rhodamine-red-anti-goat 
immunoglobulin  G  (IgG;  diluted  1:500;  Jackson  Immunoresearch)  to  identify  CTb 
immunoreactivity; cyanine 5.18-anti-mouse IgG (diluted 1:500; Jackson Immunoresearch) 
to identify the neuronal marker NeuN and Alexa-488-anti-guinea-pig IgG (diluted 1:100; 
Molecular  Probes)  to  identify  the  NK-1  receptor.    All  antibodies  were  diluted  in  PBS 
containing 0.3% Triton X-100.  After extensive rinsing of the sections, they were mounted 
using  an  anti-fade  medium  (Vectashield;  Vector  Laboratories)  and  stored  in  a  freezer 
maintained at -20°C until analysis was undertaken. 
The injection sites were confirmed using histological means.  Following perfusion, the 
brains  were  stored  overnight  in  the  4%  freshly  depolymerised  formaldehyde  with  30% 
sucrose in PBS at pH 7.6.  The next day, the brains were cut on the freezing microtome into  
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100 m  thick  sections  and  incubated  with  goat  anti-CTb  antiserum  (diluted  1:50,000; 
Sigma) for 48 hrs followed by the avidin-biotin-horseradish peroxidase (HRP) complex 
(Vector Elite) for 1 h.  Standard DAB reactions were performed followed by dehydration 
and mounting on glass slides.  The sections were then examined using a transmitted light 
microscope  to  identify  the  extent  of  the  spread  of  the  tracer.    Reconstruction  of  the 
injection sites for each of the experiments was undertaken using the Paxinos and Watson 
atlas  (1997)  and  composed  graphically  using  the  2-D  vector  graphics  editor  software 
program Xara Xtreme (Xara Group Ltd., Hemel-Hempstead, UK). 
Ten alternate sections were examined from C1 - C2, C5, and each of the lumbar spinal 
segments (L3 - 5), resulting in a total of 50 sections (each 50 m thick) from each rat.  The 
retrogradely labelled neurons (as revealed using the red channel to visualise CTb) were 
identified and then scanned with a confocal microscope (Bio-Rad MRC 1024; Bio-Rad, 
Hemel-Hempstead, UK) through dry (4X, 10X, 20X) and oil-immersion (40X, 60X) lenses.  
To prevent over-counting which may arise if transected cells are at the section surface, cells 
were only included if the nucleus (seen as a filling defect) was entirely contained within the 
Vibratome section, or if part of the nucleus was present in the first optical section from the 
z-series.  However, they were excluded if part of the nucleus was present in the last optical 
section in the z-series (Spike et al., 2003).  The low magnification images were used to plot 
the  position  of  the  CTb  labelled  cells  on  an  outline  of  the  spinal  cord.    Dark-field 
microscopy was used to distinguish laminar boundaries, with retrogradely labelled neurons 
counted as lamina I if they were close to the dorsal border of the dorsal horn or lay dorsal 
to  the  dark  band  identified  as  lamina  II  with  dark-field  microscopy.    Other  laminar 
boundaries were created individually for each section based on standard reconstructions 
seen in Paxinos and Watson (1997).  After the laminar boundaries were determined, the 
precise location of each retrogradely labelled neuron was established.  Using the image  
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analysis  programme  Neurolucida  for  Confocal  software  (MicroBrightField,  Inc., 
Colchester,  VT),  the  green  channel  was  examined  to  see  if  the  retrogradely  labelled 
neurons possessed the NK-1 receptor.  Finally, the LSN neurons were examined to identify 
the proportion of NeuN labelled neurons (observed through the blue channel) that were 
retrogradely labelled, and of them, what proportion possessed the NK-1 receptor.   
 
3.  Results 
To examine the total population of neurons in the spinal cord (including the LSN) that 
projected to the hypothalamus, as well as identifying if there are differences in projections 
to the medial and lateral hypothalamus, the retrograde tracer CTb was injected into eight 
rats.  Four of these rats received a CTb injection to the lateral hypothalamus (experiment 
numbers 1 - 4) and four received it to the medial hypothalamus (experiment numbers 5 - 8).   
 
Injection sites 
For the lateral hypothalamic injection experiments, reconstructions of the anterior and 
posterior extents including the centre of the injections are indicated in Figure 5.1.  The 
most representative photomicrograph is indicated above each of the reconstructions.  In 
experiment 1 (Figure 5.1a) slight spread of tracer was found in the ventrolateral part of the 
anteroventral thalamic nucleus and the ventral anterior thalamic nucleus.  In experiment 2 
(Figure  5.1b,)  there  was  leakage  of  the  tracer  into  the  mediododorsal  thalamic  nuclei, 
ventromedial thalamic nucleus, interanteromedial thalamic nucleus and the tuber cinereum 
area.  In experiment 3 (Figure 5.1c), there was the most extensive spread of the CTb tracer 
into  the  anteroventral  thalamic  nuclei  (both  dorsomedial  and  ventrolateral  parts), 
ventromedial and lateral thalamic nuclei, some of the mediodorsal thalamic nucleus and, 
due  to  its  proximity  to  the  hypothalamus,  a  small  part  of  the  internal  capsule.    In  
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experiment 4 (Figure 5.1d), there was least leakage of tracer with only a small amount 
identified in the reticular thalamic nucleus.  No retrograde tracer passed to the contralateral 
side in any of the four experiments. 
For  the  medial  hypothalamic  injection  experiments,  the  reconstructions  of  the  most 
anterior and posterior extents of the spread of retrograde tracer after medial hypothalamic 
injections in the four experiments (experiment numbers 5 – 8) can be seen in Figure 5.2.  
Again,  the  most  representative  image  of  the  injection  site  is  shown  above  the 
reconstructions for each of the experiments.  Experiment number 5 was the most focal 
(Figure 5.2a), with least spread of tracer into surrounding structures.  There was passage of 
tracer into the anterior hypothalamic area, zona incerta, central medial hypothalamic area, 
the ventrolateral and anterior parts of the ventromedial hypothalamic nucleus, dorsomedial 
hypothalamic nucleus (dorsal part) and the submedius thalamic nucleus.  No leakage to the 
contralateral side was noted.  The sixth experiment in this series (Figure 5.2b) had the 
greatest spread of the tracer to other nearby structures.  Tracer was found in the anterior 
hypothalamic  area,  central  and  ventrolateral  parts  of  the  ventromedial  hypothalamic 
nucleus and the dorsal part of the dorsomedial hypothalamic nucleus.  In addition, there 
was  considerable  leakage  of  tracer  into  the  central  medial  thalamic,  centrolateral  and 
mediodorsal thalamic nuclei.  There was also leakage of the tracer into the contralateral 
submedius thalamic nucleus.  The seventh experiment in this series (Figure 5.2c) had tracer 
located in the ventral anterior and ventromedial thalamic nuclei with only some in the 
medial part of the mediodorsal thalamic nucleus.  The eighth experiment (Figure 5.2d) had 
some  leakage  of  tracer  into  the  anteromedial  thalamic,  the  interanteromedial  thalamic 
nucleus and the ventral anterior thalamic nucleus.  No leakage to the contralateral side was 
identified. 
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Distribution of retrogradely labelled neurons 
The  distributions  of  retrogradely  labelled  neurons  were  generally  similar  across  all 
eight experiments where CTb was injected into either the lateral or medial hypothalamus 
(Figures 5.3 and 5.4 respectively).  However, with experiment 6, where greatest leakage 
into surrounding structures occurred (with almost twelve times the number of retrogradely 
labelled neurons compared to the next largest in the medial hypothalamic injection series), 
this was not included to allow for fair statistical comparison between the other more focal 
hypothalamic injections. Retrogradely labelled neurons were found bilaterally in the spinal 
cord  segments  i.e.  both  ipsilateral  and  contralateral  to  the  injection  sites.    In  addition, 
retrogradely  labelled  neurons  were  predominantly  found  in  two  laminae  –  V  and  VII.   
They constituted 55.6 ± 11.6% and 53.4 ± 10.1% of all retrogradely labelled neurons for 
the lateral and medial hypothalamic injections respectively.  A typical lamina V neuron is 
shown  in  Figure  5.5.    Figure  5.6  summarises  the  laminar  distribution  of  retrogradely 
labelled neurons after lateral and medial hypothalamic injections of the retrograde tracer 
CTb.    For  both  the  lateral  and  medial  hypothalamic  injections,  the  greatest  number  of 
retrogradely labelled neurons was located in the spinal segment C1 – 2 with almost a third 
located there for each of the hypothalamic regions injected with CTb (31.5 ± 13.4%, lateral 
hypothalamus; 31.9 ± 3.9%, medial hypothalamus).  The least numbers of retrogradely 
labelled  neurons  after  either  lateral  hypothalamic  or  medial  hypothalamic  injections 
occurred in the C5 spinal segment (9.72 ± 5.6% and 8.9 ± 2.5% respectively).  Figure 5.7 
shows the distribution of retrogradely labelled neurons over the spinal segments examined. 
Interestingly, however, where there was leakage into surrounding thalamic structures, 
retrogradely labelled neurons were identified in laminae I – II in both the lateral and medial 
hypothalamic injections with CTb, whereas if the injection was focussed on primarily the 
lateral or medial hypothalamic target, no laminae I – II retrogradely labelled neurons were  
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noted.    In  experiment  6  (medial  hypothalamic  injection)  where  there  was  the  greatest 
leakage of CTb tracer (of all experiments) into surrounding thalamic structures, a high 
number of retrogradely labelled neurons were identified in laminae I – II (11.4% of all 
retrogradely labelled neurons) and the white matter extending from the lateral reticulated 
area of lamina V towards the LSN (9.9%) but primarily the area around the central canal 
(26.8% of all retrogradely labelled neurons). 
 
Retrogradely labelled neurons in the LSN 
Common to both lateral and medial hypothalamic injections of the retrograde tracer 
CTb, the LSN contained a large proportion of all the retrogradely labelled neurons (25.7 ± 
5.6% and 21.3 ± 7.3% respectively).  A typical retrogradely labelled LSN neuron is shown 
in  Figure  5.8.    Of  all  the  retrogradely  labelled  neurons  found  throughout  the  vertebral 
segments that were immunoreactive for the NK-1 receptor, almost half were located in the 
LSN (45 ± 8.2%, lateral hypothalamus; 47.9 ± 4.5%, medial hypothalamus).  However, the 
retrogradely  labelled  neurons  from  hypothalamic  injections  constituted  only  a  small 
proportion of the total neuronal population (revealed by NeuN) of the LSN (Figure 5.9), yet 
greater than 80% of those retrogradely labelled LSN neurons possessed the NK-1 receptor. 
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Figure 5.1.  Reconstruction of the injection sites to the lateral hypothalamus (n=4).  a - d 
represents each of the experiments 1 – 4 respectively.  A representative photomicrograph is 
shown  above  each  of  the  reconstructions  for  each  animal.    The  spread  of  the  tracer  is 
represented by the dark grey area and in c, the paler area represents the leakage of CTb.  Note 
that there is variable leakage into the thalamus, with most occurring in experiment c, and 
least in d.  The numbers below each tracing indicates the interaural co-ordinate (Paxinos and 
Watson, 1997). 
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Figure 5.2.  Reconstruction of injection sites to the medial hypothalamus (n=4).  a - d 
represents experiments 5 - 8 respectively.  The spread of tracer is represented by the dark 
grey area, and in b, the paler area represents the caudal spread of CTb.  Note the extensive 
leakage  of  the  tracer  into  the  thalamus  in  experiment  6  (and  contralateral  spread).  The 
numbers below each tracing indicates the interaural co-ordinate (Paxinos and Watson, 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
112 
 
 
 
 
  
113 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  5.3.    Location  of  retrogradely  labelled  neurons  after  lateral  hypothalamic 
injections.   a – d represents experiments 1 - 4 where CTb was injected into the lateral 
hypothalamus (each corresponding to the reconstructions of the injection sites in Figures 5.1 
a – d respectively).  Each dark filled circle represents a single CTb labelled neuron in each of 
the named spinal segments.  The numbers of labelled neurons found in each side of the 
indicated segment are indicated in the ventral funiculus from each of the alternately selected 
segments.  Ten alternate sections were examined for each spinal segment, each 50 m thick.  
The figure in parentheses shows the total number of CTb labelled neurons in the LSN.  The 
left side of each segment diagram is contralateral to the injection site. 
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Figure  5.4.  Location  of  retrogradely  labelled  neurons  after  medial  hypothalamic 
injections.  a - d represents experiments 5 - 8 with each corresponding the reconstructions 
shown in Figure 5.2 a - d respectively in each of the stated spinal segments.  Each dark filled 
circle represents a single CTb labelled neuron in each of the named spinal segments.  The 
numbers in the ventral funiculus represents the total labelled neurons over ten alternately 
selected 50 m transverse spinal segments.  The figure in parentheses shows the total number 
of CTb labelled neurons in the  LSN.  The right side of each spinal segment diagram is 
ipsilateral to the injection. 
 
 
 
 
 
 
 
 
  
116 
 
 
 
 
 
  
117 
 
 
 
 
 
 
 
 
 
Figure 5.5. Example of a lamina V labelled neuron after CTb injection to the medial 
hypothalamus.  A – C, merged images of a transverse section of the contralateral lamina V 
(red, CTb; green, NK-1; blue, NeuN) built from 10 projected images.  A represents a single 
CTb labelled neuron in the centre of the field that is not immunoreactive for NK-1 (B), and 
shows NeuN immunoreactivity (C).   D is the merged image of A - C.  Scale bar = 50 m 
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Figure 5.6.  Histogram summarising laminar distributions of ALL retrogradely labelled 
spinohypothalamic neurons.  A represents the lateral hypothalamus, and B represents the 
medial hypothalamus.  Red = right (contralateral) to the injection, blue = left (ipsilateral) to 
the injection; error bars = ± S.D. 
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Figure 5.7.  Histograms summarising the spinal segment distributions.  A represents the 
spinal segment distribution of ALL retrogradely labelled neurons after lateral hypothalamic 
injections, and B represents the spinal segment distribution of ALL retrogradely labelled 
neurons after medial hypothalamic experiments; error bars = ± S.D. 
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Figure 5.8.  Triple labelling of CTb, NeuN and NK-1 in the LSN.  A – C, merged images 
of a transverse section of the LSN built from 10 projected confocal images (A, CTb; B, NK-
1;  C,  NeuN;  D,  merged  image  of  A  -  C).    A  contralateral  retrogradely  (from  lateral 
hypothalamic injection of tracer) labelled (CTb) neuron is in the LSN.  The SDH is present at 
the top right of each image.  Scale bar = 50 m. 
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Figure 5.9.  Histograms summarising the proportion of only LSN neurons (as labelled 
by  NeuN)  that  were  retrogradely  labelled  from  either  the  lateral  or  medial 
hypothalamus.  Histogram 1 (shown in A) shows the average percentages of NeuN labelled 
LSN neurons that were labelled either from the lateral or medial hypothalamic injections of 
CTb  (green:  right  side,  contralateral  to  injection;  red:  left  side,  ipsilateral  to  injection).  
Histogram  2  (shown  in  B)  shows  the  average  percentages  of  retrogradely  labelled  LSN 
neurons that possessed the NK-1 receptor either from the lateral or medial hypothalamic 
injections.  Error bars = ± S.D. 
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4. Discussion 
There are three main conclusions based on this study:  firstly, there are approximately 
the same numbers of projections to both the lateral and medial hypothalamus from the rat 
spinal  cord,  with  the  majority  of  retrogradely  labelled  neurons  in  laminae  V  and  VII.  
Secondly, it was more common for NK-1 retrogradely labelled neurons to be located in 
laminae V, VII and the LSN.  Finally, a similar amount of retrogradely labelled neurons 
projected to both the lateral (25.7 ± 5.6% of the total labelled) and medial (21.3 ± 7.3% of 
the total labelled) hypothalamus from the LSN, with the vast majority of those possessing 
the NK-1 receptor (>80%). 
 
The Spinohypothalamic Tract in the Rat 
This  present  study  confirms  and  extends  previous  anatomical  and  physiological 
observations made on spinal cord neurons that project bilaterally to both the medial and 
lateral  hypothalamus.    On  examination  of  the  experiments  where  the  injection  of  the 
retrograde tracer was found only, or primarily in the hypothalamic sites, there were almost 
identical distributions within the spinal cord.  Lamina V and lamina VII were consistently 
found with the greatest numbers of retrogradely labelled neurons when injection sites were 
located to the hypothalamic territories, as also shown by Burstein et al., 1990a and Katter et 
al., 1991.  This could be relevant regarding pain pathways as these two regions serve a role 
in nociceptive and proprioceptive processing (Hillman and Wall, 1969; Menetréy et al., 
1977; Light and Perl, 1979; Kevetter and Willis, 1982; Menétrey et al., 1984; Granum, 
1986;  Sugiura  et  al.,  1986;  De  Koninck  et  al.,  1992;  Mouton  and  Holstege,  1994; 
Littlewood  et  al.,  1995).    It  may  then  be  that  the  hypothalamus  serves  a  role  in  the 
autonomic responses to somatosensory stimulation, including painful stimuli.  Regardless 
of the area of the hypothalamus that was injected approximately half of all retrogradely  
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labelled neurons were located contralaterally, which is in agreement with Burstein et al. 
(1990a).   
However,  in  the  study  by  Burstein  et  al.  (1990a),  they  also  found  a  proportion  of 
retrogradely labelled neurons (using FG) were located in lamina I, and the area around the 
central  canal,  something  echoed  by  others  (Carstens  et  al.,  1990;  Katter  et  al.,  1991 
Menétrey and de Pommery, 1991; Kostarczyk et al., 1997; Kayalioglu et al., 1999).  With 
the experiments conducted in this study very few lamina I neurons were identified where 
only or mainly the hypothalamus was injected.  However, where there was leakage into 
many surrounding structures in experiment 6 (medial hypothalamic injection), there were 
large numbers of retrogradely labelled neurons in lamina I, and the area around the central 
canal. 
Projections from lamina I to the thalamus have been demonstrated in numerous species 
including cats (Trevino and Carstens, 1975; Craig et al., 1989; Zhang et al., 1996; Klop et 
al., 2004), primates (Apkarian and Hodge, 1989; Zhang and Craig, 1997) and also rats 
(Lima and Coimbra, 1988; Marshall et al., 1996; Yu et al., 2005).  This could explain why 
there  are  a  large  number  of  retrogradely  labelled  neurons  identified  in  lamina  I  in 
experiment 6, as there was extensive leakage of the tracer into the mediodorsal and ventral 
posteromedial thalamic nuclei (areas established as receiving lamina I projections).   
Recently, Gauriau and Bernard (2004) presented a very substantial projection from the 
SDH of the rat cervical spinal cord to the triangular part of the posterior thalamic nuclear 
group (PoT).  In addition, Al-Khater et al. (2008) demonstrated that there is a very specific 
projection from lamina I neurons possessing the NK-1 receptor to the PoT.  On careful 
examination of the reconstructions for experiment 6 (Figure 5.2b), it can be seen that there 
is some leakage of the retrograde tracer into the posterior thalamic nuclear group, though  
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not into the PoT as that lies at the extreme caudal end of the thalamus, providing a possible 
route that the tracer may have passed to result in the lamina I labelled neurons. 
 
Spinohypothalamic Tract Neurons and the NK-1 receptor 
The NK-1 receptor is the target of the tachykinin neuropeptide substance P (SP), which 
is secreted by small diameter, primary afferent fibres, many of which respond to noxious 
stimuli  (Duggan  and  Hendry,  1986;  Lawson  et  al.,  1997).    The  NK-1  receptor  is 
concentrated in lamina I but also scattered throughout the remaining of the dorsal horn and 
the area around the central canal (Bleazard et al., 1994; Nakaya et al., 1994; Brown et al., 
1995; Todd et al., 1998).  Interestingly, however, very few neurons in lamina II appear to 
have the receptor, despite this lamina having a rich innervation from SP containing axons 
(Marshall  et  al.,  1996).    However,  they  have  dorsally  oriented  dendrites  that  enter  the 
superficial  laminae  and  receive  substantial  SP  input  monosynaptically  from  primary 
afferents (Naim et al., 1997).  In addition, lamina V and the area round the central canal are 
established as receiving nociceptive afferent fibres (Bessou and Perl, 1969; Cuello and 
Kanazawa, 1978; Light and Perl, 1979; Mense and Praghakar, 1986; Sugiura et al., 1986; 
Willis  and  Coggeshall,  1991)  with  lamina  VII  also  showing  SP  immunoreactivity, 
suggesting  the  presence  locally  of  the  NK-1  receptor  and  second  order  nociceptive 
processing here (De Lanerolle and LaMotte, 1982).  We have shown that many of the 
neurons in lamina V and VII, and also the LSN projecting to either the medial or lateral 
hypothalamus, possess the NK-1 receptor suggesting a role of these projection neurons in 
nociception. 
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LSN neurons projecting to the hypothalamus possess the NK-1 receptor 
Almost one quarter of retrogradely labelled neurons was located in the LSN with very 
similar numbers projecting to either the lateral or medial hypothalamus (25.7 ± 5.6% and 
21.3 ± 7.3% respectively).  Regardless of the area of the hypothalamus that was injected, 
greater than 80% of all the retrogradely labelled neurons possessed the NK-1 receptor. 
 LSN  neurons  have  been  shown  to  contain  peptides  like  vasoactive  intestinal 
polypeptide, bombesin, SP and dynorphin (Leah et al., 1988) and project through many 
diverse  tracts  including  the  spinothalamic  tract  (Granum,  1986;  Burstein  et  al.,  1990b; 
Gauriau  and  Bernard,  2004),  spinoreticular  and  spinomesencephalic  tracts  (Menétrey, 
1982; Pechura and Liu, 1986).  Our findings support and extend studies done by other 
authors who have demonstrated a spinohypothalamic tract from the LSN (Burstein et al., 
1990a; Li et al., 1997), though some have only considered it from either the cervical (Dado 
et  al.,  1994a,b;  Gauriau  and  Bernard,  2004),  lumbar  (Zhang  et  al.,  1999)  or  sacral 
enlargements (Katter et al., 1996b) in isolation. 
An additional feature of the LSN is that within this nucleus there are a large numbers of 
peptidergic  varicosities.    Experimental  work  involving  interrupting  either  descending 
pathways  or  primary  afferent  input  to  the  LSN  did  not  affect  plexi  of SP,  enkephalin, 
dynorphin,  FMRF  amide  (a  neuropeptide  Y-like  substance)  or  somatostatin  at  this  site 
(Jessel et al., 1978; Larabi et al., 1983; Seybold and Elde, 1980; Giesler and Elde, 1985; 
Cliffer et al., 1988).  This shows that the peptidergic input to the LSN arises either at the 
same level, or segmental levels nearby, of the spinal cord.  Our findings support other 
authors’ studies that have shown an LSN-hypothalamic pathway, reinforcing work done by 
Li et al. (1997) who demonstrated that the LSN neurons projecting to the hypothalamus 
also possessed the substance P receptor.  We have also shown that of those that do, greater 
than 80% contain the NK-1 receptor, one of the G-protein coupled receptors, suggesting an  
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involvement  of  the  LSN  as  an  integrative  nucleus  involved  in  visceroception  and/or 
visceronociception and therefore, of autonomic and neuroendocrine regulation (Jansen and 
Loewy, 1997; Workman and Lumb, 1997; Hudson et al., 2000; Vergnano et al., 2008). 
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b)  Caudal ventrolateral medulla and mediodorsal thalamic projections from the LSN 
 
1.  Introduction 
The mediodorsal thalamus (MDT) is a major component of the thalamus of all mammals, 
and is especially developed in humans (Le Gros Clark, 1932a,b).  Indeed the functions of the 
MDT  are  wide  and  varied  with  it  being  well  established  that  it  plays  a  major  role  in 
emotional changes, anterograde amnesia where post-operative learning is severely affected 
especially in visual memory tasks (Schulman, 1957; Zola-Morgan and Squire, 1985; Parker 
et al., 1997; Gaffan and Watkins, 1991; Gaffan and Parker, 2000; Mitchell et al., 2007) and 
memory acquisition (Mitchell and Gaffan (2008). 
Major reciprocal connections exist between the MDT and the prefrontal cortex (Parker 
and Gaffan, 1998; McFarland and Haber, 2002; Erickson and Lewis, 2004) and (along with 
the  orbitofrontal  cortex)  has  descending  pathways  linked  to  the  amygdala  and  the 
hypothalamic nuclei (Barbas et al., 2003) in the primate.  As the MDT has been shown to 
serve a role in nociceptive processing (Casey, 1966; Palestini et al., 1987; Dostrovsky and 
Guilbaud, 1990), it could be said that a loop exists forming the “basolateral limbic system” 
composed of the MDT, amygdala, orbitofrontal cortex including that also of the rat (Krettek 
and  Price,  1977;  Sarter  and  Markowitsch,  1983,  1984;  Bachevalier  and  Mishkin,  1986; 
Cassell  and  Wright,  1986;  Gaffan  et  al.,  1993)  and  the  prefrontal  cortex  (Fuster,  1997).  
Therefore, the MDT could serve a role in the motivational and affective components of pain, 
including that of visceroception and visceronociception.  As well as the thalamus playing a 
major role in nociceptive processing, in recent years an increasing number of studies have 
been undertaken in examining the role of the medulla oblongata in its role in nociception. 
The medulla oblongata has the highest density of pain modulation areas in the brain. 
Several areas of the medulla are involved in endogenous antinociceptive processes including 
the rostroventromedial medulla (RVM), the nucleus tractus solitarius (NTS), ventral reticular  
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nucleus (VRt), dorsal reticular nucleus (DRt) and the caudal ventrolateral medulla (CVLM).  
In  recent  times,  the  CVLM  has  been  shown  to  have  a  significant  role  in  modulation  of 
nociception.  Indeed, the CVLM has a very important role in the inhibitory modulation of 
pain, and has been shown to inhibit nociceptive dorsal horn neurons (through monitoring 
electrical  thresholds  for  inhibition  and  the  magnitude  of  duration  of  suppression  of 
nociceptive reflexes (Gebhart and Ossipov, 1986; Janss and Gebhart, 1987, 1988)) more than 
areas including the locus coeruleus (Jones and Gebhart, 1986a,b), the periaqueductal grey 
(Carstens and Watkins, 1986; Jensen and Yaksh, 1984) and the RVM (Satoh et al., 1983; 
Ness and Gebhart, 1987). 
Stimulation of the CVLM has a potent antinociceptive effect, as demonstrated by the 
resulting marked inhibition of nociceptive spinal dorsal horn neurons (Morton et al., 1983; 
Janss and Gebhart, 1988; Liu and Zhao, 1992), which the CVLM forms a loop system with 
(reviewed  by  Tavares  and  Lima,  2002),  and  specifically  lamina  I  neurons,  but 
communications also exist between lamina IV – V and X (Fields et al., 1990).  The CVLM 
depresses  nociceptive  reflexes  (Gebhart  and  Ossipov,  1986;  Janss  and  Gebhart,  1987) 
through apposition to spinally projecting neurons only in the pontine A5 noradrenergic cell 
group and the RVM (Tavares et al., 1996).  Specifically, it is the lateral part of the CVLM 
where the α2-adrenoceptor anti-nociception produced in the CVLM is triggered in its lateral 
part, and mediated by the A5 noradrenergic cell group then passing to the spinal cord (and 
subsequent superficial dorsal horn) via the dorsolateral funiculus (Janss and Gebhart, 1988). 
It has been suggested that the LSN plays a role in nociception (as discussed in previous 
chapters), and projects to both the CVLM (Olave and Maxwell, 2004) and MDT (Gauriau 
and Bernard, 2004).  Therefore, this study was undertaken to identify the laminar distribution 
(including  the  LSN)  of  NK-1  projection  neurons  that  were  labelled  from  either/both  the 
CVLM  and  the  MDT.    Firstly,  the  retrograde  tracers  CTb  and  Fluoro-Gold  (FG)  were  
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injected into the CVLM and the MDT respectively.  This was combined with quadruple 
labelling immunofluorescence for the NK-1 receptor and the neuronal marker NeuN. 
 
2.  Experimental Procedures 
Experimental materials and methodology used in this study were the same as for the 
spinohypothalamic studies.  However, each rat used here (n = 3), received a single injection 
of 50nl 4% FG (Fluorochrome Inc., Englewood, CO) through a glass micropipette into the 
mediodorsal thalamus [coordinates = AP + 6.2; DV + 4.0; ML + 0.7] and 200nl of 1% 
cholera  toxin  B  subunit  (CTb;  Sigma,  Poole,  UK)  into  the  caudal  ventrolateral  medulla 
(CVLM) [coordinates = AP – 4.8; DV – 0.6; ML + 2.1], specifically the region between the 
spinal trigeminal nucleus and the lateral reticular nucleus.   
In addition to the same primary and secondary antibodies used for the spinohypothalamic 
studies, rabbit anti-FG (diluted 1:1000; Chemicon) was used as the primary antibody, and 
this was coupled to Alexa-488-anti-guinea-pig (diluted 1:500; Molecular Probes) to reveal 
FG immunoreactivity (as well as the NK-1 receptor).  Data collection and analysis were 
undertaken as previously described in the spinohypothalamic study. 
 
3.  Results 
Injection Sites  
To examine the total population of neurons in the spinal cord (including the LSN) that 
projected to the mediodorsal thalamus and/or the caudal ventrolateral medulla, the retrograde 
tracers FG and CTb (respectively) were injected into three rats. 
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Injection site – mediodorsal thalamus 
Reconstructions of the anterior and posterior extents of the spread of tracers, including 
the centre of the injections, are indicated in  Figures 5.10 (A - C). The light micrograph 
image, epifluorescent image, merged image (both light and epifluorescent images combined) 
and  reconstructions  are  shown  for  each  of  the  experiments  used.    The  first  of  the  three 
experiments studied had the least amount of FG tracer in the mediodorsal thalamus, whereas 
the other two cases filled the mediodorsal thalamus more extensively with greater leakage of 
tracer into nearby structures.  In the first experiment in this series (A), there was filling of the 
mediodorsal thalamic nuclei (central, lateral and medial), with some leakage into the dentate 
gyrus, paraventricular thalamic nucleus, medial and lateral habenular nucleus, hippocampus 
and some leakage into the posterior thalamic nuclear group.  In addition, there was some 
leakage  into  the  contralateral  central  and  lateral  mediodorsal  thalamus.    In  the  second 
experiment (B), more of the mediodorsal thalamic nucleus was filled ipsilaterally but also 
more  leakage  into  the  central  medial  thalamic  nucleus,  centrolateral  thalamic  nucleus, 
ventrolateral and ventromedial thalamic nucleus, submedius thalamic nucleus, ventral and 
dorsal  parts  of  the  subcoeruleus  nucleus,  medial  and  lateral  habenular  nucleus,  posterior 
thalamic nuclear group and the hippocampus.  No contralateral spread was present.  In the 
third experiment (C), there was extensive filling of the mediodorsal thalamic nuclei, with 
filling of the central medial thalamic nucleus, ventral anterior thalamic nucleus, ventromedial 
thalamic nucleus, submedius thalamic nucleus, medial and lateral habenular nucleus, and the 
posterior  thalamic  nuclear  group.    No  tracer  spread  to  the  contralateral  side.    In  all 
experiments,  there  were  small  foci  of  necrosis  identified  with  the  retrograde  tracer  FG, 
generally centrally located in the injection site. 
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Injection site – caudal ventrolateral medulla 
Injections into the dorsal part of the caudal medulla (Figure 5.10, D) were centred on the 
reticular nucleus reaching the lateral reticular nucleus, dorsal and ventral reticular nucleus, 
with  spread  into  the  spinal  trigeminal  nucleus  laterally.    No  contralateral  spread  was 
identified.   
 
Retrogradely labelled neurons  
The greatest numbers of retrogradely labelled neurons were double labelled with both FG 
and CTb, with the least number of retrogradely labelled neurons showing labelling with only 
CTb immunoreactivity (Figure 5.11).  Retrogradely labelled neurons were found bilaterally 
(i.e. ipsilateral and contralateral to the injection sites).  In general, the greatest numbers of 
retrogradely  labelled  neurons  occurred  in  the  C1-  2  spinal  segment  (38.7%,  CVLM  and 
MDT; 27.9% MDT) though there were slightly more labelled neurons from only the CVLM 
in the L3 segment (25.9%; Figure 5.11).  The spinal segmental distribution of retrogradely 
labelled neurons is shown in Figure 5.12.  Indeed, over all experimental groups that were 
retrogradely labelled from both the CVLM and the MDT, only the MDT or only to the 
CVLM,  there  was  a  similar  laminar  distribution  of  neurons  (Figure  5.13).    Retrogradely 
labelled neurons were found in one of four laminar territories: I – II, V and VII, and to a 
lesser degree the LSN.  Figures 5.14 and 5.15 show typical examples of lamina I and lamina 
VII retrogradely labelled neurons respectively. 
For each of the categories of retrogradely labelled neurons, the greatest frequency of 
labelled neurons occurred in the following laminae: laminae I – II that were retrogradely 
labelled from both the CVLM and MDT (38.7 ± 8.9%); laminae V – VII (59.5 ± 4.8%) that 
were retrogradely labelled from only the CVLM and laminae I – II (26.4 ± 4.4%) that were 
retrogradely labelled from the MDT.  
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NK-1 receptor labelling over all experimental groups was in greatest numbers found in 
the SDH in laminae I – II.  Of the total NK-1 receptor labelling for those neurons that were 
retrogradely labelled from both the CVLM and the MDT, 65.4 ± 4.7% were found in laminae 
I – II. 47.5 ± 4.7% of NK-1 receptor immunoreactivity where retrograde labelling occurred 
only from the MDT were found in laminae I – II.  Of the total NK-1 receptor labelling in the 
category of neurons that were retrogradely labelled only from the CVLM was 50 ± 10% in 
laminae I – II. 
 
Retrogradely labelled neurons in the LSN 
 Unlike  the  retrogradely  labelled  neurons  identified  after  hypothalamic  injections 
(discussed in Investigation 3a), the total retrogradely labelled neurons in the after CVLM and 
MDT  injections  was  lower  proportionally,  of  all  retrograde  neurons  identified  in  each 
grouping. 
As a total of all retrogradely labelled neurons that were double labelled from both the 
CVLM and the MDT, the proportion found in the LSN was 11.5 ±2.5%.  Of all retrogradely 
labelled  neurons  from  the  CVLM,  the  LSN  constituted  14.7  ±  5.3%  of  the  total.    For 
retrogradely labelled neurons only from the MDT, the LSN constituted 6.9 ± 4.3% of the 
total labelled neurons.  As a proportion of all LSN NeuN labelled neurons, they constituted a 
small proportion of the total (revealed by NeuN) as shown in Figure 5.16. 
A  similar  proportion  of  LSN  neurons  possessed  the  NK-1  receptor  that  were  double 
labelled from both the CVLM and the MDT (Figures 5.17, 5.18) and only labelled from the 
CVLM (52.5 ± 5.9% and 52.2 ± 8.7% respectively), but a smaller proportion only labelled 
from the MDT (25.3 ± 3.2%).   
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Figure 5.10.  Photomicrographs and diagrams showing the spread of the tracer for the 
CVLM and MDT injections.  A, B and C represent light micrograph images of the position 
of the retrograde tracer FG which was injected into the mediodorsal thalamus.  Ai, Bi and Ci 
represent  epifluorescent  images  of  the  same  site.    Aii,  Bii  and  Cii  are  the  merged 
photomicrograph and the epifluorescent images for each experiment.  Aiii, Biii and Ciii are 
reconstructions of the anterior and posterior extents of the leakage of FG.   D represents 
diagrams showing the spread of the retrograde tracer CTb after injection into the caudal 
ventrolateral medulla where i – iii represent experiments 1 – 3 as seen in A – C respectively.  
Numbers related to each of the reconstruction diagrams represents the approximate position 
of the section anterior (+) or posterior (-) to the ear bar.  Drawings based on those of Paxinos 
and Watson (1997).  Scale bar = 1 m. 
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Figure  5.11.    Location  of  ALL  retrogradely  labelled  neurons  after  injections  to  the 
CVLM  and  the  MDT,  including  those  with  the  NK-1  receptor.    A  represents  those 
retrogradely  labelled  neurons  from  both  the  CVLM  and  the  MDT,  B  represents  those 
retrogradely  labelled  neurons  from  only  the  CVLM  and  C  represents  those  retrogradely 
labelled neurons from only the MDT.  The left hand side of each diagram is contralateral to 
the  injection  sites.    The  number  in  the  ventral  white  matter  indicates  the  total  in  each 
vertebral segment on each side.  The number in parenthesis indicates the total number in the 
LSN. 
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Figure 5.12.   Mean percentages (including standard deviation) of ALL retrogradely 
labelled neurons.  Projections to both the CVLM and the MDT (A), only to the CVLM (B) 
or only to the MDT (C) according to ipsilateral or contralateral to the injection site across the 
spinal  segments  C1  –  2,  C5  and  L3  –  5.                                                                  .                                  
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Figure 5.13.  Histograms summarising the laminar distributions of ALL retrogradely 
labelled  neurons.    The  laminar  distributions  of  retrogradely  labelled  neurons  from  the 
CVLM and the MDT, only the CVLM and only the MDT (including those possessing the 
NK-1 receptor).  The contralateral and ipsilateral sides are shown respectively.  Error bars = 
± S.D. 
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Figure 5.14.  Quadruple labelling of CTb, FG, NK-1 and FG in the SDH.  A – C shows a 
single optical transverse section of the SDH (A, red, CTb; B, green, FG and NK-1; C, blue, 
NeuN; D, merged image of A, B and C).  1 represents an NK-1 labelled neuron (as shown by 
NeuN, blue) in lamina I which has not been retrogradely labelled from either the CVLM or 
MDT.  2 represents a lamina I neuron (labelled with NeuN, blue) that has been labelled from 
both the CVLM (CTB, red) and the MDT (FG, green), but not showing immunoreactivity for 
the NK-1 receptor.  3 represents a lamina I neuron (labelled with NeuN, blue) which shows 
immunoreactivity for the NK-1 receptor and has been retrogradely labelled from both the 
CVLM (CTB, red) and the MDT (FG, green).  Scale bar = 50 m. 
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Figure 5.15.  Quadruple labelling of CTb, FG, NK-1 and FG in lamina VII.  A – C, 
represents optical transverse image of lamina VII  (A, CTb, red; B, FG and NK-1, green; C, 
NeuN, blue; D, merged image of A - C).  A contralateral retrogradely labelled neuron (shown 
by immunoreactivity for NeuN, blue) in lamina VII that is labelled from both the CVLM 
(CTb, red) and the MDT (FG, green), though does not display immunoreactivity for the NK-
1 receptor.  This neuron is found at the centre of each of the images A – D.   Scale bar = 
20 m 
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Figure 5.16.  Histograms summarising the percentages of only retrogradely labelled 
LSN neurons (as revealed by NeuN) from both the CVLM and MDT, only the CVLM 
and only the MDT.  Histogram 1 (shown in A) shows the average percentages (within the 
LSN)  of  only  NeuN  labelled  LSN  neurons  that  were  labelled  from  each  of  the  sites.  
Histogram  2  (shown  in  B)  shows  the  average  percentages  (of  only  NeuN  labelled)  LSN 
retrogradely labelled neurons that possessed the NK-1 receptor. 
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Histogram 1.  Percentage of LSN neurons retrogradely labelled 
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Histogram 2.  Percentages of LSN neurons retrogradely labelled that possessed the NK-1 
receptor 
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Figure  5.17.    Quadruple  labelling  of  CTb,  FG,  NK-1  and  FG  in  the  LSN.    A  –  C 
represents 9 projected confocal images of a transverse section of the region of the LSN (A, 
CTb, red; B, FG and NK-1, green; C, NeuN, blue; D, merged image of A, B and C).  A 
contralateral retrogradely labelled neuron in the LSN that is labelled from both the CVLM 
(CTb,  red)  and  the  MDT  (FG,  green).    This  neuron  (as  indicated  by  *)  is  also 
immunoreactive for the NK-1 receptor.  The superficial dorsal horn (SDH) is to the right of 
each of the images A – D.  Scale bar = 50 m. 
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Figure  5.18.    Quadruple  labelling  of  CTb,  FG,  NK-1  and  FG  in  the  LSN.    A  –  C 
represents the neuron indicated by * in Fig. 5.18 at a higher magnification (A, CTb, red; B, 
FG and NK-1, green; C, NeuN, blue; D, merged image of A, B and C).    Scale bar = 10 m. 
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4.  Discussion 
The main finding of this study was that the majority of neurons in the spinal cord, whose 
cell bodies are primarily located in laminae I – II, V, VII and the LSN, project to both the 
CVLM and the MDT, rather than just to either the CVLM or the MDT, which are areas 
responsible for very different components of pain (Casey, 1966; Feltz et al., 1967; Gebhart 
and  Ossipov,  1986;  Sotgiu,  1986;  Janss  and  Gebhart,  1987;  Palestini  et  al.,  1987;  Price, 
1995).  In addition, more of the projection neurons to both of these sites were located in the 
cervical segments (especially the C1 – 2 spinal segments) compared to the lumbar segments.  
Those neurons projecting to both the CVLM and the MDT also possessed the NK-1 receptor, 
though  were  more  numerous  where  this  receptor  has  been  established  to  be  present  i.e. 
laminae I – IV, X and in the LSN (Bleazard et al., 1994; Liu et al., 1994; Nakaya et al., 1994; 
Brown et al., 1995; Littlewood et al., 1995). 
It is well established that a closed reciprocal loop exists with laminae I – II and the lateral 
part of the CVLM with terminal boutons labelled from these laminae having round vesicles 
and making asymmetrical synapses with this brain region projecting to those spinal laminae 
(Tavares and Lima, 2004).  Also, in lamina I there are flattened boutons which are labelled 
from the lateral caudal ventrolateral medulla.  As it has been shown that terminal boutons 
with round vesicles are excitatory, and those with flattened boutons are inhibitory (Uchizono, 
1965; Gray, 1969; Todd, 1991), the lamina I neurons delivering nociceptive information to 
the medulla at that point will result in descending modulation of pain through both excitatory 
and inhibitory means. 
This study has also identified many projection neurons to the medullary and thalamic 
sites in lamina V and VII.  Tavares and Lima (2004), in their diagrammatic representation of 
the circuitry between the spinal cord and the medulla, show that lamina V (and lamina IV) 
receives projections from the lateral ventrolateral medulla, thus explaining why many of the  
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neurons in our study have been labelled at this site.  However, lamina VII contains mainly 
pre-motor interneurons, and is targeted exclusively by the lateral reticular nucleus (Tavares 
and Lima, 2002).    On careful examination of the injection sites carried out in this study 
where CTb was injected into the CVLM, it can be seen that there is indeed filling of the 
lateral  reticulated  nucleus  in  all  three  experiments,  explaining  the  lamina  VII  labelled 
neurons from filling of this site.  As the lateral reticular nucleus can result in inhibition of 
nociceptive spinal neurons, as shown by electrical or glutamate stimulation (Morton et al., 
1983;  Gebhart  and  Ossipov,  1986)  of  the  lateral  reticulated  nucleus  (Janss  and  Gebhart, 
1988), it also responds to noxious visceral and cutaneous stimulation (Ness et al., 1998) with 
the electrical stimulation required to produce analgesia from this site lower than in other 
caudal ventrolateral medullary sites (Gebhart and Ossipov, 1986), with involvement of the 
LSN also in these roles through circuitry between laminae I, V and VII. 
In addition to the projections to the CVLM, many of these retrogradely labelled neurons 
were  also  labelled  from  FG  injected  into  the  MDT.    However,  although  it  has  been 
established that the neurons projecting to the medial thalamus have been found to be in the 
intermediate zone, laminae V and VII and the ventral horn, as this study also proves, many 
neurons were also retrogradely labelled that are present in lamina I, traditionally labelled 
from the lateral, and not the medial thalamus (Carstens and Trevino, 1978; Giesler et al., 
1979; Willis et al., 1979). 
As the diaminobenzidine (DAB) horseradish peroxides (HRP) procedure had been used 
in  some  of  these  previous  studies,  it  may  not  have  been  as  sensitive  as  the 
tetramethylbenzidine  reactions  used  by  Craig  and  Burton  (1981).    However,  Craig  and 
Burton (1981) used the anterograde tracer HRP and autoradiographic techniques and were 
the first to establish a unique projection of lamina I neurons to the nucleus submedius in the 
medial thalamus.  Examination of the injection sites in the second and third experiments used  
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in this study shows extensive leakage into this nucleus, perhaps explaining the numbers in 
this study in the superficial laminae.  Indeed, Craig and Burton (1981) also reported the 
existence  of  a  direct  projection  from  the  spinal  cord  and  the  caudal  part  of  the  spinal 
trigeminal nucleus (Sp5C) to the submedius nucleus of the thalamus.  Of note was that the 
cells of origin of both the spinothalamic and trigeminothalamic pathways (in the cat) were 
almost exclusively located in the marginal layer of both the spinal dorsal horn and the Sp5C 
(Craig and Burton, 1981), the area where there was also leakage of the tracer in the dorsal 
medullary injections in this study, but established as regions known to contain primarily 
nociceptive and thermoreceptive neurons (Dostrovsky and Hellon, 1978; Hu et al., 1981; 
Dubner and Bennett, 1983; Craig and Kniffki, 1985; Besson and Chaouch, 1987).  Their 
original  study  concentrated  on  the  cat,  but  in  the  rat,  the  cells  of  origin  of  the  spinal 
projection to the submedius nucleus are located in the deeper layers (Menétrey et al., 1984; 
Dado and Giesler, 1990) in contrast to their mainly exclusive location in the marginal layer in 
the cat.  In the rat trigeminal sensory nucleus less than 20% of the neurons are located in the 
marginal layer of the Sp5C and 60% are actually located in the interpolar part of the spinal 
trigeminal  nucleus  (Sp5I)  rather  than  in  Sp5C  (Yoshida  et  al.,  1991).    However,  in  our 
studies, leakage also occurred into the Sp5I.  Initially, Craig and Burton (1981) reported that 
lamina I neurons, after injections of HRP and titriated amino acids, projected to the nucleus 
submedius  in  the  medial  thalamus  in  the  cat,  monkey  and  rat.    They,  however,  used 
considerably more cats (14) compared to monkeys (2) and rats (3).  However, since that 
study Peschanski (1984) and then Iwata et al. (1992) also confirmed the lamina  I spinal 
neurons  projecting  to  the  nucleus  submedius  but  Dado  and  Giesler  (1990),  Cliffer  et  al. 
(1991) and Yoshida et al. (1991) were all unable to find this projection from both spinal and 
medullary superficial laminae.  These three investigators only used rats in their experimental 
work suggesting perhaps a species difference.  Therefore, the lamina I projections to the  
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nucleus  submedius  may  not  be  as  significant  as  first  thought.    Indeed,  in  the  rat,  the 
projection arising from the cervical enlargement is very sparse (Dado and Giesler, 1990), but 
from the trigeminal projection appears to originate from two regions as shown by Dado and 
Giesler (1990) and Yoshida et al. (1991): the interpolaris region and the ventral portion of the 
caudalis division.  Therefore, the lamina I labelled neurons could be explained by the leakage 
into the posterior thalamic group, as shown by Gauriau and Bernard (2004) and discussed 
earlier. 
Specifically,  the  ventral  posterolateral  thalamic  nucleus  (VPL),  ventral  posteromedial 
thalamic nucleus (VPM) and the posterior thalamic group (Po) regions contain numerous 
nociceptive neurons in the rat (Guilbaud et al., 1980; Peschanski et al., 1980).  In the rat, 
these nociceptive properties were from both superficial and deep spinal/trigeminal laminae 
(Lund and Webster, 1967; Peschanski et al., 1980; Granum, 1986; Burstein et al., 1990b; 
Cliffer et al., 1991; Iwata et al., 1992).  However, Gauriau and Bernard (2004) showed that 
most of the lamina I neurons projected to the VPL/VPM/Po regions.  We, however, have 
shown that many lamina I neurons project to both the mediodorsal thalamus and the caudal 
ventrolateral medulla, not the lateral areas of the thalamus mentioned in other studies. 
However, the injection sites in the three experiments used in this part of the study had 
leakage into the Po in all cases, explaining the greater number of lamina I neurons in our 
study, both for neurons retrogradely labelled from both the caudal ventrolateral medulla and 
the  mediodorsal  thalamus,  and  also  for  the  retrogradely  labelled  neurons  only  from  the 
mediodorsal  thalamus  as  according  to  Gauriau  and  Bernard  (2004).    More  recently,  Al-
Khater et al. (2008) showed, using fluorescent latex microspheres, a very discrete projection 
from lamina I to the PoT with the NK-1 receptor, and it may be that the lamina I neurons in 
this study also specifically project to this site via the leakage into the Po.  
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Interestingly, a significant number of retrogradely labelled neurons exist in the LSN that 
project  to  both  the  CVLM  and  the  MDT,  with  approximately  half  possessing  the  NK-1 
receptor.    The  LSN  has  also  been  shown  to  have  a  role  in  the  processing  of  visceral 
information (Menétrey et al., 1980; Leah et al., 1988; Schramm et al., 1993; Jansen et al., 
1995; Jansen et al., 1995), and potentially involved in nociception as previously discussed, 
with this nucleus projecting also through the spinothalamic (Gauriau and Bernard, 2004), 
spinoreticular, spinomesencephalic (Menétrey and Basbaum, 1987; Leah et al., 1988) and the 
spinohypothalamic tract (Burstein et al., 1996).  It is also known that LSN neurons project to 
laminae  I,  II,  V  and  VII  (Jansen  and  Loewy,  1997)  and  electrophysiological  studies 
demonstrated  that  these  neurons  exhibit  a  variety  of  intrinsic  properties,  which  could 
significantly contribute to sensory processing, including nociceptive processing (Jiang et al., 
1999).  Therefore, the LSN may serve an integrative role between these laminae and be 
involved in processing a variety of nociceptive pathways, including descending modulation 
(Carlton et al., 1985; Masson et al., 1991), and as the mediodorsal thalamus projects to the 
medial and orbital regions of the prefrontal cortex (areas strategically involved in autonomic 
visceromotor and cognitive functions (Neafsey et al., 1986, 1993; Loewy, 1991; Verberne 
and Owens, 1998; Gabbot et al., 2005)), it could be suggested that the LSN could have an 
integrative  role  in  visceral  function  and  visceronociception  providing  the  emotional  and 
motivational aspects of pain. 
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c)  Lateral globus pallidus projections from the LSN  
1.  Introduction 
The corpus striatum comprises the striatum (caudate nucleus and putamen) and the 
pallidum (globus pallidus), and forms the anatomical basis of the basal ganglia.  It is well 
established that the corpus striatum collectively is the site in which instructions for parts of 
learned movements are “remembered” and from which they transmit to the motor cortex 
for  integration  by  corticospinal  and  reticulospinal  pathways  to  the  motor  neurons.  
However, in addition to the areas traditionally associated with nociceptive processing, as 
previously  discussed,  and  the  spinothalamic  and  spinoreticular  pathways  thought  to 
constitute the major tracts transmitting nociceptive information, the globus pallidus has 
been suggested to also play a role in somatosensory transmission.  Studies have shown that 
the basal ganglia are important for processing sensory information, where electrical and 
mechanical stimulation of trigeminal receptive fields are important in activating neurons 
both in the caudate nucleus and the globus pallidus (Carelli and West, 1991; Levine et al., 
1987;  Lidsky  et  al.,  1978;  Manetto  and  Lidsky,  1989;  Schneider  et  al.,  1982,  1985; 
Schneider  and  Lidsky,  1981).    This  is  further  enhanced  by  high  concentrations  of 
endogenous  opiate  receptors  in  both  the  neostriatum  and  the  globus  pallidus  from 
immunocytochemistry and radioimmunoassay activity (Atweh and Kuhar, 1977; Hong et 
al., 1977a,b; Gros et al., 1978; Sar et al., 1978; Gramsch et al., 1979; Pickel et al., 1980; 
Herkenham and Pert, 1981; Jones et al., 1991; La Motte et al., 1978). Further to this, the 
globus  pallidus  also  has  been  implicated  in  nociception  as  injecting  morphine  into  the 
neostriatum or globus pallidus resulted in a naloxone reversible analgesia (Anagnostakis et 
al., 1992).  In addition, the caudate nucleus and putamen receive afferent fibres from the 
intralaminar nuclei of the thalamus (Jones and Leavitt, 1974; Van der Kooy, 1979; Veening  
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et al., 1980; Herkenham and Pert, 1981; Kaufman and Rosenquist, 1985; Kincaid et al., 
1991; Sadikot et al., 1992a,b) and the primary somatosensory cortex (Webster et al., 1961; 
Carman et al., 1965; Mercier et al., 1990).  This could offer an explanation to related motor 
activities that can be seen in response to pain.  Indeed, some patients with nerve injury 
induced  persistent  pain  conditions  have  profound  abnormalities  of  posture  and  motor 
control.    In  addition,  the  positions  of  injured  limbs  are  in  resembles  that  occurring  in 
patients with extra-pyramidal lesions (Schwartzman and Kerrigan, 1990). 
Spinopallidal connections, however, were studied using traditional anterograde tracing 
studies  in  the  rat  (Cliffer  et  al.,  1991;  Gauriau  and  Bernard,  2004)  and  the  primate 
(Newman  et  al.,  1996)  that  showed  occasional  spinal  cord  axons  entering  the  globus 
pallidus.  These studies showed that the spinopallidal projection was, in fact, a minor one.  
However, more recently, Braz et al. (2005) showed that there was a significant projection 
from the spinal cord to the globus pallidus. 
Using transgenic mice that expressed the transneuronal tracer WGA, Braz et al. (2005) 
induced  this  tracer  in  dorsal  root  ganglion  neurons  that  expressed  the  voltage  gated 
tetrodotoxin resistant Na
+ channel (Nav1.8) which, as they state, through mosaic express of 
the transgene, resulted in labelling for the Nav1.8 positive neurons that corresponded to the 
non-peptide  class  of  primary  afferent  nociceptors.    They  had  shown  that  lamina  II 
interneurons  were  part  of  the  major  ascending  pathways  targeted  by  that  class  of 
nociceptors.  From lamina II, Braz et al. (2005) stated that those interneurons contacted 
lamina V projection neurons, which projected to amongst other areas, the globus pallidus 
and constituted a greater pathway to this site than previously thought.  They expanded by 
showing that there was no transneuronal labelling in subcortical regions which link the 
spinal cord and the globus pallidus e.g., the pedunculopontine nucleus (Nakano, 2000), 
midline thalamic nuclei, parafascicularis and submedius (Groenewegen et al., 1990) or the  
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parabrachial  nuclei  (Bernard  and  Besson,  1990).    Interestingly  though,  in  the  study 
undertaken by Braz et al. (2005) using transneuronal transport of the genetically expressed 
lectin tracer, no labelling occurred in areas traditionally associated with the spinal cord 
projections for nociception like the ventroposterolateral nucleus of the thalamus. 
As there appears to be a discrepancy between studies regarding input to the globus 
pallidus, especially direct spinopallidal projections, a series of retrograde injections were 
undertaken to identify those projection neurons to the globus pallidus from the spinal cord, 
including the LSN.  Differences exist in input to different regions of the globus pallidus 
(Bernard et al., 1991) so this study used the retrograde tracer CTb injected into the lateral 
globus pallidus combined with immunocytochemistry for the tracer and the NK-1 receptor 
to quantify both the laminar distribution of spinopallidal projection neurons, and to identify 
those LSN neurons which may sub-serve a role for the motor activity, potentially related to 
pain. 
 
2.  Experimental Procedures 
Experimental procedures and methodologies used were similar to previous retrograde 
experiments.  Three adult male Sprague-Dawley rats (150-250g) were used where CTb was 
injected into the lateral GP (coordinates = anterior-posterior [AP] +6.9; dorsal-ventral [DV] 
+ 3.0; medial-lateral [ML] + 3.6), and the spinal segments (C1 – 2, C5, L3 – 5) were 
processed and analysed for CTb, NeuN and the NK-1 receptor as previously described 
using the same primary and secondary antibodies and processing techniques. 
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3.  Results 
The retrograde tracer CTb was injected into three rats, and immunocytochemistry for 
this was combined with the NK-1 receptor to establish if this pathway may be involved in 
nociceptive processing, and if so, to what extent. 
Injection sites 
Reconstructions of the anterior and posterior extent of the spread of the tracer CTb, is 
demonstrated in Figure 5.19.  Above each reconstruction (based on the atlas by Paxinos 
and Watson (1997)) is the most representative photomicrograph.  In the first experiment in 
this series (Figure 5.19a), CTb was found mainly in the lateral globus pallidus, with some 
spread  into  internal  capsule,  posterior  part  of  the  anterior  commissure  and  the  ventral 
pallidum.  The second of the experiments (Figure 5.19b) was the most focal of the three 
undertaken for the lateral globus pallidus where only a very small amount of tracer was 
found in the internal capsule, posterior part of the anterior commissure and the caudate 
putamen.    The  final  experiment  (Figure  5.19c)  had  greatest  leakage  outside  the  lateral 
globus pallidus with more extensive leakage into the caudate putamen and also into the 
anterodorsal part of the medial amygdaloid nucleus, central amygdaloid nucleus (medial, 
lateral  and  capsular  parts),  interstitial  nucleus  of  the  posterior  limb  of  the  anterior 
commissure,  basal  nucleus,  reticular  thalamic  nucleus  and  the  stria  terminalis.    No 
retrograde tracer was found on the contralateral side. 
 
Distribution of retrogradely labelled neurons 
The  distribution  of  retrogradely  labelled  neurons  after  CTb  injection  to  the  lateral 
globus pallidus can be seen in Figure 5.20.  Overall, the numbers of retrogradely labelled 
neurons was low, with only 43 neurons identified with CTb and were found bilaterally, but 
with predominantly contralateral to the injection site (67.4 ± 2.7%).  As with previous  
170 
 
 
 
 
retrograde labelling experiments, retrogradely labelled neurons were found in laminae V – 
VII with 53.4 ± 3.2% located in these locations. Interestingly, although total numbers were 
very low for retrograde labelling, the LSN comprised 29.9% of all CTb labelled neurons, 
were found bilaterally but preferentially on the contralateral side to the injection (20.67 ± 
9.2%, contralateral; 9.4 ± 8.3% ipsilateral).  This is summarised in Figure 5.21. 
Similar  to  previous  retrograde  labelling  experiments,  the  greatest  number 
proportionally of CTb labelling occurred in the cervical segments, specifically C1 – 2 (34.7 
± 3.5%).  The least number of retrogradely labelled neurons were found in L5 (7.3 ± 7.2%).  
This is summarised in Figure 5.21. 
This study also used immunocytochemistry for the NK-1 receptor, and interestingly 
none of the retrogradely labelled neurons from the lateral globus pallidus contained this 
receptor.  Representative images of a retrogradely labelled neuron in lamina V and the LSN 
are shown in Figure 5.22 and 5.23 respectively. 
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Figure 5.19.  Reconstruction of injections to the lateral globus pallidus (n = 3).  a - c 
represents  experiments  1  -  3  respectively  in  this  series.    The  spread  of  CTb  tracer  is 
represented by the dark grey area.  The numbers below each tracing indicates the interaural 
co-ordinate (Paxinos and Watson, 1997). 
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Figure  5.20.  Location  of  retrogradely  labelled  neurons  after  lateral  globus  pallidus 
injections.    a  -  c  represents  experiments  1  -  3  with  each  corresponding  with  the 
reconstructions shown in Figure 5.19a – c respectively, in each of the stated spinal segments.  
Each dark filled circle represents a single CTb labelled neuron in each of the named spinal 
segments.  The numbers in the ventral funiculus represents the total labelled neurons over ten 
alternately selected 50 m transverse spinal segments.  The figure in parentheses shows the 
total number of CTb labelled neurons in the LSN.  The right side of each spinal level diagram 
is ipsilateral to the injection. 
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Figure 5.21.  Distribution of ALL retrogradely labelled neurons after lateral globus 
pallidus  injections.    A  shows  the  mean  percentage  of  retrogradely  labelled  neurons  as 
distributed over the spinal segments C1 – 2, C5 and L3 – 5.  B shows the laminar distribution 
of retrogradely labelled neurons, including the LSN. 
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Figure 5.22.  Example of a lamina VII neuron labelled after CTb injection to the lateral 
globus pallidus.  A transverse section of lamina VII built from 9 projected confocal images 
(red, CTb;  green, NK-1; blue, NeuN).   A represents the single lamina  VII CTb labelled 
neuron in the middle of the field, that is not immunoreactive for NK-1 (B), and C represents 
the neuronal population.  D is the merged image of A, B and C.  Scale bar = 20 m 
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Figure 5.23.  Example of a LSN neuron labelled after CTb injection to the lateral globus 
pallidus.  Projected image of a transverse section of the ipsilateral LSN (red, CTb; green, 
NK-1; blue, NeuN) built from 9 confocal images.  A represents a single CTb labelled neuron 
identified by 1, that is not immunoreactive for NK-1 (B), and shows NeuN immunoreactivity 
(C).    2  represents  an  NK-1  immunoreactive  neuron  in  the  LSN  that  is  not  retrogradely 
labelled by CTb injected to the lateral globus pallidus.  D is the merged image of A - C.  
Scale bar = 50 m 
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4.  Discussion 
The main findings of this study are fourfold.  Firstly, the overall number of retrogradely 
labelled neurons identified was relatively small.  Secondly, of those retrogradely labelled 
neurons identified with CTb immunocytochemistry, the most common laminar distribution 
was in laminae V and VII.  Thirdly, almost one-third of all retrogradely labelled neurons 
were  found  in  the  LSN.    Fourthly,  of  those  retrogradely  labelled  neurons  found,  none 
possessed the NK-1 receptor. 
 
The Spinopallidal Tract in the Rat 
Recently, Braz et al. (2005) used transneuronal transport of a genetically expressed 
lectin  tracer  WGA  in  sensory  neurons  of  NaV1.8-expressing  mice.    They  showed  the 
densest accumulation of transganglionic transportation of WGA was found in terminals and 
cell bodies within neurons in lamina II, and corresponded to primarily to the IB4 non-
peptide class.  Indeed, they also stated that there was extensive transportation of WGA to 
the lateral aspect of the globus pallidus, and did not project to the subthalamic nucleus and 
substantia nigra pars reticulata due to a lack of co-localisation with parvalbumin (Ruskin 
and Marshall, 1997). .  They claimed because no labelling was found in subcortical regions 
that link the spinal cord and the globus pallidus e.g. submedius, parafascicularis and the 
midline thalamic nucleus (Groenewegen et al., 1990), pedunculopontine nucleus (Nakano, 
2000) or parabrachial nucleus (Bernard and Besson, 1990), that it must be a direct pathway. 
However, the results presented here show that the spinopallidal projection is not as 
significant as Braz et al. (2005) may have suggested.  Newan et al. (1996) had used the 
anterograde  tracer  Phaesolus  vulgaris-leucoagglutinin  (PHA-L)  and  biotinylated 
dextranamine  injected  it  into  the  upper  cervical  spinal  cord  (C1  –  2)  and  the  cervical 
enlargement at C5, and had showed a large number of labelled terminals in the globus  
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pallidus, many of which were from C1 – 2, in agreement with this study.  However, the 
limitation of that study was that the anterograde transport was only examined in the upper 
cervical  spinal  cord  and  the  cervical  enlargement  in  the  rat.    Although  the  material 
presented here also demonstrates predominance in the upper cervical segments (C1 – 2), 
the overall numbers were indeed very low. 
This study is also in agreement with anterograde tracing studies in the rat (Cliffer et al., 
1991; Gauriau and Bernard, 2004) that showed that a direct spinopallidal tract is in fact 
minor.    Interestingly,  although  Braz  et  al.  (2005)  demonstrated  large  numbers  of 
transneuronal labelling in the globus pallidus, very little labelling was found in traditional 
targets of the spinal cord like the ventroposterolateral nucleus of the thalamus.  As this 
study  shows  that  it  is  laminae  V  and  VII  neurons  that  were  labelled  more  frequently 
(despite overall numbers being low), Braz et al. (2005) propose that these neurons arising 
from  this  site  could  be part  of  the  nociceptive  circuit  engaged  especially  by  lamina  V 
neurons  that  receive  an  input  from  the  non-peptide  NaV1.8  expressing  population  of 
primary afferent nociceptors.  Gauriau and Bernard (2004) have demonstrated that it is the 
deeper laminae that target the globus pallidus, though in contrast to Braz et al. (2005), they 
have  shown  that  the  numbers  (from  the  cervical  segments  only)  are  indeed  low,  in 
agreement with the results presented here. 
Although the globus pallidus is a target of deeper spinal laminae, with wide dynamic 
range neurons projecting there (Bernard et al., 1992; Chudler et al., 1993), and the globus 
pallidus established (amongst many other functions) in nociception (Richards and Taylor, 
1992; Lin et al., 1985; Bernard et al., 1992; Chudler et al., 1993; Chudler and Dong, 1995), 
the actual numbers of retrogradely labelled neurons found in this study are relatively small 
compared to other traditional nociceptive pathways.  As this study has shown there to be 
relatively  few  retrogradely  labelled  neurons  (with  only  some  in  the  LSN),  and  none  
183 
 
 
 
 
possessing the NK-1 receptor, a direct nociceptive pathway to the globus pallidus from the 
spinal  cord  may  not  exist  to  the  extent  as  some  authors  have  claimed  previously.  
Therefore, although the globus pallidus is considered to be an output of the basal ganglia 
system  and  concerned  in  regulation  of  movement  (Delong,  1990;  Chesselet  and  Delfs, 
1996)  and  has  been  demonstrated  to  be  involved  in  sensory  and  cognitive  processing 
(Brown et al., 1997), the spinopallidal pathway is indeed very complex in the relations of 
pain and movement. 
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Chapter 6 
 
General Discussion 
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The aim of this chapter is to discuss further the functional significance of the results 
discussed  in  previous  chapters.    The  main  conclusions  of  each  investigation  are 
summarised briefly followed by hypothetical functional models. 
 
1.  Conclusions and models 
Investigation 1:   
The hypotheses initially proposed (p25) suggested the following: 
a)   LSN neurons receive cutaneous information 
b)   LSN neurons are activated by noxious cutaneous stimulation  
c)  There is a variable degree of expression of Fos depending on the stimulus, as in the 
SDH 
From this it can be concluded that the LSN does indeed receive cutaneous information, 
and  in  this  case  from  peripheral  cutaneous  noxious  stimuli  (thermal  and  chemical). 
However, only a small number of LSN neurons are activated by these various stimuli (in 
this  case  four  stimuli  were  used).  A  hot  thermal  stimulus  activated  the  most  of  those 
neurons as demonstrated by  Fos immunoreactivity, but approximately  15% of the total 
neuronal population at the site of the LSN were activated.  Interestingly, unlike the SDH, 
LSN neurons were activated on both the ipsilateral and contralateral sides to the application 
of  the  noxious  stimulus  applied  (apart  from  formaldehyde  application  to  the  hind-paw, 
which  showed  only  Fos  immunoreactivity  in  the  LSN  ipsilateral  to  the  side  of  the 
stimulus). 
 
The  LSN  could  play  a  role  in  nociception  based  on  its  neurochemical  profile 
(Ljungdahl et al., 1978; Barber et al., 1979; Seybold and Elde, 1980; Bresnahan et al., 
1984; Sasek et al., 1984; Vikman et al., 1998; Aarnisalo and Panula, 1998; Olave and  
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Maxwell,  2004)  and  target  projection  sites  (Pechura  and  Liu,  1986;  Leah  et  al.,  1988; 
Burstein  et  al.,  1996;  Jansen  and  Loewy,  1997;  Gauriau  and  Bernard,  2004),  though 
perhaps not to the extent as previously suggested. 
 The  work  presented  here  has  shown  varying  degrees  of  Fos  immunoreactivity 
dependent  on  the  stimulus  used,  with  hot  water  activating  most  LSN  neurons,  with 
approximately 15% of all LSN neurons showing Fos immunoreactivity.  However, despite 
the advantages of using c-Fos immunoreactivity to demonstrate nociceptive neurons, it also 
comes with its drawbacks.  Unlike electrophysiological studies, it is not a dynamic way of 
recording nociceptive responses of the neurons.  Indeed, stimulus intensity and duration, 
play key factors in showing Fos immunoreactivity (Bullitt et al., 1992; Lima and Avelino, 
1994).  In addition, not all neurons express the gene when activated (Dragunow and Faull, 
1989).  Even the ventroposterolateral nucleus of the thalamus, an area clearly established in 
nociception,  failed  to  elicit  Fos  immunoreactivity  after  the  application  of  noxious 
stimulation  (Bullitt,  1990).    More  recently,  activity  dependent  phosphorylation  of 
extracellular related kinases 1 and 2 (p-ERK1/2) has been shown to highlight nociceptive 
neurons within 5 minutes of noxious mechanical, thermal or chemical stimulation (Polgár 
et al., 2007), and this may well be better at demonstrating nociceptive neurons, though 
further studies will be needed to determine that.  
The LSN neurons project to spinal laminae I, II, V and VII (Jansen and Loewy, 1997) 
and a loop system may well exist for the processing of nociceptive information at this site, 
before projecting to higher brain centres that process nociceptive stimuli.  In addition, the 
LSN  neurons  form  a  continuous  column  underneath  the  pial  surface  and  some  of  the 
dendrites  pass  laterally  (Réthelyi,  2003)  and  some  almost  appose  the  pial  surface 
Bresnahan  et  al.  (1984).    Indeed,  on  close  inspection  of  Réthelyi’s  (2003)  electron 
micrographs, the dendrites actually do pass to the pial surface. That brings into question the  
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possibility that the LSN neurons may also be under the influence of components of the 
cerebrospinal fluid surrounding the spinal cord (Vigh et al., 2004) as well having a small 
role in nociception.   
In addition, SDH neurons that express the NK-1 receptor (more than 80% (Ding et al., 
1995; Marshall et al., 1996; Li et al., 1998; Todd et al., 2000; Spike et al., 2003)) activate 
descending pathways that control spinal excitability (Suzuki et al., 2002).  It may be that 
the descending pathways are activated by the ascending NK-1 neurons from the SDH and 
activates those descending paths (that project bilaterally), and could explain the bilateral 
expression of Fos in the LSN.   
Another potential source of LSN activation could be from lamina I neurons.  Grudt and 
Perl (2002) showed that some lamina I neurons had axon collaterals which entered the 
dorsolateral funiculus, in and around the region of the LSN.  It may be that, those lamina I 
neurons (also with thick axons that passed to the contralateral ventrolateral funiculus) are 
activated  by  primary  afferent  input  and  through  the  axon  collateral,  activate  the  LSN 
neurons.    Indeed,  neurons  in  the  lateral  dorsal  horn  have  also  been  shown  to  have 
commissural  axons  which  project  to  the  lateral  region  of  the  dorsal  horn  on  the 
contralateral  side  (Petkó  and  Antal,  2000),  and  could  also  activate  the  LSN  on  the 
contralateral  side  thus  again  explaining  the  bilateral  activation  of  the  LSN.  Figure  6.1 
summarises a potential circuit for the LSN, its role in nociceptive processing, and other 
influences on it.  
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Investigation 2:  
The hypotheses initially proposed (p26-27) suggested the following: 
a)   As SP is present in abundance in the LSN, the majority of LSN neurons are NK-1 
immunoreactive 
b)   If  a  majority  of  LSN  neurons  are  immunoreactive  for  the  NK-1  receptor,  only  a 
minority be immunoreactive for PKC-γ, which like the NK-1 receptor, has also been 
associated with nociceptive processing (Malmberg et al., 1997)  
c)    As NOS has been found to enhance the release of SP in the SDH (Garry et al., 1994; 
Aimar et al., 1998; Kamasaki et al., 1995), SP and NOS will be intimately related 
immunocytochemically in the LSN 
d)   If a close relationship exists between SP and NOS, as in the SDH, then the same will 
hold for the relationship of NOS and the target of SP, the NK-1 receptor in the LSN  
e)  As in the SDH, the NOS terminals in the LSN will be associated with inhibitory   
     GABAergic neurons 
From this it can be concluded that although the LSN is abundant in SP, the total number 
of NK-1 immunoreactive neurons there represented only approximately one-third of the 
entire population, with PKC-γ representing even less (at approximately 10%).  Also, SP 
and NOS immunoreactivity in the LSN were closely related, and the NOS preferentially 
targeted the cell bodies of NK-1 immunoreactive neurons, whereas SP was related to both 
the cell bodies and the dendritic tree of those neurons.  However, unlike in the SDH, the 
work presented previously shows that NOS in the LSN (as revealed by GAD) is not derived 
principally from GABAergic inhibitory neurons (nor that from excitatory  glutamatergic 
neurons).  Therefore, the exact source of NOS in the LSN is yet to be determined.  A 
possibility that could be used in the future is combining NOS immunoreactivity with the 
use  of  the  vesicular  GABA  transporter  (VGAT),  which  has  been  shown  to  localise  in  
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synaptic  vesicles  in  both  glycinergic  and  GABAergic  neurons  (Chaudry  et  al.,  1998).  
Indeed, they found that although the vast majority of nerve terminals that contained GABA 
or glycine co-localised with VGAT, there are subpopulations of terminals that were rich in 
GABA or glycine that were not immunoreactive for VGAT.  On the contrary, it may be 
that there are more GABAergic terminals in the LSN that have not been revealed with the 
antibodies used in this study, and may be revealed with VGAT. 
Whatever the source of NOS is in the LSN, the precise role of NO in the superficial 
dorsal horn has also been the subject of debate. There is abundant evidence to support the 
idea that NO has a role in pain but its precise role remains unclear. There are a variety of 
reasons for this, for example NO modulates nociception at spinal and supraspinal levels 
and NOS inhibitors have different effects depending upon whether they are administered 
systemically, intrathecally or spinally (Kitto et al., 1992; Meller et al. 1992; Yonehara et 
al., 1997; Osborne and Coderre, 1999; Hoheisel et al., 2005).  
Furthermore, in addition to nNOS, two other variants of NOS have been identified 
(the endothelial and inductable isoforms) and these may also have a role in nociceptive 
modulation (Ruscheweyh et al., 2006).  We have shown that NOS terminals in the LSN are 
preferentially associated with NK-1 neuronal cell bodies.  As discussed in the introduction, 
NO may enhance release of SP from spinal axon terminals (Garry et al., 1994; Aimar et al., 
1998) which has a well established role in transmission of nociceptive information.   NO 
was shown to regulate release of SP from rat spinal cord synaptosomes, but in contrast to 
the studies cited above, it was reported to attenuate release  (Kamisaki et al., 1995).  An 
alternative possibility is that NO may generate long term potentiation  (LTP) at nociceptive 
synapses, (Sandkühler, 2000) a phenomenon that occurs in lamina I projection cells but not 
in interneurons (Ruscheweyh et al., 2006). These findings provide a morphological basis 
for both of these possible modes of action of NO in the LSN.   A possible functional model  
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based on work within the CNS is demonstrated in Figure 6.2 and suggests how SP, NOS 
and NK-1 may be related to each other in the LSN. 
 
Investigation 3:   
The hypothesis initially proposed (p28) suggested the following: 
a)  If NK-1 neurons are abundant in the LSN, then many will be projection neurons and  
      target brain areas known to be involved in nociception 
 
Using retrograde injection techniques, this Investigation focussed on the projections of 
LSN neurons to areas of the brain traditionally associated with nociceptive processing, but 
also to the  globus pallidus and to the hypothalamus.   It shows that of all retrogradely 
labelled neurons in each of the three sets of experiments, many LSN neurons project to 
these sites, with a bilateral projection system existing to the CVLM, MDT, lateral and 
medial hypothalamus and also the lateral globus pallidus. 
Of  all  retrogradely  labelled  neurons  in  each  of  the  three  sets  of  experiments,  LSN 
neurons  constituted  proportionally:  25%  projecting  to  the  lateral  hypothalamus,  21% 
projecting to the medial hypothalamus, 12% projecting to both the CVLM and MDT, 15% 
projecting only to the CVLM, 7% projecting only to the MDT and 30% projecting to the 
lateral globus pallidus (although numbers were very low that were retrogradely labelled). 
Although the NK-1 receptor represent only approximately 30% of all neurons within 
the LSN (as discussed in Investigation 2), of all those LSN retrogradely labelled neurons, 
NK-1  receptor  immunoreactivity  represents:  80%  for  either  the  lateral  or  medial 
hypothalamic projections, more than 50% for either the CVLM and the MDT or just the 
CVLM projections, 25% for MDT projections, but none of the LSN projection neurons to 
the lateral globus pallidus.  Figure 6.3 presents a summary of the findings of these studies.  
191 
 
 
 
 
Although the LSN and the SDH share similar characteristics, they both possess very 
unique  properties,  suggesting  that  they  sub-serve  divergent  functions  that  are  probably 
complimentary.  There is a great deal of research into the roles and functions within the 
grey matter, including that of the SDH, though the precise role of the LSN has remained 
uncertain. 
This Investigation along with the previous work presented, shows that although the 
LSN has been implicated in nociception in the literature, the extent of its involvement in 
this process is less than previously thought.  Interestingly, approximately one-quarter of 
LSN  neurons  project  to  either  the  lateral  or  medial  hypothalamus,  areas  traditionally 
associated with autonomic and homeostatic processing, with many of them possessing the 
NK-1  receptor  associated  with  nociceptive  transmission  especially  in  the  SDH.  
Interestingly, LSN neurons have also been shown to project to the MDT (and also the 
CVLM)  which  projects  to  the  prefrontal  cortex.    It  could  be  postulated  that  the  LSN 
functions as an integrative nucleus for autonomic and homeostatic functions, and with the 
projections  to  the  MDT  (and  then  to  the  prefrontal  cortex),  could  be  involved  in  the 
motivational and affective components of autonomic function. 
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Figure 6.1.  A model of a possible mechanism of activation of the LSN.  LSN neurons 
could be activated by a number of means (see p159).  They could be activated by NK-1 
neurons in the SDH that activate descending fibres that originate from supraspinal nuclei (1); 
lamina  I  neurons  could  pass  to  the  dorsolateral  funiculus  via  their  axon  collaterals,  thus 
activating LSN neurons (2), or those neurons in the lateral part of the dorsal horn could 
project (via commissural axons) to the lateral region of the contralateral dorsal horn, and 
from there activate the contralateral LSN (3). 
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Figure  6.2.    Possible  interactions  and  relations  of  NOS  in  the  LSN.    The  close 
relationship  of  NOS  terminals  to  NK-1  neuronal  cell  bodies,  and  the  relation  of  SP 
terminals to the NK-1 neuron in the LSN could be activated as shown in the diagram.  
Glutamate that is released from SP containing presynaptic terminals, perhaps from lamina 
I neurons, will act on NMDA and AMPA receptors.  When the postsynaptic site (e.g. 
LSN NOS terminal) is depolarised, Ca
2+ enters, and via calmodulin (CaM), activation of 
NOS occurs (Bredt and Snyder, 1990).  The NO may then have some type of regulatory 
effect on the SP release that is targeting the NK-1 neuronal cell body (Investigation 2) in 
the LSN, including activation of guanylate cyclase in the SP/glutamate containing cell, 
and perhaps local astrocyte processes.  
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Figure  6.3.    Summary  diagram  representing  the  projection  targets  of  NK-1 
immunoreactive LSN neurons.  There is a bilateral projection from the LSN to each of the 
areas studied previously.  The thickness of the lines indicates how many NK-1 neurons in the 
LSN  project  to  each  of  the  brain  regions,  with  projections  to  the  lateral  and  medial 
hypothalamus (LH and MH respectively) being greater than projections to the CVLM and 
MDT and the lateral globus pallidus (GP).   
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